Processing 00000000.tx.1: Luteinizing Hormone, a Reproductive Regulator That Modulates the Processing of Amyloid- Precursor Protein and Amyloid- Deposition* Richard L. 

Phrase: "Luteinizing Hormone,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "a Reproductive Regulator"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0182953:REGULATOR [Medical Device]
   861   C1704734:Regulator [Medical Device]
   861   C1704735:Regulator [Conceptual Entity]

Phrase: "That"

Phrase: "Modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the Processing of Amyloid- Precursor Protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0033666:protein processing [Molecular Function]
   753   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "Amyloid- Deposition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011560:Amyloid deposition [Pathologic Function]
  1000   C1705760:Amyloid Deposition [Finding]
   861   C0333562:Deposition [Functional Concept]

Phrase: "* Richard L."
Processing 00000000.tx.2: Bowen,ab Giuseppe Verdile,bcd Tianbing Liu,e Albert F. 

Phrase: "Bowen,"

Phrase: "ab Giuseppe Verdile,"

Phrase: "bcd Tianbing Liu,"

Phrase: "e Albert F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.3: Parlow,f George Perry,g Mark A. 

Phrase: "Parlow,"

Phrase: "f George Perry,"

Phrase: "g Mark A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.4: Smith,g Ralph N. 

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "g Ralph N."
Processing 00000000.tx.5: Martins,cd and Craig S. 

Phrase: "Martins,"

Phrase: "cd"

Phrase: "and"

Phrase: "Craig S."
Processing 00000000.tx.6: Atwoodceghi From the aVoyager Pharmaceutical Corporation, Raleigh, North Carolina 27615, the cCentre for Aging and Alzheimer's Disease, School of Biomedical and Sports Science, Edith Cowan University, Joondalup, Western Australia 6027, Australia, the dDepartment of Psychiatry and Clinical Neurosciences, The University of Western Australia and The Sir James McCusker Alzheimer's Disease Research Unit, Hollywood Private Hospital, Perth, Western Australia 6009, Australia, the eDepartment of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin 53705, the fNational Hormone and Peptide Program, Harbor-UCLA Medical Center, Torrance, California 90509, the gInstitute of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, and the hDepartment of Medicine, University of Wisconsin, Madison, Wisconsin 53705 Received for publication, November 3, 2003 , and in revised form, February 8, 2004.  

Phrase: "Atwoodceghi From the aVoyager Pharmaceutical Corporation,"

Phrase: "Raleigh,"

Phrase: "North Carolina 27615,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0028407:North Carolina [Geographic Area]
   827   C1709269:North [Spatial Concept]

Phrase: "the cCentre for Aging"

Phrase: "and"

Phrase: "Alzheimer's Disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "School of Biomedical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0036375:School [Manufactured Object,Organization]

Phrase: "and"

Phrase: "Sports Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "Edith Cowan University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Joondalup,"

Phrase: "Western Australia 6027,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0043128:Western Australia [Geographic Area]
   827   C0004340:Australia [Geographic Area]
   827   C1705493:Western [Spatial Concept]
   755 E C0238711:AUSTRALIAN [Finding]

Phrase: "Australia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004340:Australia [Geographic Area]
   928 E C0238711:AUSTRALIAN [Finding]

Phrase: "the dDepartment of Psychiatry"

Phrase: "and"

Phrase: "Clinical Neurosciences,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027910:Neurosciences [Biomedical Occupation or Discipline]
   827 E C1552241:Neuroscience [Professional or Occupational Group]
   827 E C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "The University of Western Australia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0043128:Western Australia [Geographic Area]
   812   C0004340:Australia [Geographic Area]
   812   C0041740:University [Manufactured Object,Organization]
   812   C1705493:Western [Spatial Concept]
   741 E C0238711:AUSTRALIAN [Finding]

Phrase: "and"

Phrase: "The Sir James McCusker Alzheimer's Disease Research Unit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0439148:Unit [Quantitative Concept]
   795   C1519795:Unit [Quantitative Concept]
   795   C1704753:Unit [Manufactured Object]
   795   C1880519:Unit [Quantitative Concept]

Phrase: "Hollywood Private Hospital,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0033173:Private hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C1510665:Hospital [Qualitative Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "Perth,"

Phrase: "Western Australia 6009,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0043128:Western Australia [Geographic Area]
   827   C0004340:Australia [Geographic Area]
   827   C1705493:Western [Spatial Concept]
   755 E C0238711:AUSTRALIAN [Finding]

Phrase: "Australia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004340:Australia [Geographic Area]
   928 E C0238711:AUSTRALIAN [Finding]

Phrase: "the eDepartment of Pathology"

Phrase: "and"

Phrase: "Laboratory Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013227:Medicine, NOS [Pharmacologic Substance]
   861   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "University of Wisconsin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041740:University [Manufactured Object,Organization]
   827   C0043193:Wisconsin [Geographic Area]

Phrase: "Madison,"

Phrase: "Wisconsin 53705,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043193:Wisconsin [Geographic Area]

Phrase: "the fNational Hormone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "Peptide Program,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1709697:Program [Conceptual Entity]
   861   C2728259:Program [Pharmacologic Substance]
   861   C3484370:Program [Functional Concept]

Phrase: "Harbor-UCLA Medical Center,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   861   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   812   C0205099:Center [Spatial Concept]
   812   C0205476:Medical [Functional Concept]
   812   C0475311:Harbor [Manufactured Object]

Phrase: "Torrance,"

Phrase: "California 90509,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006754:California [Geographic Area]
   861   C3146274:California [Plant]

Phrase: "the gInstitute of Pathology,"

Phrase: "Case Western Reserve University,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0041740:University [Manufactured Object,Organization]
   812   C0868928:Case [Functional Concept]
   812   C1705493:Western [Spatial Concept]
   812   C1706255:CASE [Medical Device]
   812   C1706256:Case [Conceptual Entity]
   812   C2347957:Reserve [Activity]

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "Ohio 44106,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028905:Ohio [Geographic Area]

Phrase: "and"

Phrase: "the hDepartment of Medicine,"

Phrase: "University of Wisconsin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041740:University [Manufactured Object,Organization]
   827   C0043193:Wisconsin [Geographic Area]

Phrase: "Madison,"

Phrase: "Wisconsin 53705"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043193:Wisconsin [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "November 3,"

Phrase: "2003 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "February 8,"

Phrase: "2004."
Processing 00000000.tx.7: ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Hormonal changes associated with the dysregulation of the hypothalamic-pituitary-gonadal (HPG) axis following menopause/andropause have been implicated in the pathogenesis of Alzheimer's disease (AD). 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Hormonal changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1134488:hormonal changes [Finding]
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "associated with the dysregulation of the hypothalamic-pituitary-gonadal (HPG) axis"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   806   C0814030:Hypothalamic-pituitary-gonadal axis [Body Part, Organ, or Organ Component]
   782   C0597247:pituitary gonadal axis [Body System]
   777   C0678897:hypothalamic pituitary axis [Organ or Tissue Function]
   760   C0332281:Associated with [Qualitative Concept]
           Associated
   739   C0004457:Axis [Body Part, Organ, or Organ Component]
   739   C0018067:Gonadal [Body Part, Organ, or Organ Component]
   739   C0020663:Hypothalamic [Body Part, Organ, or Organ Component]
   739   C0032005:Pituitary, NOS [Body Part, Organ, or Organ Component]
   739   C0999597:Axis [Mammal]
   739   C1522496:Axis [Spatial Concept]
   706 E C0750490:Associate [Idea or Concept]
   706 E C1706221:Associate [Professional or Occupational Group]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "menopause/andropause"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0232984:Andropause [Finding]

Phrase: "have"

Phrase: "been"

Phrase: "implicated in the pathogenesis of Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0543483:pathogenesis [Functional Concept]
   748   C0699748:Pathogenesis [Pathologic Function]

Phrase: "(AD"

Phrase: ")."
Processing 00000000.tx.8: Experimental support for this has come from studies demonstrating an increase in amyloid- (A) deposition following ovariectomy/castration. 

Phrase: "Experimental support for this"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0183683:Support [Medical Device]
   770   C1521721:Support [Conceptual Entity]

Phrase: "has"

Phrase: "come from studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0947630:studies [Laboratory Procedure]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "demonstrating"

Phrase: "an increase in amyloid- (A) deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "ovariectomy/castration."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0007344:Castration [Therapeutic or Preventive Procedure]
   861   C0029189:Castration [Therapeutic or Preventive Procedure]
Processing 00000000.tx.9: Because sex steroids and gonadotropins are both part of the HPG feedback loop, any loss in sex steroids results in a proportionate increase in gonadotropins. 

Phrase: "Because"

Phrase: "sex steroids"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0009253:Sex [Organism Function]
   861   C0036864:Sex [Behavior]
   861   C0038317:Steroids [Steroid]
   861   C0079399:sex [Organism Attribute]
   861   C1314687:Sex [Finding]
   861   C1522384:sex [Organism Attribute]

Phrase: "and"

Phrase: "gonadotropins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0018061:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1522385:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   966 E C3536870:Gonadotropin [Pharmacologic Substance]

Phrase: "are"

Phrase: "both part of the HPG feedback loop,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C1292711:Part of [Spatial Concept]
   762   C1285101:Pituitary part [Body Part, Organ, or Organ Component]
   742   C0449719:Part [Spatial Concept]
   742   C1709471:Part [Quantitative Concept]

Phrase: "any loss in sex steroids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "results in a proportionate increase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205351:Proportionate [Qualitative Concept]
   760   C0442805:Increase [Functional Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "in gonadotropins."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0018061:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1522385:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   966 E C3536870:Gonadotropin [Pharmacologic Substance]
Processing 00000000.tx.10: To assess whether A generation was due to the loss of serum 17-estradiol or to the up-regulation of serum gonadotropins, we treated C57Bl/6J mice with the anti-gonadotropin leuprolide acetate, which suppresses both sex steroids and gonadotropins. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "whether"

Phrase: "A generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]

Phrase: "was due to the loss of serum 17-estradiol"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C0678226:Due to [Functional Concept]
           due
   762   C0474672:estradiol serum [Laboratory Procedure]
   742   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   742   C0043194:WAS [Disease or Syndrome]
   742   C0229671:Serum [Body Substance]
   742   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1421478:WAS [Gene or Genome]
   742   C1517945:Loss [Quantitative Concept]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]
   742   C3146286:Due [Idea or Concept]

Phrase: "or to the up-regulation of serum gonadotropins,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   744   C0018061:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0229671:Serum [Body Substance]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]
   744   C1522385:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]
   711 E C3536870:Gonadotropin [Pharmacologic Substance]

Phrase: "we"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "C57Bl/6J mice with the anti-gonadotropin leuprolide acetate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0025921:Mice, C57BL [Mammal]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]

Phrase: "which"

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "both sex steroids"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0009253:Sex [Organism Function]
   861   C0036864:Sex [Behavior]
   861   C0038317:Steroids [Steroid]
   861   C0079399:sex [Organism Attribute]
   861   C1314687:Sex [Finding]
   861   C1522384:sex [Organism Attribute]

Phrase: "and"

Phrase: "gonadotropins."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0018061:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1522385:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   966 E C3536870:Gonadotropin [Pharmacologic Substance]
Processing 00000000.tx.11: Leuprolide acetate treatment resulted in a 3.5-fold (p < 0.0001) and a 1.5-fold (p < 0.024) reduction in total brain A1-42 and A1-40 concentrations, respectively, after 8 weeks of treatment. 

Phrase: "Leuprolide acetate treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0700596:Leuprolide Acetate [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "resulted in a 3.5-fold"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0332462:Fold [Spatial Concept]
   753   C1880834:FOLD [Phenomenon or Process]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "(p < 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "a 1.5-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332462:Fold [Spatial Concept]
   812   C1880834:FOLD [Phenomenon or Process]

Phrase: "(p < 0.024"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "reduction in total brain A1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "A1-40 concentrations,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "respectively,"

Phrase: "after"

Phrase: "8 weeks of treatment."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439230:weeks [Temporal Concept]
   737 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.12: To further explore the role of gonadotropins in promoting amyloidogenesis, M17 neuroblastoma cells were treated with the gonadotropin luteinizing hormone (LH) at concentrations equivalent to early adulthood (10 mIU/ml) or post-menopause/andropause (30 mIU/ml). 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "explore"

Phrase: "the role of gonadotropins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in promoting amyloidogenesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706803:Amyloidogenesis [Cell or Molecular Dysfunction]

Phrase: "M17 neuroblastoma cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C0815000:neuroblastoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with the gonadotropin luteinizing hormone (LH)"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0018061:Gonadotrophin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0019932:Hormone [Hormone]
   753   C1522326:Treated [Functional Concept]
   753   C3536870:Gonadotropin [Pharmacologic Substance]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "at concentrations equivalent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205163:Equivalent [Qualitative Concept]
   861   C0439185:equivalent [Quantitative Concept]

Phrase: "to early adulthood"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0680085:early adulthood [Age Group]
   861   C0700597:Adulthood [Temporal Concept]

Phrase: "(10 mIU/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439457:mIU/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "or"

Phrase: "post-menopause/andropause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0232984:Andropause [Finding]
   734   C0206159:Post-Menopause [Organism Function]

Phrase: "(30 mIU/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439457:mIU/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.13: LH did not alter amyloid- precursor protein (APP) expression but did alter APP processing toward the amyloidogenic pathway as evidenced by increased secretion and insolubility of A, decreased APP secretion, and increased APP-C99 levels. 

Phrase: "LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter amyloid- precursor protein (APP) expression"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1171362:protein expression [Genetic Function]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   721   C0392747:Altered [Functional Concept]

Phrase: "but"

Phrase: "did"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "APP processing"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033666:protein processing [Molecular Function]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   804   C1709694:Processing [Activity]
   721   C0392747:Altered [Functional Concept]

Phrase: "toward the amyloidogenic pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "as"

Phrase: "evidenced by increased secretion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   737   C0332120:Evidence [Functional Concept]

Phrase: "and"

Phrase: "insolubility of A,"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "APP secretion,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1159339:Protein Secretion [Cell Function]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   721   C0392747:Altered [Functional Concept]

Phrase: "and"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "APP-C99 levels."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   861   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   861   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   839   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   822   C0428479:Protein level [Laboratory or Test Result]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0441889:Levels [Qualitative Concept]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1709634:Precursor [Idea or Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
   716   C0392747:Altered [Functional Concept]
Processing 00000000.tx.14: These results suggest the marked increases in serum LH following menopause/andropause as a physiologically relevant signal that could promote A secretion and deposition in the aging brain. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the marked increases in serum LH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0520970:Hormone increase [Laboratory or Test Result]
   748   C0442805:increases [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "menopause/andropause as a physiologically relevant signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0232984:Andropause [Finding]

Phrase: "that"

Phrase: "could"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "A secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "and"

Phrase: "deposition in the aging brain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.15: Suppression of the age-related increase in serum gonadotropins using anti-gonadotropin agents may represent a novel therapeutic strategy for AD.  

Phrase: "Suppression of the age-related increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0221103:Suppression [Pathologic Function]
   753   C0301625:Suppression [Organism Function]
   753   C0439181:% suppression [Quantitative Concept]
   753   C0728721:suppression [Mental Process]

Phrase: "in serum gonadotropins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0018061:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1522385:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827 E C3536870:Gonadotropin [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-gonadotropin agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0040616:anti-agents [Pharmacologic Substance]
   793   C0450442:Agent [Chemical Viewed Functionally]
   793   C1254351:Agent [Pharmacologic Substance]
   793   C1521826:Agent [Intellectual Product]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a novel therapeutic strategy for AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0679199:strategy [Mental Process]
Processing 00000000.tx.16: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Alzheimer's disease (AD)1 is a neurodegenerative disorder of the elderly that leads to progressive memory loss, impairments in behavior, language, visuo-spatial skills, and ultimately death. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)1"

Phrase: "is"

Phrase: "a neurodegenerative disorder of the elderly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0524851:Neurodegenerative Disorder [Disease or Syndrome]
   753   C0012634:Disorder [Disease or Syndrome]

Phrase: "that"

Phrase: "leads to progressive memory loss,"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   806   C0002622:Memory loss [Mental or Behavioral Dysfunction]
   806   C0751295:Memory Loss [Sign or Symptom]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0025260:Memory [Mental Process]
   760   C0181586:leads [Medical Device]
   760   C0205329:Progressive [Functional Concept]
   760   C0700327:memory [Finding]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1517945:Loss [Quantitative Concept]
   760   C1522538:Lead [Functional Concept]
   760   C1706377:Memory [Manufactured Object]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
   704 E C0679055:mnemonic [Mental Process]

Phrase: "impairments in behavior,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0684336:Impairments [Pathologic Function]
   790   C2598156:Impairments [Clinical Attribute]

Phrase: "language,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023008:Language [Language]

Phrase: "visuo-spatial skills,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678856:skills [Individual Behavior]

Phrase: "and"

Phrase: "ultimately death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011065:Death [Organism Function]
   861   C1306577:Death, NOS [Finding]
Processing 00000000.tx.17: The one or more underlying biochemical mechanisms leading to AD are unknown. 

Phrase: "The one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "underlying"

Phrase: "biochemical mechanisms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0678659:biochemical mechanisms [Molecular Function]
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "leading to AD"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0332152:Leading [Temporal Concept]
   790   C1522538:Leading [Functional Concept]
   756 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   756 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   756 E C2348269:Lead [Element, Ion, or Isotope]
   756 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "are"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.18: Genetic studies have shown that mutations in APP and the presenilin genes lead to early onset (65 years) AD, which accounts for 5% of all AD cases. 

Phrase: "Genetic studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C2827447:Genetic Study [Research Activity]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that mutations in"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0026882:Mutations [Genetic Function]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   729   C0392747:Altered [Functional Concept]

Phrase: "and"

Phrase: "the presenilin genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "lead to early onset"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1833334:Early-onset [Finding]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0332162:Onset [Qualitative Concept]
   770   C1279919:Early [Temporal Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(65 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "AD,"

Phrase: "which"

Phrase: "accounts for 5% of all AD cases."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   774   C0050718:AD 5 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   748   C1551359:account [Idea or Concept]
   748   C2741673:Account # [Clinical Attribute]
   748   C2981730:Account [Classification]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.19: The vast majority of these mutations promote the overproduction and deposition of amyloid- (A) (1-7), the major component of the extracellular amyloid plaques, in the hippocampus and frontal cortex (8, 9). 

Phrase: "The vast majority of these mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680220:majority [Social Behavior]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the overproduction"

Phrase: "and"

Phrase: "deposition of amyloid-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0011560:Amyloid deposition [Pathologic Function]
   858   C1705760:Amyloid Deposition [Finding]
   790   C0333562:Deposition [Functional Concept]

Phrase: "(A"

Phrase: ")"

Phrase: "(1-7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3541329:1-7 [Gene or Genome]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "the major component of the extracellular amyloid plaques,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0449432:Component [Manufactured Object]
   744   C1705248:Component [Conceptual Entity]

Phrase: "in the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "frontal cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0205123:Frontal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "(8,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.20: Amyloid deposition also is a hallmark of the late-onset or "sporadic" form of AD, which accounts for 95% of AD cases. 

Phrase: "Amyloid deposition also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0011560:Amyloid deposition [Pathologic Function]
   901   C1705760:Amyloid Deposition [Finding]
   827   C0333562:Deposition [Functional Concept]

Phrase: "is"

Phrase: "a hallmark of the late-onset or ""sporadic"" form"

Phrase: "of AD,"

Phrase: "which"

Phrase: "accounts for 95% of AD cases."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   753   C1551359:account [Idea or Concept]
   753   C2741673:Account # [Clinical Attribute]
   753   C2981730:Account [Classification]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.21: The primary factors responsible for A deposition and disease progression in late onset AD remain to be elucidated. 

Phrase: "The primary factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "responsible for A deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "disease progression in late onset AD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0242656:Disease Progression [Pathologic Function]
           progression
   790   C1947900:Disease progression NOS [Finding]
   753   C0449258:Progression [Functional Concept]

Phrase: "remain"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "elucidated."
Processing 00000000.tx.22: Aging, the strongest risk factor for late-onset AD, is associated with major changes in serum concentrations of all hormones that comprise the hypothalamic-pituitary-gonadal (HPG) axis, including declines in the serum concentrations of the sex steroids, 17-estradiol and testosterone. 

Phrase: "Aging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "the strongest risk factor for late-onset AD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0035648:Risk factor [Quantitative Concept]
   744   C0035647:Risk [Qualitative Concept]
   744   C1521761:Factor [Functional Concept]
   744   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "associated with major changes"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0205164:Major [Qualitative Concept]
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1705241:Change [Quantitative Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in serum concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C0683149:serum concentration [Quantitative Concept]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of all hormones"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019932:Hormones [Hormone]
   916 E C0458083:Hormonal [Qualitative Concept]

Phrase: "that"

Phrase: "comprise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "the hypothalamic-pituitary-gonadal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018067:Gonadal [Body Part, Organ, or Organ Component]

Phrase: "(HPG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018067:Gonadal [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "axis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0004457:Axis [Body Part, Organ, or Organ Component]
  1000   C0999597:Axis [Mammal]
  1000   C1522496:Axis [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "declines in the serum concentrations of the sex steroids,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   762   C0683149:concentrations serum [Quantitative Concept]
   742   C0009253:Sex [Organism Function]
   742   C0036864:Sex [Behavior]
   742   C0038317:Steroids [Steroid]
   742   C0079399:sex [Organism Attribute]
   742   C0086045:Concentrations [Mental Process]
   742   C0229671:Serum [Body Substance]
   742   C1314687:Sex [Finding]
   742   C1522384:sex [Organism Attribute]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]
   708 E C1446561:Concentration [Quantitative Concept]

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "testosterone."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0039601:Testosterone [Hormone,Pharmacologic Substance,Steroid]
   944 E C0113075:Depo-testosterone [Hormone,Pharmacologic Substance,Steroid]
Processing 00000000.tx.23: Such changes have been correlated with the prevalence of the disease (e.g. Refs. 10-14), and it has been shown that there is a decreased incidence (15) and delay in the onset (16) of AD among women on hormone replacement therapies following menopause (17). 

Phrase: "Such changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "correlated with the prevalence of the disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0012634:Disease [Disease or Syndrome]
   748   C0033105:Prevalence [Quantitative Concept]
   748   C0220900:prevalence [Quantitative Concept]
   748   C1707520:Correlated [Qualitative Concept]

Phrase: "("

Phrase: "e.g. Refs. 10-14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that there"

Phrase: "is"

Phrase: "a decreased incidence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0021149:Incidence [Quantitative Concept]
   861   C0220856:incidence [Functional Concept]
   789 E C1551358:incident [Idea or Concept]

Phrase: "(15"

Phrase: ")"

Phrase: "and"

Phrase: "delay in the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205421:Delay [Temporal Concept]

Phrase: "(16"

Phrase: ")"

Phrase: "of AD"

Phrase: "among women"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "on hormone replacement therapies"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0282402:Therapies, Hormone Replacement [Therapeutic or Preventive Procedure]
           hormone replacement
   913   C0279025:hormone therapies [Therapeutic or Preventive Procedure]
   867   C0279033:Replacement therapy [Therapeutic or Preventive Procedure]
   827   C0035139:Replacement [Therapeutic or Preventive Procedure]
   827   C0087111:therapies [Therapeutic or Preventive Procedure]
   827   C0559956:Replacement [Functional Concept]
   827   C1555302:Replacement [Idea or Concept]
   793 E C0039798:therapy [Functional Concept]
   793 E C1363945:Therapy [Finding]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "menopause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025320:Menopause [Physiologic Function]
  1000   C0567312:Menopause [Finding]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.24: There also is biochemical evidence suggesting that sex steroids modulate A deposition in animal models (18, 19). 

Phrase: "There also"

Phrase: "is"

Phrase: "biochemical evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that sex steroids"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0009253:Sex [Organism Function]
   861   C0036864:Sex [Behavior]
   861   C0038317:Steroids [Steroid]
   861   C0079399:sex [Organism Attribute]
   861   C1314687:Sex [Finding]
   861   C1522384:sex [Organism Attribute]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "A deposition in animal models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0011560:Amyloid deposition [Pathologic Function]
   806   C1705760:Amyloid Deposition [Finding]
   760   C0333562:Deposition [Functional Concept]

Phrase: "(18,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.25: Taken together, these studies have driven the idea that the loss of sex steroids following menopause/andropause is primarily responsible for the cognitive and neuropathological changes observed in the disease. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "the idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "that"

Phrase: "the loss of sex steroids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "menopause/andropause"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0232984:Andropause [Finding]

Phrase: "is"

Phrase: "primarily responsible for the cognitive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "neuropathological changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "observed in the disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0012634:Disease [Disease or Syndrome]
   770   C1441672:Observed [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.26: Sex steroid production is, however, under the control of complex feedback loops within the HPG axis, such that during menopause the loss of negative feedback by estrogen on gonadotropin production (20) results in 3-4-fold and 4-18-fold increases in the concentrations of serum luteinizing hormone (LH) and follicle-stimulating hormone (FSH), respectively (21). 

Phrase: "Sex steroid production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033268:production [Occupational Activity]

Phrase: "is"

Phrase: ","

Phrase: "however,"

Phrase: "under the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of complex feedback"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015744:Feedback [Phenomenon or Process]
   861   C2911691:Feedback [Mental Process]

Phrase: "loops within the HPG axis,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   853   C0814030:Hypothalamic-pituitary-gonadal axis [Body Part, Organ, or Organ Component]
   814   C0597247:pituitary gonadal axis [Body System]
   804   C0678897:hypothalamic pituitary axis [Organ or Tissue Function]
   748   C0004457:Axis [Body Part, Organ, or Organ Component]
   748   C0018067:Gonadal [Body Part, Organ, or Organ Component]
   748   C0020663:Hypothalamic [Body Part, Organ, or Organ Component]
   748   C0032005:Pituitary, NOS [Body Part, Organ, or Organ Component]
   748   C0181687:loops [Medical Device]
   748   C0419518:Loop [Medical Device]
   748   C0445022:Loop [Spatial Concept]
   748   C0999597:Axis [Mammal]
   748   C1522496:Axis [Spatial Concept]

Phrase: "such"

Phrase: "that during menopause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0025320:Menopause [Physiologic Function]
   790   C0567312:Menopause [Finding]

Phrase: "the loss of negative feedback"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "by estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "on gonadotropin production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "(20"

Phrase: ")"

Phrase: "results in 3-4-fold"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0332462:Fold [Spatial Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C1880834:FOLD [Phenomenon or Process]
   760   C2825142:Result [Finding]

Phrase: "and"

Phrase: "4-18-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "increases in the concentrations of serum luteinizing hormone"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   770   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   767   C0520970:Hormone increase [Laboratory or Test Result]
   767   C0683149:concentrations serum [Quantitative Concept]
   751   C0151680:LUTEINIZING HORMONE INCREASED [Finding]
   744   C0019932:Hormone [Hormone]
   744   C0086045:Concentrations [Mental Process]
   744   C0229671:Serum [Body Substance]
   744   C0442805:Increase [Functional Concept]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]
   711 E C1446561:Concentration [Quantitative Concept]

Phrase: "(LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "follicle-stimulating hormone (FSH),"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0733758:Follicle Stimulating Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0018120:Follicle [Body Part, Organ, or Organ Component]
   827   C0019932:Hormone [Hormone]
   827   C1571705:Follicle [Body Part, Organ, or Organ Component]
   827   C1948023:Stimulating [Natural Phenomenon or Process]
   755 E C0439682:Follicular [Qualitative Concept]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: "respectively"

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.27: Likewise, during andropause, men experience increases of more than 2- and 3-fold in LH and FSH, respectively (22). 

Phrase: "Likewise,"

Phrase: "during andropause,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232984:Andropause [Finding]

Phrase: "men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]

Phrase: "experience"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237607:experience [Mental Process]
  1000   C0596545:Experience [Mental Process]

Phrase: "increases of more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0442805:increases [Functional Concept]

Phrase: "than 2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "3-fold in LH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332462:Fold [Spatial Concept]
   760   C1880834:FOLD [Phenomenon or Process]

Phrase: "and"

Phrase: "FSH,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0733758:Follicle Stimulating Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0018120:Follicle [Body Part, Organ, or Organ Component]
   827   C0019932:Hormone [Hormone]
   827   C1571705:Follicle [Body Part, Organ, or Organ Component]
   827   C1948023:Stimulating [Natural Phenomenon or Process]
   755 E C0439682:Follicular [Qualitative Concept]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: "respectively"

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.28: Thus, the neurological and biochemical changes previously ascribed to sex steroids could just as easily be explained by the large increases in the circulating concentrations of LH and/or FSH or other hormones of the HPG axis that are dysregulated by menopause/andropause. 

Phrase: "Thus,"

Phrase: "the neurological"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205494:Neurological [Qualitative Concept]
  1000   C2707261:Neurological [Clinical Attribute]

Phrase: "and"

Phrase: "biochemical changes previously"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]

Phrase: "ascribed to sex steroids"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0009253:Sex [Organism Function]
   770   C0036864:Sex [Behavior]
   770   C0038317:Steroids [Steroid]
   770   C0079399:sex [Organism Attribute]
   770   C1314687:Sex [Finding]
   770   C1522384:sex [Organism Attribute]

Phrase: "could"

Phrase: "just as easily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332219:Easily [Qualitative Concept]

Phrase: "be"

Phrase: "explained by the large increases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0442805:increases [Functional Concept]
   760   C0549177:Large [Quantitative Concept]

Phrase: "in the circulating concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "and/or"

Phrase: "FSH"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0733758:Follicle Stimulating Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0018120:Follicle [Body Part, Organ, or Organ Component]
   827   C0019932:Hormone [Hormone]
   827   C1571705:Follicle [Body Part, Organ, or Organ Component]
   827   C1948023:Stimulating [Natural Phenomenon or Process]
   755 E C0439682:Follicular [Qualitative Concept]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: "or"

Phrase: "other hormones of the HPG axis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   776   C1260930:Hypothalamic/pituitary hormone [Hormone]
   767   C0020656:Hypothalamic Hormones [Amino Acid, Peptide, or Protein,Hormone]
   767   C0032015:Pituitary Hormones [Amino Acid, Peptide, or Protein,Hormone]
   767   C0301819:Gonadal Hormones [Hormone]
   744   C0019932:Hormones [Hormone]

Phrase: "that"

Phrase: "are"

Phrase: "dysregulated by menopause/andropause."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025320:Menopause [Physiologic Function]
   770   C0232984:Andropause [Finding]
   770   C0567312:Menopause [Finding]
Processing 00000000.tx.29: Evidence for a role of gonadotropins in the disease process is indicated by the 2-fold increase in the concentration of circulating gonadotropins in individuals with AD, above that of the already elevated concentrations of serum gonadotropins in age-matched control individuals (13, 23). 

Phrase: "Evidence for a role of gonadotropins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in the disease process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "is"

Phrase: "indicated by the 2-fold increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0332462:Fold [Spatial Concept]
   753   C0442805:Increase [Functional Concept]
   753   C1444656:Indicated [Finding]
   753   C1880834:FOLD [Phenomenon or Process]

Phrase: "in the concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of circulating gonadotropins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0018061:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1522385:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827 E C3536870:Gonadotropin [Pharmacologic Substance]

Phrase: "in individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "with AD,"

Phrase: "above that"

Phrase: "of the already elevated concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of serum gonadotropins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0018061:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1522385:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827 E C3536870:Gonadotropin [Pharmacologic Substance]

Phrase: "in age-matched control individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0027361:Individual [Population Group]
   779   C0237401:Individual [Human]

Phrase: "(13,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.30: Further support for a role of LH in AD is given by the findings that the highest density of LH receptors in the brain is found within the hippocampus (24-26), that LH crosses the blood-brain barrier (27), and that LH accumulates intracellularly in the pyramidal neurons of AD compared with age-matched control brains (28). 

Phrase: "Further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "support for a role of LH"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   778   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0019932:Hormone [Hormone]
   748   C0035820:Role [Social Behavior]
   748   C0183683:Support [Medical Device]
   748   C1521721:Support [Conceptual Entity]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in AD"

Phrase: "is"

Phrase: "given by the findings"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   770   C1442162:GIVEN [Conceptual Entity]
   770   C1550718:given [Idea or Concept]
   770   C2607943:findings [Functional Concept]
   770   C2926606:Findings [Clinical Attribute]
   770   C3244317:given [Intellectual Product]
   770   C3539655:Findings [Intellectual Product]
   737 E C0037088:Finding [Sign or Symptom]
   737 E C0243095:Finding [Finding]
   737 E C1947971:Give [Functional Concept]
   737 E C2825141:Finding [Finding]

Phrase: "that"

Phrase: "the highest density of LH receptors"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   757   C0599283:receptor density [Genetic Function]
   748   C0178587:density [Quantitative Concept]
   748   C1522410:Highest [Qualitative Concept]
   714 E C0205250:High [Qualitative Concept]
   714 E C1299351:High [Qualitative Concept]
   714 E C2700149:HIGH [Intellectual Product]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "found within the hippocampus"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   770   C0150312:Found [Quantitative Concept]
   770   C0949582:Hippocampus [Fish]
   770   C1029104:Hippocampus [Fish]
   770   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
   737 E C0243095:Find [Finding]

Phrase: "(24-26"

Phrase: ")"

Phrase: ","

Phrase: "that LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "crosses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828360:Cross [Conceptual Entity]

Phrase: "the blood-brain barrier"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
  1000   C1305865:Blood-brain barrier [Organ or Tissue Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0229664:Blood [Body Substance]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1706912:BARRIER [Medical Device]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "that LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "accumulates"

Phrase: "intracellularly in the pyramidal neurons of AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0027882:Neurons [Cell]

Phrase: "compared with age-matched control brains"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   783   C0596948:brains control [Mental Process]
   753   C0001779:Age [Organism Attribute]
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   753   C0150103:matched [Research Activity]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1707455:Compared [Activity]
   753   C1708943:Matched [Qualitative Concept]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.31: These findings have led us to investigate whether the expression and processing of APP, a molecular pathway relevant to AD neuropathology, also is regulated by gonadotropins.  

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "have"

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "processing of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1709694:Processing [Activity]

Phrase: "APP,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   729   C0392747:Altered [Functional Concept]

Phrase: "a molecular pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1704259:molecular pathway [Molecular Function]
           Pathway
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "relevant to AD neuropathology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2347946:Relevant [Qualitative Concept]

Phrase: "also"

Phrase: "is"

Phrase: "regulated by gonadotropins."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0018061:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   790   C1522385:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   756 E C3536870:Gonadotropin [Pharmacologic Substance]
Processing 00000000.tx.32: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  AntibodiesThe human-specific PS1 monoclonal antibody, NT1, directed against residues 41-49 of PS1 and the APP monoclonal antibody C1/1.6, directed against the last 20 residues of APP, have been described previously (29, 30). 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "AntibodiesThe human-specific PS1 monoclonal antibody,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   799   C0746619:monoclonal [Finding]

Phrase: "NT1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]

Phrase: "directed against residues 41-49 of PS1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1418985:PS1 [Gene or Genome]
   748   C2986918:PS1 [Gene or Genome]
   714   C0439851:Direct [Qualitative Concept]
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]
   714   C1947931:Direct [Qualitative Concept]

Phrase: "and"

Phrase: "the"

Phrase: "APP monoclonal antibody C1/1.6,"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   827   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   827   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   817   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   817   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   807   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   807   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   807   C1317659:Protein.monoclonal [Laboratory or Test Result]
   791   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   791   C0011560:Amyloid [Pathologic Function]
   791   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0746619:monoclonal [Finding]
   791   C1709634:Precursor [Idea or Concept]
   708   C0392747:Altered [Functional Concept]

Phrase: "directed against the last 20 residues of"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   714   C0439851:Direct [Qualitative Concept]
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]
   714   C1947931:Direct [Qualitative Concept]

Phrase: "APP,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   729   C0392747:Altered [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(29,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.33: Antibody WO2, raised against amino acid residues 5-8 (31) of the A domain of APP, was kindly provided by Prof. 

Phrase: "Antibody WO2,"

Phrase: "raised against amino acid residues 5-8"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C2917660:Amino Acid [Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0442818:Raised [Quantitative Concept]
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "of the A domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "of"

Phrase: "APP,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   729   C0392747:Altered [Functional Concept]

Phrase: "was"

Phrase: "kindly"

Phrase: "provided by Prof."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0599518:Prof. [Professional or Occupational Group]
   790   C1999230:Provided [Activity]
Processing 00000000.tx.34: C. 

Phrase: "C."
Processing 00000000.tx.35: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.36: Masters (University of Melbourne, Victoria, Australia). 

Phrase: "Masters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "(University of Melbourne,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Victoria,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042645:Victoria [Geographic Area]
  1000   C0997115:Victoria [Plant]

Phrase: "Australia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004340:Australia [Geographic Area]
   928 E C0238711:AUSTRALIAN [Finding]

Phrase: ")."
Processing 00000000.tx.37: Antibody 6E10 (amino acid residues 1-17 of A) was from Senetek (Maryland Heights, MO). 

Phrase: "Antibody 6E10"

Phrase: "(amino acid residues 1-17 of A"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C2917660:Amino Acid [Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: ")"

Phrase: "was from Senetek"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]

Phrase: "(Maryland Heights,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0489786:heights [Organism Attribute]
   777 E C0205250:High [Qualitative Concept]
   777 E C1299351:High [Qualitative Concept]
   777 E C1522410:Highest [Qualitative Concept]
   777 E C2700149:HIGH [Intellectual Product]

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.38: Rabbit antisera R208 (specific for A40) was kindly provided by Prof. 

Phrase: "Rabbit antisera R208"

Phrase: "(specific for A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "kindly"

Phrase: "provided by Prof."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0599518:Prof. [Professional or Occupational Group]
   790   C1999230:Provided [Activity]
Processing 00000000.tx.39: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.40: D. 

Phrase: "D."
Processing 00000000.tx.41: Mehta (Institute for Basic Research in Developmental Disabilities, New York, NY). 

Phrase: "Mehta"

Phrase: "(Institute for Basic Research"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0035172:Research Institute [Organization]
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "in Developmental Disabilities,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0008073:Developmental Disabilities [Mental or Behavioral Dysfunction]
  1000   C1552527:Developmental Disabilities [Health Care Related Organization,Manufactured Object]
   861   C0231170:Disabilities [Finding]
   861   C0458003:Developmental [Qualitative Concept]
   861   C0678723:Developmental [Organism Function]
   789 E C0243107:development [Physiologic Function]
   789 E C1527148:Development [Functional Concept]
   777 E C0018576:Disabled [Patient or Disabled Group]
   777 E C1880351:Disabled [Qualitative Concept]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.42: Rabbit anti-rat LH receptor polyclonal antibodies (raised against the N-terminal peptide sequence (15-38) of the rat LH/CG receptor) were kindly provided by Dr. 

Phrase: "Rabbit anti-rat LH receptor polyclonal antibodies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   878   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   806   C0034805:receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   793   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "raised against the N-terminal peptide sequence"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0920679:peptide sequence [Amino Acid Sequence]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C0205088:Terminal [Temporal Concept]
   748   C0442818:Raised [Quantitative Concept]
   748   C1519249:Sequence [Functional Concept]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]

Phrase: "(15-38"

Phrase: ")"

Phrase: "of the rat LH/CG receptor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   888   C0034823:Luteinizing Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   888   C1416843:LUTEINIZING HORMONE RECEPTOR [Gene or Genome]
   853   C0019929:Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   853   C1367453:HORMONE RECEPTOR [Gene or Genome]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: "were"

Phrase: "kindly"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.43: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.44: C. 

Phrase: "C."
Processing 00000000.tx.45: Roche (Mayo Clinic, Rochester, MN). 

Phrase: "Roche"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: "(Mayo Clinic,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   861   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   789 E C0205210:Clinical [Qualitative Concept]

Phrase: "Rochester,"

Phrase: "MN"

Phrase: ")."
Processing 00000000.tx.46: Anti-human LH receptor monoclonal antibody 3B5 was kindly provided by Dr. 

Phrase: "Anti-human LH receptor monoclonal antibody 3B5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "kindly"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.47: J. 

Phrase: "J."
Processing 00000000.tx.48: Wimalasena (The University of Tennessee, Knoxville, TN). 

Phrase: "Wimalasena"

Phrase: "("

Phrase: "The University of Tennessee,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0039514:Tennessee [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Knoxville,"

Phrase: "TN"

Phrase: ")."
Processing 00000000.tx.49: Horseradish peroxidase linked goat anti-mouse and goat anti-rabbit IgG were from Amersham Biosciences (Buckinghamshire, UK). 

Phrase: "Horseradish peroxidase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   861   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0330510:Horseradish [Food]
   861   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   861   C1110641:Horseradish [Plant]
   861   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "linked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "goat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018019:goat [Mammal]
  1000   C1265549:goat [Mammal]
  1000   C1510458:Goat [Mammal]

Phrase: "anti-mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "goat anti-rabbit IgG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0034493:Rabbit [Mammal]

Phrase: "were from Amersham Biosciences"

Phrase: "(Buckinghamshire,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454842:Buckinghamshire [Geographic Area]

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.50: RadioimmunoassayPooled fetal calf serum (FCS) (from HyClone, Logan, UT) was analyzed for LH, FSH, and prolactin by radioimmunoassay using reagents from The National Hormone and Peptide Program, NIDDK, National Institutes of Health. 

Phrase: "RadioimmunoassayPooled fetal calf serum (FCS)"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: "("

Phrase: "from HyClone,"

Phrase: "Logan,"

Phrase: "UT)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042124:UT [Geographic Area]

Phrase: "was"

Phrase: "analyzed for LH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   833   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0019932:Hormone [Hormone]
   770   C0936012:Analyzed [Research Activity]

Phrase: "FSH,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0733758:Follicle Stimulating Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0018120:Follicle [Body Part, Organ, or Organ Component]
   827   C0019932:Hormone [Hormone]
   827   C1571705:Follicle [Body Part, Organ, or Organ Component]
   827   C1948023:Stimulating [Natural Phenomenon or Process]
   755 E C0439682:Follicular [Qualitative Concept]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "prolactin by radioimmunoassay"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0033371:Prolactin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1744644:prolactin [Molecular Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "reagents from The National Hormone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "Peptide Program,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1709697:Program [Conceptual Entity]
   861   C2728259:Program [Pharmacologic Substance]
   861   C3484370:Program [Functional Concept]

Phrase: "NIDDK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1513898:NIDDK [Health Care Related Organization]

Phrase: "National Institutes of Health."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]
Processing 00000000.tx.51: Table I summarizes the concentration ranges of pituitary hormones in FCS. 

Phrase: "Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "summarizes"

Phrase: "the concentration ranges of pituitary hormones"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]
   753   C1514721:*Ranges [Quantitative Concept]
   719 E C2348147:Range [Quantitative Concept]
   719 E C3542016:Range [Intellectual Product]

Phrase: "in FCS."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0230445:Calf [Body Location or Region]
   827   C0521457:Fetal [Functional Concept]
   827   C1305418:Calf [Body Part, Organ, or Organ Component]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   771 E C0626053:sural [Pharmacologic Substance]
Processing 00000000.tx.52: The concentration of bovine LH in media containing 0.5% FCS was 80-fold lower than that of the lowest concentration (1 mIU/ml or 0.25 ng/ml) of human LH added to media. 

Phrase: "The concentration of bovine LH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "in media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.5% FCS"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   804   C0015965:Fetal [Embryonic Structure]
   804   C0229671:Serum [Body Substance]
   804   C0230445:Calf [Body Location or Region]
   804   C0521457:Fetal [Functional Concept]
   804   C1305418:Calf [Body Part, Organ, or Organ Component]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]
   748 E C0626053:sural [Pharmacologic Substance]

Phrase: "was"

Phrase: "80-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "lower than that of the lowest concentration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0441994:Lower [Spatial Concept]
   748   C1548802:Lower [Body Location or Region]
   748   C2003888:Lower [Activity]

Phrase: "(1 mIU/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439457:mIU/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "or"

Phrase: "0.25 ng/ml) of human LH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439275:ng/mL [Quantitative Concept]
   744   C0439526:/mL [Quantitative Concept]

Phrase: "added to media."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0009458:Media [Intellectual Product]
   790   C0162867:Media [Tissue]
   790   C1254021:Media [Tissue]
   790   C1524062:Added [Functional Concept]
   756 E C0439536:Medium [Quantitative Concept]
   756 E C1705217:Medium [Substance]
   756 E C1883712:Add [Functional Concept]
   756 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.53: View this table: [in this window] [in a new window]  TABLE I Concentration of pituitary hormones in fetal calf serum  Cell CultureThe M17 human neuroblastoma cell line was maintained in Opti-MEM media supplemented with 5% (v/v) FCS, 2 mM L-glutamine, 10 mM D-glucose, 50 IU/ml penicillin, 50 g/ml streptomycin, and 0.7 mM -mercaptoethanol. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE I Concentration of pituitary hormones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "in fetal calf serum  Cell CultureThe M17 human neuroblastoma cell line"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   857   C0007600:Cell Line [Cell]
   790   C0027819:Neuroblastoma [Neoplastic Process]
   790   C0205132:Line [Spatial Concept]
   790   C0700095:neuroblastoma [Neoplastic Process]
   790   C1550648:Line [Substance]
   790   C1552960:Line [Quantitative Concept]
   790   C3540583:Neuroblastoma [Intellectual Product]

Phrase: "was"

Phrase: "maintained in Opti-MEM media"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0009458:Media [Intellectual Product]
   760   C0162867:Media [Tissue]
   760   C1254021:Media [Tissue]
   760   C1314677:Maintained [Functional Concept]
   726 E C0024501:Maintain [Activity]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "supplemented with 5%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0242295:Supplement [Food]
   756   C1947943:Supplement [Intellectual Product]
   756   C2348609:Supplement [Functional Concept]

Phrase: "(v/v) FCS,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   804   C0015965:Fetal [Embryonic Structure]
   804   C0229671:Serum [Body Substance]
   804   C0230445:Calf [Body Location or Region]
   804   C0521457:Fetal [Functional Concept]
   804   C1305418:Calf [Body Part, Organ, or Organ Component]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]
   748 E C0626053:sural [Pharmacologic Substance]

Phrase: "2 mM L-glutamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "10 mM"

Phrase: "D-"

Phrase: "glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "50 IU/ml penicillin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030842:Penicillin [Antibiotic,Organic Chemical]
   812   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "50 g/ml streptomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "and"

Phrase: "0.7 mM -mercaptoethanol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0025402:Mercaptoethanol [Organic Chemical]
Processing 00000000.tx.54: All cells were cultured in a humidified atmosphere containing 5% CO2 in air, at 37 C. 

Phrase: "All cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured in a humidified atmosphere"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0004178:Atmosphere [Natural Phenomenon or Process]
   760   C0678214:atmosphere [Quantitative Concept]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5% CO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "in air,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0001861:Air [Substance]
   861   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   777 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "at 37 C."
Processing 00000000.tx.55: Cells were plated at a density of 1.0 x 106 cells/ml 1 day prior to experiments in Opti-MEM media containing dialyzed 0.5% FCS (to remove endogenous sex steroids and to minimize the effects of endogenous gonadotropins). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated at a density"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0178587:density [Quantitative Concept]
   737   C0005971:Plate [Medical Device]
   737   C1139930:plate [Medical Device]
   737   C3537155:Plate [Manufactured Object]

Phrase: "of 1.0 x 106 cells/ml 1 day"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   892   C1442449:1 Day [Temporal Concept]
   822   C0439446:mL/day [Quantitative Concept]
   793   C0332173:/day [Temporal Concept]
   793   C0439228:day [Temporal Concept]
   793   C0439505:/day [Temporal Concept]

Phrase: "prior to experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "in Opti-MEM media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0009458:Media [Intellectual Product]
   827   C0162867:Media [Tissue]
   827   C1254021:Media [Tissue]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "dialyzed"

Phrase: "0.5% FCS"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   804   C0015965:Fetal [Embryonic Structure]
   804   C0229671:Serum [Body Substance]
   804   C0230445:Calf [Body Location or Region]
   804   C0521457:Fetal [Functional Concept]
   804   C1305418:Calf [Body Part, Organ, or Organ Component]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]
   748 E C0626053:sural [Pharmacologic Substance]

Phrase: "(to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "endogenous sex steroids"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C0815055:endogenous steroids [Steroid]
   827   C0009253:Sex [Organism Function]
   827   C0036864:Sex [Behavior]
   827   C0038317:Steroids [Steroid]
   827   C0079399:sex [Organism Attribute]
   827   C1314687:Sex [Finding]
   827   C1522384:sex [Organism Attribute]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "minimize"

Phrase: "the effects of endogenous gonadotropins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.56: The next day, M17 cells were treated with human LH (0-30 mIU/ml; National Hormone and Peptide Program, Harbor-UCLA, Torrance, CA) or 17-estradiol (0-100 nM) at 37 C for various time periods as indicated in the results section. 

Phrase: "The next day,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "M17 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with human LH"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   806   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0019932:Hormone [Hormone]
   760   C0086418:Human [Human]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "(0-30 mIU/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439457:mIU/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "; National Hormone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "Peptide Program,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1709697:Program [Conceptual Entity]
   861   C2728259:Program [Pharmacologic Substance]
   861   C3484370:Program [Functional Concept]

Phrase: "Harbor-UCLA,"

Phrase: "Torrance,"

Phrase: "CA)"

Phrase: "or"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(0-100 nM) at 37 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0312860:NM [Cell Function]

Phrase: "for various time periods"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   901   C0439582:Time periods [Temporal Concept]
   873 E C0585019:Temporal periods [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   793   C0439531:/period [Temporal Concept]
   793   C1948053:Period [Temporal Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C0332182:Periodic [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]
   743 E C1706381:PERIODIC [Intellectual Product]
   721 E C0031084:Periodicities [Temporal Concept]

Phrase: "as"

Phrase: "indicated in the results"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1444656:Indicated [Finding]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "section."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205155:Section [Spatial Concept]
  1000   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
  1000   C1522472:Section [Substance]
  1000   C1552923:Section [Quantitative Concept]
  1000   C1705191:Section [Physical Object]
Processing 00000000.tx.57: Medium was changed with fresh medium containing the appropriate hormone concentration every 2 days. 

Phrase: "Medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "changed with fresh medium"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0009458:Medium [Intellectual Product]
   770   C0392747:Changed [Functional Concept]
   770   C0439536:Medium [Quantitative Concept]
   770   C0443172:Changed [Quantitative Concept]
   770   C0443224:Fresh [Qualitative Concept]
   770   C1705217:Medium [Substance]
   770   C2827486:Fresh [Body Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the appropriate hormone concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "every 2 days."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442455:2 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.58: Cell Lysis and Western ImmunoblottingFollowing incubation with LH the M17 cells were scraped in ice-cold PBS using a rubber policeman and centrifuged at 200 x g for 10 min to obtain a cell pellet. 

Phrase: "Cell Lysis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0024348:Lysis [Pathologic Function]
   861   C1536403:lysis [Cell Function]
   789 E C0439680:Lytic [Qualitative Concept]

Phrase: "and"

Phrase: "Western ImmunoblottingFollowing incubation with LH"

Phrase: "the M17 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "scraped in ice-cold PBS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0456963:Ice cold [Qualitative Concept]
   760   C0009264:Cold [Natural Phenomenon or Process]
   760   C0009443:Cold [Disease or Syndrome]
   760   C0020746:Ice [Inorganic Chemical]
   760   C0184933:scraped [Therapeutic or Preventive Procedure]
   760   C0234192:Cold [Physiologic Function]
   760   C0444082:scraped [Body Substance]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a rubber policeman"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086825:Policeman [Professional or Occupational Group]

Phrase: "and"

Phrase: "centrifuged at 200 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 10 min to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0456692:/10 min [Temporal Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "a cell pellet."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441436:Pellet [Manufactured Object]
   827   C0993610:Pellet [Biomedical or Dental Material]
   827   C1998480:Pellet [Quantitative Concept]
Processing 00000000.tx.59: The pellet was washed with ice-cold PBS prior to lysing the cells with lysis buffer (50 mM Tris-HCl, pH 7.6, containing 150 mM NaCl, 2 mM EDTA, 1% Nonidet P-40, 5 g/ml leupeptin, 5 g/ml aprotinin, and 0.1 mM phenylmethylsulfonyl fluoride). 

Phrase: "The pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "washed with ice-cold PBS"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0456963:Ice cold [Qualitative Concept]
   760   C0009264:Cold [Natural Phenomenon or Process]
   760   C0009443:Cold [Disease or Syndrome]
   760   C0020746:Ice [Inorganic Chemical]
   760   C0234192:Cold [Physiologic Function]
   760   C1548982:Washed [Idea or Concept]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]
   726 E C0441648:Wash [Activity]

Phrase: "prior to lysing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysing [Pathologic Function]

Phrase: "the cells with lysis buffer"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:THE CELL [Cell]
           Cells
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(50 mM Tris-HCl,"

Phrase: "pH 7.6,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "2 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: "5 g/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "5 g/ml aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.1 mM phenylmethylsulfonyl fluoride"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   804   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.60: Total protein (25 g) was resuspended in sample buffer (70 mM Tris-HCl, pH 6.8, containing 3.2% (w/v) SDS, 0.4 mM glycine, 6 M urea, 0.1 M dithiothreitol, and 0.01% (w/v) phenol red) and separated using polyacrylamide gel electrophoresis. 

Phrase: "Total protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0555903:Total protein [Laboratory Procedure]
  1000   C1261360:total protein [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "(25 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "resuspended in sample buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0370003:Sample [Substance]
   770   C2347026:Sample [Conceptual Entity]

Phrase: "(70 mM Tris-HCl,"

Phrase: "pH 6.8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "3.2%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "SDS,"

Phrase: "0.4 mM glycine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0522461:Glycine [Plant]

Phrase: "6 M urea,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   771 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: "0.1 M dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.01%"

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "phenol red"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0031430:Phenol Red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   861   C0031428:phenol [Organic Chemical,Pharmacologic Substance]
   861   C0070570:phenol [Organic Chemical,Pharmacologic Substance]
   861   C0332575:Red [Finding]
   861   C1260956:Red [Qualitative Concept]
   789 E C0359916:phenolic [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "separated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086972:Separated [Finding]
  1000   C0443299:separated [Spatial Concept]
  1000   C0687118:Separated [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "polyacrylamide gel electrophoresis."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   901   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   901   C0596607:Gel Electrophoresis [Laboratory Procedure]
   827   C0013855:Electrophoresis [Laboratory Procedure]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   827   C1382104:Gel [Substance]
Processing 00000000.tx.61: Following electrophoresis and electrophoretic transfer, the membranes were immunoblotted using the antibodies against full-length APP (WO2), PS1 (NT1), APP-C99 (C1/1.6), and/or LH receptor (rabbit polyclonal and 3B5) using standard techniques as previously described (29, 32). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "electrophoresis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: "and"

Phrase: "electrophoretic transfer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040671:Transfer [Mental Process]
   861   C1705822:Transfer [Activity]

Phrase: "the membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "immunoblotted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the antibodies against full-length"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   729   C0392747:Altered [Functional Concept]

Phrase: "(WO2"

Phrase: ")"

Phrase: ","

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "(NT1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "APP-C99"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   721   C0392747:Altered [Functional Concept]

Phrase: "(C1/1.6"

Phrase: ")"

Phrase: ","

Phrase: "and/or"

Phrase: "LH receptor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0034823:Luteinizing Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1416843:LUTEINIZING HORMONE RECEPTOR [Gene or Genome]
   901   C0019929:Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1367453:HORMONE RECEPTOR [Gene or Genome]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   734   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(rabbit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]

Phrase: "polyclonal"

Phrase: "and"

Phrase: "3B5"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "standard techniques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025664:techniques [Intellectual Product]
   861   C0449851:Techniques [Functional Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(29,"

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.62: Sub-cellular Fractionation and Quantitation of AFollowing incubation with LH, the cells were washed twice with ice-cold PBS. 

Phrase: "Sub-cellular Fractionation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016640:fractionation [Laboratory Procedure]
   827   C0524811:fractionation [Therapeutic or Preventive Procedure]
   827   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Quantitation of AFollowing incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantitation [Quantitative Concept]

Phrase: "with LH,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with ice-cold PBS."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0456963:Ice cold [Qualitative Concept]
   760   C0009264:Cold [Natural Phenomenon or Process]
   760   C0009443:Cold [Disease or Syndrome]
   760   C0020746:Ice [Inorganic Chemical]
   760   C0234192:Cold [Physiologic Function]
   760   C1720725:Twice [Intellectual Product]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]
   760   C1948050:Twice [Quantitative Concept]
Processing 00000000.tx.63: After washing, the cells were lysed with 50 mM Tris-HCl (pH 7.6), containing 1% Triton X-100 and 150 mM NaCl. 

Phrase: "After washing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed with 50 mM Tris-HCl (pH 7.6"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C1882074:pH 7 [Qualitative Concept]
   742   C0020283:[pH] [Quantitative Concept]
   742   C0024348:lysed [Pathologic Function]
   742   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   742   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   742   C0450407:ph+ [Finding]
   742   C0450408:ph++ [Finding]
   742   C0450409:ph+++ [Finding]
   742   C0814229:TRI [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "and"

Phrase: "150 mM NaCl."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]
Processing 00000000.tx.64: The cell lysate was centrifuged at 60,000 x g for 20 min to obtain a supernatant and cell pellet. 

Phrase: "The cell lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "was"

Phrase: "centrifuged at 60,000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 20 min to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "a supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "and"

Phrase: "cell pellet."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441436:Pellet [Manufactured Object]
   861   C0993610:Pellet [Biomedical or Dental Material]
   861   C1998480:Pellet [Quantitative Concept]
Processing 00000000.tx.65: The supernatant (Triton-soluble fraction) was analyzed using ELISA. 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "(Triton-soluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "was"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ELISA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]
Processing 00000000.tx.66: The cell pellet was washed once with 50 mM Tris-HCl (pH 7.6), containing 1% Triton X-100 and 150 mM NaCl, to remove remaining Triton-soluble proteins. 

Phrase: "The cell pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441436:Pellet [Manufactured Object]
   861   C0993610:Pellet [Biomedical or Dental Material]
   861   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once with 50 mM Tris-HCl (pH 7.6"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C1882074:pH 7 [Qualitative Concept]
   742   C0020283:[pH] [Quantitative Concept]
   742   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   742   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   742   C0450407:ph+ [Finding]
   742   C0450408:ph++ [Finding]
   742   C0450409:ph+++ [Finding]
   742   C0814229:TRI [Intellectual Product]
   742   C1720092:Once [Intellectual Product]
   742   C1948045:Once [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "and"

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "remaining Triton-soluble proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.67: The pellet was sonicated in 50 mM Tris-HCl (pH 7.6) containing 6 M guanidine hydrochloride (33-35). 

Phrase: "The pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "sonicated in 50 mM Tris-HCl (pH 7.6"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C1882074:pH 7 [Qualitative Concept]
   742   C0020283:[pH] [Quantitative Concept]
   742   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   742   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   742   C0450407:ph+ [Finding]
   742   C0450408:ph++ [Finding]
   742   C0450409:ph+++ [Finding]
   742   C0814229:TRI [Intellectual Product]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "6 M guanidine hydrochloride"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0120447:Guanidine Hydrochloride [Organic Chemical,Pharmacologic Substance]
   812   C0018320:guanidine [Organic Chemical]
   812   C0120446:Guanidine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   812   C1512523:hydrochloride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(33-35"

Phrase: ")."
Processing 00000000.tx.68: Following centrifugation at 250,000 x g for 20 min, the supernatant was diluted 1:12 to give a final concentration of guanidine hydrochloride of 0.5 M (which has been shown not to affect protein-antibody binding (34)). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "centrifugation at 250,000 x g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "for 20 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "12 to"

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "a final concentration of guanidine hydrochloride of 0.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0086045:Concentration [Mental Process]
   742   C1446561:Concentration [Quantitative Concept]

Phrase: "M ("

Phrase: "which"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "not to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "protein-antibody binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0033618:Protein Binding [Molecular Function]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   734   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(34"

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.69: The samples were then subjected to a double sandwich ELISA as previously described (36, 37). 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to a double sandwich ELISA"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0014441:ELISA [Laboratory Procedure]
   753   C0205173:Double [Functional Concept]
   753   C1705764:Double [Activity]
   753   C1705765:Double [Qualitative Concept]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(36,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.70: Briefly, ELISA plates were coated with the antibody 6E10, and the A was captured with the rabbit polyclonal R208 antibody conjugated with biotin. 

Phrase: "Briefly,"

Phrase: "ELISA plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1139930:plates [Medical Device]
   827 E C0005971:Plate [Medical Device]
   827 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "coated with the antibody 6E10,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C1522408:Coated [Qualitative Concept]
   726 E C0453946:Coat [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "captured with the rabbit polyclonal R208 antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0034493:Rabbit [Mammal]

Phrase: "conjugated with biotin."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
   790   C0522529:Conjugated [Spatial Concept]
   790   C2700256:Biotin [Laboratory Procedure]
   756 E C0301869:Conjugate [Immunologic Factor]
Processing 00000000.tx.71: The optical density was measured at 450 nm using a Bio-Rad Model 3550 microplate reader. 

Phrase: "The optical density"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0439164:Optical density [Quantitative Concept]
  1000   C1268822:Optical density [Clinical Attribute]
   861   C0178587:density [Quantitative Concept]
   805   C0042789:Vision [Organism Function]
   805   C2707266:Vision [Clinical Attribute]
   789 E C0439794:Dense [Qualitative Concept]

Phrase: "was"

Phrase: "measured at 450 nm"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0312860:NM [Cell Function]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Bio-Rad Model 3550 microplate reader."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0182258:Microplate Reader [Medical Device]
   799   C1514743:Reader [Professional or Occupational Group]
   799   C1706461:Reader [Manufactured Object]
Processing 00000000.tx.72: All samples were treated similarly to allow comparisons between treatments. 

Phrase: "All samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "similarly to"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "comparisons between treatments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1707455:Comparison [Activity]
Processing 00000000.tx.73: The levels of A are expressed as picograms per milligram of total protein. 

Phrase: "The levels of A"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "expressed as picograms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439213:picograms [Quantitative Concept]

Phrase: "per milligram"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439210:milligram [Quantitative Concept]

Phrase: "of total protein."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0555903:Total protein [Laboratory Procedure]
  1000   C1261360:total protein [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]
Processing 00000000.tx.74: Leuprolide Acetate Treatment of Mice and Quantitation of Brain AFemale C57Bl/6J mice (3 months of age) received either leuprolide acetate (1.5 mg/kg, slow release (depot) formulation) or vehicle for 0, 4, or 8 weeks and were then sacrificed. 

Phrase: "Leuprolide Acetate Treatment of Mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "Quantitation of Brain AFemale C57Bl/6J mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709793:Quantitation [Quantitative Concept]

Phrase: "(3 months of age)"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C1442461:3 Months [Temporal Concept]
   819   C1510828:Age-Months [Organism Attribute]
   770   C0439231:months [Temporal Concept]
   737 E C0439507:/month [Temporal Concept]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "either leuprolide acetate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0700596:Leuprolide Acetate [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   827   C0085272:Leuprolide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "(1.5 mg/kg,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0439272:mg kg [Quantitative Concept]
   812   C0022718:KG [Geographic Area]
   812   C0439209:kg [Quantitative Concept]
   812   C0439269:mg% [Quantitative Concept]
   812   C1960952:mg % [Quantitative Concept]
   812   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "slow release"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0439834:Slow [Qualitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(depot"

Phrase: ")"

Phrase: "formulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0524527:Formulation [Research Activity]

Phrase: ")"

Phrase: "or"

Phrase: "vehicle for 0,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0042444:Vehicle [Biomedical or Dental Material]
   790   C0348005:Vehicle [Manufactured Object]
   718 E C0445373:Vehicular [Functional Concept]

Phrase: "4,"

Phrase: "or"

Phrase: "8 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "and"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "sacrificed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0681205:Sacrifice [Idea or Concept]
Processing 00000000.tx.75: Brains were removed and dissected in half, and one hemisphere was frozen (-80 C) for biochemical analysis. 

Phrase: "Brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "dissected in half,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205239:dissected [Functional Concept]
   790   C2825407:Half [Quantitative Concept]

Phrase: "and"

Phrase: "one hemisphere"

Phrase: "was"

Phrase: "frozen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016701:Frozen [Natural Phenomenon or Process]
  1000   C0677542:Frozen [Functional Concept]

Phrase: "(-80 C"

Phrase: ")"

Phrase: "for biochemical analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.76: This hemisphere (to maximize yield and minimize inter-animal variability) was homogenized and used to determine the concentrations of A1-40 and A1-42 using an ELISA assay as described above or previously (38) with a modification for rodent brain tissues (Techno-Synapse Inc., Quebec, Canada) (39). 

Phrase: "This hemisphere"

Phrase: "(to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "maximize"

Phrase: "yield"

Phrase: "and"

Phrase: "minimize"

Phrase: "inter-animal variability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C2827666:Variability [Conceptual Entity]
   755 E C0439828:Variable [Qualitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "homogenized"

Phrase: "and"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the concentrations of A1-40"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "A1-42"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an ELISA assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0014441:ELISA assay [Laboratory Procedure]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "as"

Phrase: "described above"

Phrase: "or"

Phrase: "previously"

Phrase: "(38"

Phrase: ")"

Phrase: "with a modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392747:Modification [Functional Concept]
  1000   C1554963:modification [Qualitative Concept]

Phrase: "for rodent brain tissues"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0440746:brain tissues [Tissue]
   867 E C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0040300:Tissues [Tissue]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   793 E C1547928:Tissue [Intellectual Product]

Phrase: "(Techno-Synapse Inc.,"

Phrase: "Quebec,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034390:Quebec [Geographic Area]

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.77: Each sample was run in duplicate or triplicate and normalized with -tubulin content for each sample. 

Phrase: "Each sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "run in duplicate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205173:Duplicate [Functional Concept]
   827   C3539942:Duplicate [Intellectual Product]
   734   C3274438:RUN-IN [Temporal Concept]

Phrase: "or"

Phrase: "triplicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triplicate [Quantitative Concept]

Phrase: "and"

Phrase: "normalized with -tubulin content"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0423896:Content [Mental Process]
   770   C0456205:Content [Conceptual Entity]
   770   C1882115:Normalized [Research Activity]
   770   C2937342:tubulin [Cell Component]

Phrase: "for each sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.78: As in other species, leuprolide acetate has been shown to lower serum gonadotropin and sex steroid levels in previous studies (40, 41) and in this study.2 Data AnalysisExposed films from Western blots were scanned (transmission scanning) using a visual light scanner (UMAX) at a resolution of 600 dpi. 

Phrase: "As in other species,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705920:Species [Conceptual Entity]

Phrase: "leuprolide acetate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0700596:Leuprolide Acetate [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   861   C0085272:Leuprolide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "serum gonadotropin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018061:Gonadotrophin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C3536870:Gonadotropin [Pharmacologic Substance]

Phrase: "and"

Phrase: "sex steroid levels in previous studies"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "(40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41"

Phrase: ")"

Phrase: "and in this study.2 Data AnalysisExposed"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0681873:study data [Research Activity]
   748   C0557651:Study [Manufactured Object]
   748   C1511726:Data [Idea or Concept]
   748   C1515981:And [Idea or Concept]
   748   C2603343:Study [Research Activity]
   748   C3245479:data [Medical Device]

Phrase: "films from Western blots"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0949466:Western Blots [Laboratory Procedure]
   799 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0086296:Film [Manufactured Object]
   770   C1561571:film [Biomedical or Dental Material]
   770   C1561572:film [Substance]
   770   C1705493:Western [Spatial Concept]

Phrase: "were"

Phrase: "scanned"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0441633:scanned [Diagnostic Procedure]
   966 E C0034606:Scan [Diagnostic Procedure]
   966 E C2826292:SCAN [Finding]

Phrase: "(transmission scanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034606:Scanning [Diagnostic Procedure]
   861   C0441633:Scanning [Diagnostic Procedure]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a visual light scanner"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0183115:scanner [Medical Device]
   827   C1710020:Scanner [Medical Device]

Phrase: "(UMAX) at a resolution of 600 dpi."
Processing 00000000.tx.79: Scanned images were quantified using the public domain program Image (National Institutes of Health; version 1.61) to measure the density of the protein bands. 

Phrase: "Scanned images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the public domain program Image"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1704254:Image [Intellectual Product]
   812   C1704922:Image [Entity]
   812   C3542466:Image [Intellectual Product]

Phrase: "(National Institutes of Health"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "; version 1.61"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0333052:Version [Functional Concept]
   827   C2607870:Version [Spatial Concept]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "the density of the protein bands."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0178587:density [Quantitative Concept]
Processing 00000000.tx.80: Data collation and analysis were performed using Microsoft Excel 2000. 

Phrase: "Data collation"

Phrase: "and"

Phrase: "analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Microsoft"

Phrase: "Excel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2740529:Excel [Pharmacologic Substance]

Phrase: "2000."
Processing 00000000.tx.81: This program was also used for statistical analysis of data via the Students t test (independent, two-tailed, assuming unequal variances).  

Phrase: "This program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1709697:Program [Conceptual Entity]
  1000   C2728259:Program [Pharmacologic Substance]
  1000   C3484370:Program [Functional Concept]

Phrase: "was"

Phrase: "also"

Phrase: "used for statistical analysis of data"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   814   C0010998:Data Analysis, Statistical [Quantitative Concept]
   790   C0871424:statistical analysis [Research Activity]
   783   C0010992:Data Analysis [Occupational Activity]
   783   C2828391:statistical data [Quantitative Concept]
   767   C1524063:Use of [Functional Concept]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0038215:Statistical [Occupation or Discipline]
   753   C0936012:Analysis [Research Activity]
   753   C1273517:used [Finding]
   753   C1511726:Data [Idea or Concept]
   753   C1524024:analysis [Functional Concept]
   753   C3245479:data [Medical Device]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "via the Students t test"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:Students [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   793 E C1551041:student [Idea or Concept]
   793 E C1552573:student [Intellectual Product]

Phrase: "(independent, two-tailed,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0039259:tailed [Body Part, Organ, or Organ Component]
   827   C0205448:Two [Quantitative Concept]

Phrase: "assuming"

Phrase: "unequal variances"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1711260:Variance [Qualitative Concept]
   827   C2348152:Variance [Quantitative Concept]
   777 E C0205419:Variant [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.82: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Gonadotropin Lowering Hormone Decreases the Concentration of Brain A in MiceTo determine whether gonadotropins alter APP processing and A generation, we administered a GnRH analogue (leuprolide acetate, 1.5 mg/kg) to depress serum LH concentrations in 3-month-old C57Bl/6J female mice (n = 6) and then analyzed A1-40 and A1-42 levels. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Gonadotropin Lowering Hormone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0019932:Hormone [Hormone]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: "Decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the Concentration of Brain A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "in MiceTo"

Phrase: "determine"

Phrase: "whether"

Phrase: "gonadotropins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0018061:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1522385:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   966 E C3536870:Gonadotropin [Pharmacologic Substance]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "APP processing"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033666:protein processing [Molecular Function]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   804   C1709694:Processing [Activity]
   721   C0392747:Altered [Functional Concept]

Phrase: "and"

Phrase: "A generation,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]

Phrase: "we"

Phrase: "administered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521801:Administered [Functional Concept]
   966 E C1621583:Administer [Functional Concept]

Phrase: "a GnRH analogue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1268900:GnRH Analogue [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0243071:Analog [Chemical Viewed Structurally]
   755 E C0679213:analogies [Idea or Concept]

Phrase: "(leuprolide acetate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0700596:Leuprolide Acetate [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   861   C0085272:Leuprolide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "1.5 mg/kg"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0439272:mg kg [Quantitative Concept]
   812   C0022718:KG [Geographic Area]
   812   C0439209:kg [Quantitative Concept]
   812   C0439269:mg% [Quantitative Concept]
   812   C1960952:mg % [Quantitative Concept]
   812   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "depress"

Phrase: "serum LH concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   886   C0683149:serum concentration [Quantitative Concept]
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   729 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "in 3-month-old C57Bl/6J female mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   845   C0025921:Mice, C57BL [Mammal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "(n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "then analyzed A1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0439509:/40 [Temporal Concept]
   812   C0936012:Analyzed [Research Activity]
   812   C1883708:Then [Temporal Concept]

Phrase: "and"

Phrase: "A1-42 levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.83: Leuprolide is a GnRH agonist that down-regulates GnRH receptors and acts as a potent antagonist, suppressing LH and FSH secretion (reviewed in Ref. 42). 

Phrase: "Leuprolide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085272:Leuprolide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "is"

Phrase: "a GnRH agonist"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0083220:GnRH Agonist [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C2987634:Agonist [Pharmacologic Substance]

Phrase: "that"

Phrase: "down-regulates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "GnRH receptors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034811:Receptors, GnRH [Amino Acid, Peptide, or Protein,Receptor]
   861   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "acts as a potent antagonist,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C0231491:Antagonist [Organ or Tissue Function]

Phrase: "suppressing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1260953:suppressing [Functional Concept]
  1000   C2003921:Suppressing [Phenomenon or Process]

Phrase: "LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "FSH secretion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1325889:follicle-stimulating hormone secretion [Cell Function]
   861   C0312431:Hormone secretion [Organ or Tissue Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0733758:Follicle Stimulating Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "("

Phrase: "reviewed in Ref. 42"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.84: The actions of GnRH and its analogues are mediated by high affinity receptors for GnRH found on the membranes of the pituitary gonadotrophs (43). 

Phrase: "The actions of GnRH"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441472:actions [Functional Concept]
   737 E C3266814:Action [Activity]

Phrase: "and"

Phrase: "its analogues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0243071:Analogue [Chemical Viewed Structurally]

Phrase: "are"

Phrase: "mediated by high affinity receptors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0205250:High [Qualitative Concept]
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   760   C1299351:High [Qualitative Concept]
   760   C1510827:Affinity [Natural Phenomenon or Process]
   760   C2700149:HIGH [Intellectual Product]

Phrase: "for GnRH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "found on the membranes of the pituitary gonadotrophs"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   744   C0025255:Membranes [Tissue]
   744   C0032005:Pituitary, NOS [Body Part, Organ, or Organ Component]
   744   C0150312:Found [Quantitative Concept]
   744   C1708248:Gonadotrophs [Cell]
   711 E C0243095:Find [Finding]
   711 E C0596901:Membrane [Cell Component]
   711 E C1706182:Membrane [Manufactured Object]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.85: An acute administration of agonists of GnRH induces a marked initial release of LH and FSH. 

Phrase: "An acute administration of agonists of GnRH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0001554:Administration [Occupational Activity]
   748   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a marked initial release of LH"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0030685:Release [Health Care Activity]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "FSH."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0733758:Follicle Stimulating Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0018120:Follicle [Body Part, Organ, or Organ Component]
   827   C0019932:Hormone [Hormone]
   827   C1571705:Follicle [Body Part, Organ, or Organ Component]
   827   C1948023:Stimulating [Natural Phenomenon or Process]
   755 E C0439682:Follicular [Qualitative Concept]
   755 E C0458083:Hormonal [Qualitative Concept]
Processing 00000000.tx.86: However, continuous stimulation of the pituitary by chronic administration of GnRH agonists produces an inhibition of the hypophyseal-gonadal axis through the process of "down-regulation" of pituitary receptors for GnRH, desensitization of the pituitary gonadotrophs, and a suppression of circulating levels of LH and sex steroids (42). 

Phrase: "However,"

Phrase: "continuous stimulation of the pituitary"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "by chronic administration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001554:Administration [Occupational Activity]
   861   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "of GnRH agonists"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0083220:GnRH Agonist [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C0243192:agonists [Pharmacologic Substance]
   861   C2987634:agonists [Pharmacologic Substance]

Phrase: "produces"

Phrase: "an inhibition of the hypophyseal-gonadal axis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "through the process of ""down-regulation"""
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0013081:Down-Regulation [Cell Function,Molecular Function]
   812   C0851285:Regulation [Governmental or Regulatory Activity]
   812   C1327622:Regulation [Biologic Function]
   756   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   756   C2626739:Lanugo [Eukaryote]

Phrase: "of pituitary receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "for GnRH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "desensitization of the pituitary gonadotrophs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0178702:Desensitization [Therapeutic or Preventive Procedure]
   760   C1709852:Desensitization [Molecular Function]

Phrase: "and"

Phrase: "a suppression of circulating levels of LH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0221103:Suppression [Pathologic Function]
   744   C0301625:Suppression [Organism Function]
   744   C0439181:% suppression [Quantitative Concept]
   744   C0728721:suppression [Mental Process]

Phrase: "and"

Phrase: "sex steroids"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0009253:Sex [Organism Function]
   861   C0036864:Sex [Behavior]
   861   C0038317:Steroids [Steroid]
   861   C0079399:sex [Organism Attribute]
   861   C1314687:Sex [Finding]
   861   C1522384:sex [Organism Attribute]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.87: This down-regulation of GnRH receptors, produced by sustained administration of GnRH agonists, prevents GnRH signaling for the secretion of LH and FSH and provides the basis for clinical applications in numerous reproductive hormone-related disorders (42). 

Phrase: "This down-regulation of GnRH receptors,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0949469:Receptor Down-Regulation [Molecular Function]
   790   C0013081:Down-Regulation [Cell Function,Molecular Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "produced by sustained administration of GnRH agonists,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0001554:Administration [Occupational Activity]
   748   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   748   C0243192:agonists [Pharmacologic Substance]
   748   C0443318:Sustained [Functional Concept]
   748   C1533734:Administration [Therapeutic or Preventive Procedure]
   748   C2987634:agonists [Pharmacologic Substance]
   745   C0083220:GnRH Agonist [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "GnRH signaling for the secretion of LH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0037083:Signaling [Cell Function]
   744   C3537152:signaling [Biologic Function]

Phrase: "and"

Phrase: "FSH"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0733758:Follicle Stimulating Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0018120:Follicle [Body Part, Organ, or Organ Component]
   827   C0019932:Hormone [Hormone]
   827   C1571705:Follicle [Body Part, Organ, or Organ Component]
   827   C1948023:Stimulating [Natural Phenomenon or Process]
   755 E C0439682:Follicular [Qualitative Concept]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "the basis for clinical applications"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1527178:Basis [Functional Concept]
   760   C1874451:Basis [Pharmacologic Substance]

Phrase: "in numerous reproductive hormone-related disorders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0012634:Disorders [Disease or Syndrome]
   800   C3263685:Hormonal disorder [Finding]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.88: Leuprolide treatment dramatically reduced the concentration (picograms/mg of protein) of brain A1-42, by 40% after 4 weeks (24.1  2.0 versus 14.5  2.6, p < 0.015) and further decreased the concentration to 71% (24.1  2.0 versus 7.1  1.0, p < 0.0001; mean  S.E.) that of controls after 8 weeks (Fig. 1). 

Phrase: "Leuprolide treatment dramatically"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(picograms/mg of protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439269:mg% [Quantitative Concept]
   770   C1960952:mg % [Quantitative Concept]
   770   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")"

Phrase: "of brain A1-42,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "by 40%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "after 4 weeks"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442465:4 Weeks [Temporal Concept]
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "(24.1  2.0"

Phrase: "versus"

Phrase: "14.5  2.6,"

Phrase: "p < 0.015"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the concentration to 71%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "(24.1  2.0"

Phrase: "versus"

Phrase: "7.1  1.0,"

Phrase: "p < 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E.)"

Phrase: "that of controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "after 8 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.89: Leuprolide treatment also reduced brain A1-40 levels by 23% after 4 weeks (5.8  0.3 versus 4.5  1.1, ns) and further reduced the concentration to 35% (5.8  0.3 versus 3.8  0.4, p < 0.024) after 8 weeks compared with control mice. 

Phrase: "Leuprolide treatment also reduced brain A1-40 levels by 23%"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "after 4 weeks"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442465:4 Weeks [Temporal Concept]
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "(5.8  0.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439084:>5 [Quantitative Concept]
   812   C0728893:+5 [Quantitative Concept]

Phrase: "versus"

Phrase: "4.5  1.1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450367:4 5 [Quantitative Concept]

Phrase: "ns)"

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the concentration to 35%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "(5.8  0.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439084:>5 [Quantitative Concept]
   812   C0728893:+5 [Quantitative Concept]

Phrase: "versus"

Phrase: "3.8  0.4,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0442757:3 4 [Finding]
   812   C0439086:<3 [Quantitative Concept]
   812   C2827736:3+ [Quantitative Concept]
   812   C2981702:3+ [Classification]

Phrase: "p < 0.024"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "after 8 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "compared with control mice."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.90: Given that leuprolide acetate suppresses serum gonadotropin concentrations, these results suggest that gonadotropin hormones may modulate A generation (44). 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that leuprolide acetate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0700596:Leuprolide Acetate [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   861   C0085272:Leuprolide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "serum gonadotropin concentrations,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   896   C0683149:serum concentration [Quantitative Concept]
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that gonadotropin hormones"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019932:Hormones [Hormone]
   777 E C0458083:Hormonal [Qualitative Concept]

Phrase: "may"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "A generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.91: View larger version (17K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.92: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.93: Leuprolide, a gonadotropin-lowering drug, decreases brain A levels in mice. 

Phrase: "Leuprolide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085272:Leuprolide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "a gonadotropin-lowering drug,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0013227:Drug [Pharmacologic Substance]
   827   C1254351:Drug [Pharmacologic Substance]
   771 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   771 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   734 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "brain A levels in mice."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.94: C57Bl/6J mice (3 months old) were administered either vehicle or a slow release leuprolide acetate (1.5 mg/kg; intraperitoneal monthly) mixture at 0 and 4 weeks. 

Phrase: "C57Bl/6J mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0025921:Mice, C57BL [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(3 months"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442461:3 Months [Temporal Concept]
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]

Phrase: "old)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0580836:Old [Temporal Concept]

Phrase: "were"

Phrase: "administered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521801:Administered [Functional Concept]
   966 E C1621583:Administer [Functional Concept]

Phrase: "either vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0042444:Vehicle [Biomedical or Dental Material]
   861   C0348005:Vehicle [Manufactured Object]
   789 E C0445373:Vehicular [Functional Concept]

Phrase: "or"

Phrase: "a slow release leuprolide acetate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0700596:Leuprolide Acetate [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   812   C0085272:Leuprolide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "(1.5 mg/kg"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0439272:mg kg [Quantitative Concept]
   812   C0022718:KG [Geographic Area]
   812   C0439209:kg [Quantitative Concept]
   812   C0439269:mg% [Quantitative Concept]
   812   C1960952:mg % [Quantitative Concept]
   812   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "; intraperitoneal monthly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332177:Monthly [Temporal Concept]
   861   C0439507:Monthly [Temporal Concept]
   861   C0442120:Intraperitoneal [Spatial Concept]

Phrase: ")"

Phrase: "mixture at 0"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439962:Mixture [Substance]

Phrase: "and"

Phrase: "4 weeks."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442465:4 Weeks [Temporal Concept]
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.95: Mice were euthanized at 0, 4, and 8 weeks, the brains were dissected, the frontal cortex tissues were homogenized and centrifuged, and the supernatant analyzed for A1-40 and A1-42 levels via an A ELISA assay. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "euthanized at 0,"

Phrase: "4,"

Phrase: "and"

Phrase: "8 weeks,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "dissected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:dissected [Functional Concept]

Phrase: ","

Phrase: "the frontal cortex tissues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0040300:Tissues [Tissue]
   793 E C1547928:Tissue [Intellectual Product]
   734   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "homogenized"

Phrase: "and"

Phrase: "centrifuged,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "and"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "analyzed for A1-40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439509:/40 [Temporal Concept]
   770   C0936012:Analyzed [Research Activity]

Phrase: "and"

Phrase: "A1-42 levels via an A ELISA assay."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.96: Results are expressed as picograms/mg of total protein (mean  S.D., n = 6 mice at each time point). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as picograms/mg of total protein"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0555903:Total protein [Laboratory Procedure]
   778   C1261360:total protein [Laboratory or Test Result]
   774 E C0439177:Protein.total [Quantitative Concept]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439175:% total [Quantitative Concept]
   748   C0439213:picograms [Quantitative Concept]
   748   C0439269:mg% [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C1960952:mg % [Quantitative Concept]
   748   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(mean  S.D.,"

Phrase: "n = 6 mice at each time point"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]

Phrase: ")."
Processing 00000000.tx.97: *, p < 0.05; 

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.98: **, p < 0.0001 for differences between vehicle and treated animals at the same time point.  

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.0001 for differences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C2603361:P' [Clinical Attribute]
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "between vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: "and"

Phrase: "treated animals at the same time point."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0003062:Animals [Animal]
Processing 00000000.tx.99: Secreted, Triton-soluble, and Triton-insoluble Amyloid- Levels in Cells Treated with LHTo determine how gonadotropins may be acting to modulate the concentration of A in the brain, we next assessed the effects of gonadotropins on the expression and processing of APP in a neuroblastoma cell line. 

Phrase: "Secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: ","

Phrase: "Triton-soluble,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1749467:soluble [Cell Component]
   861   C1948047:Soluble [Qualitative Concept]

Phrase: "and"

Phrase: "Triton-insoluble Amyloid- Levels in Cells"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "Treated with LHTo"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "determine"

Phrase: "how gonadotropins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0018061:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1522385:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827 E C3536870:Gonadotropin [Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "acting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the concentration of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "in the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "we next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "the effects of gonadotropins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "processing of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1709694:Processing [Activity]

Phrase: "APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   729   C0392747:Altered [Functional Concept]

Phrase: "in a neuroblastoma cell line."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   901   C0007600:Cell Line [Cell]
   901   C0815000:neuroblastoma cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0027819:Neuroblastoma [Neoplastic Process]
   827   C0205132:Line [Spatial Concept]
   827   C0700095:neuroblastoma [Neoplastic Process]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C3540583:Neuroblastoma [Intellectual Product]
Processing 00000000.tx.100: Because FSH receptors are primarily located in reproductive tissues, and others and we have not detected FSH receptors in neuronal cell types, we focused our efforts on biochemical changes modulated by LH. 

Phrase: "Because"

Phrase: "FSH receptors"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C0034806:Receptors, Follicle-Stimulating Hormone [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1414828:FOLLICLE-STIMULATING HORMONE RECEPTOR [Gene or Genome]
   923   C0733758:Follicle Stimulating Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019929:hormone receptors [Amino Acid, Peptide, or Protein,Receptor]
   827 E C1367453:HORMONE RECEPTOR [Gene or Genome]
   812   C0018120:Follicle [Body Part, Organ, or Organ Component]
   812   C0019932:Hormone [Hormone]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   812   C1571705:Follicle [Body Part, Organ, or Organ Component]
   812   C1948023:Stimulating [Natural Phenomenon or Process]
   741 E C0439682:Follicular [Qualitative Concept]
   741 E C0458083:Hormonal [Qualitative Concept]

Phrase: "are"

Phrase: "primarily"

Phrase: "located in reproductive tissues,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0035150:Reproductive [Organism Function]
   770   C0040300:Tissues [Tissue]
   770   C0748342:REPRODUCTIVE [Classification]
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "and"

Phrase: "we"

Phrase: "have"

Phrase: "not detected FSH receptors in neuronal cell types,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   806   C0034806:Receptors, Follicle-Stimulating Hormone [Amino Acid, Peptide, or Protein,Receptor]
   782   C0733758:Follicle Stimulating Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   773 E C1414828:FOLLICLE-STIMULATING HORMONE RECEPTOR [Gene or Genome]
   760   C0019929:hormone receptors [Amino Acid, Peptide, or Protein,Receptor]
   741   C1514760:Receptor Cell [Cell]
   741   C2325760:Neuronal receptor [Cell Component]
   739   C0018120:Follicle [Body Part, Organ, or Organ Component]
   739   C0019932:Hormone [Hormone]
   739   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   739   C1571705:Follicle [Body Part, Organ, or Organ Component]
   739   C1948023:Stimulating [Natural Phenomenon or Process]
   726 E C1367453:HORMONE RECEPTOR [Gene or Genome]

Phrase: "we"

Phrase: "focused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205234:Focused [Spatial Concept]
  1000   C1285542:focused [Functional Concept]

Phrase: "our efforts on biochemical changes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0015264:Effort [Organism Function]

Phrase: "modulated by LH."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   833   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0019932:Hormone [Hormone]
   770   C0443264:Modulated [Spatial Concept]
Processing 00000000.tx.101: To test whether LH impacts A generation we used the M17 neuroblastoma cell line (widely used for studying APP processing (1, 3, 45, 46)) to examine whether LH altered APP expression and/or processing. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "impacts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1825598:IMPACT [Gene or Genome]

Phrase: "A generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the M17 neuroblastoma cell line"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   861   C0007600:Cell Line [Cell]
   861   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0027819:Neuroblastoma [Neoplastic Process]
   812   C0205132:Line [Spatial Concept]
   812   C0700095:neuroblastoma [Neoplastic Process]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   812   C3540583:Neuroblastoma [Intellectual Product]

Phrase: "(widely"

Phrase: "used for studying"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   824   C0869040:study use [Research Activity]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756   C0557651:Study [Manufactured Object]
   756 E C1947944:Use [Intellectual Product]
   756   C2603343:Study [Research Activity]

Phrase: "APP processing"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033666:protein processing [Molecular Function]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   804   C1709694:Processing [Activity]
   721   C0392747:Altered [Functional Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "45,"

Phrase: "46"

Phrase: ")"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "APP expression"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1171362:protein expression [Genetic Function]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   721   C0392747:Altered [Functional Concept]

Phrase: "and/or"

Phrase: "processing."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]
Processing 00000000.tx.102: Immunoblot analysis using polyclonal (Fig. 2D) and monoclonal (Fig. 2E) antibodies against LH receptor indicated that M17 neuroblastoma cells contain a number of LH receptor variants, including the mature glycosylated and phosphorylated LH receptor protein (92 kDa), the immature full-length LH receptor (59 kDa isoform (47, 48)) and a number of minor variants migrating at 36, 40, 48, 68, and 110 kDa (Fig. 2, D and E). 

Phrase: "Immunoblot analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "polyclonal"

Phrase: "(Fig. 2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1705052:2D [Spatial Concept]
   861   C2986796:2D [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "monoclonal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0746619:monoclonal [Finding]

Phrase: "(Fig. 2E"

Phrase: ")"

Phrase: "antibodies against LH receptor"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0034805:antibodies receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that M17 neuroblastoma cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C0815000:neuroblastoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a number of LH receptor variants,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the mature glycosylated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   789   C0017982:Glycosylations [Natural Phenomenon or Process]
   789   C0376322:Glycosylation [Molecular Function]

Phrase: "and"

Phrase: "phosphorylated LH receptor protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C0682768:hormone protein [Amino Acid, Peptide, or Protein,Hormone]
   840   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0034823:Luteinizing Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C1416843:LUTEINIZING HORMONE RECEPTOR [Gene or Genome]

Phrase: "(92 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the immature full-length LH receptor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0034823:Luteinizing Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1416843:LUTEINIZING HORMONE RECEPTOR [Gene or Genome]
   827   C0019929:Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1367453:HORMONE RECEPTOR [Gene or Genome]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(59 kDa isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "(47,"

Phrase: "48"

Phrase: ")"

Phrase: ")"

Phrase: "and"

Phrase: "a number of minor variants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "migrating at 36,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0232902:migrating [Functional Concept]

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "48,"

Phrase: "68,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "and"

Phrase: "110 kDa (Fig. 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0349966:Fig [Food]
   812   C1337208:FIG [Food]
   812   C1532717:kDa [Quantitative Concept]

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "E"

Phrase: ")."
Processing 00000000.tx.103: These results indicate the presence of the immature, mature, and truncated forms of the LH receptor on M17 neuroblastoma cells by which LH might mediate signaling. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "the presence of the immature, mature,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "truncated forms of the LH receptor"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "on M17 neuroblastoma cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C0815000:neuroblastoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "by which LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "might"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
Processing 00000000.tx.104: View larger version (19K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.105: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.106: LH induces A secretion and insolubility in neuroblastoma cells. 

Phrase: "LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "A secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "and"

Phrase: "insolubility in neuroblastoma cells."
Processing 00000000.tx.107: Human M17 neuroblastoma cells were cultured in Opti-MEM medium with 0.5% of dialyzed donor calf serum and 1% of penicillin/streptomycin and treated with 0, 10, and 30 mIU/ml of LH for 5 days. 

Phrase: "Human M17 neuroblastoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   902   C0427861:Human cells [Laboratory or Test Result]
   844   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured in Opti-MEM medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   781   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "with 0.5%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "of dialyzed donor calf serum"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: "and"

Phrase: "1% of penicillin/streptomycin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0030842:Penicillin [Antibiotic,Organic Chemical]
   770   C0038425:Streptomycin [Antibiotic,Carbohydrate]
   770   C0220892:Penicillin [Antibiotic,Organic Chemical]
   770   C2827734:1+ [Quantitative Concept]
   770   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "treated with 0,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "10,"

Phrase: "and"

Phrase: "30 mIU/ml of LH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439457:mIU/mL [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "for 5 days."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442466:5 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.108: Media with corresponding LH concentrations were replaced every 2 days. 

Phrase: "Media with corresponding LH concentrations"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0009458:Media [Intellectual Product]
   753   C0162867:Media [Tissue]
   753   C1254021:Media [Tissue]
   719 E C0439536:Medium [Quantitative Concept]
   719 E C1705217:Medium [Substance]
   719 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "replaced"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0559956:Replaced [Functional Concept]
  1000   C1299987:replaced [Functional Concept]
   966 E C1554078:Replace [Idea or Concept]

Phrase: "every 2 days."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442455:2 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.109: The medium from each experiment was used to measure secreted A1-40 (A). 

Phrase: "The medium from each experiment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "secreted A1-40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439509:/40 [Temporal Concept]
   827   C1327616:Secreted [Cell Function]

Phrase: "(A"

Phrase: ")."
Processing 00000000.tx.110: Cell pellets were solubilized in Triton X-100 and centrifuged to generate soluble (B) and insoluble fractions (C). 

Phrase: "Cell pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0993610:pellets [Biomedical or Dental Material]
   827 E C0441436:Pellet [Manufactured Object]
   827 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "solubilized in Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   806   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   760   C0242759:Triton [Geographic Area]

Phrase: "and"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "insoluble fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "(C"

Phrase: ")."
Processing 00000000.tx.111: A concentration is expressed as picograms/mg of total protein (mean  S.D.). 

Phrase: "A concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "is"

Phrase: "expressed as picograms/mg of total protein"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0555903:Total protein [Laboratory Procedure]
   778   C1261360:total protein [Laboratory or Test Result]
   774 E C0439177:Protein.total [Quantitative Concept]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439175:% total [Quantitative Concept]
   748   C0439213:picograms [Quantitative Concept]
   748   C0439269:mg% [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C1960952:mg % [Quantitative Concept]
   748   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(mean  S.D."

Phrase: ")."
Processing 00000000.tx.112: Experiments were performed three times in duplicate (i.e. n = 6, p < 0.01). 

Phrase: "Experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "three times in duplicate"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "(i.e. n = 6,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C1515148:I 6 [Cell]
   861   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.113: LH receptor expression pattern in human M17 neuroblastoma cells was determined by immunoblot analysis with (D) a rabbit polyclonal antibody against residues 15-38 and (E) a mouse monoclonal antibody (3B5). 

Phrase: "LH receptor expression pattern in human M17 neuroblastoma cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0449774:Pattern [Spatial Concept]

Phrase: "was"

Phrase: "determined by immunoblot analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "with"

Phrase: "(D) a rabbit polyclonal antibody against residues 15-38"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0369095:D not otherwise specified Antibody [Immunologic Factor]
   762   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and ("

Phrase: "E) a mouse monoclonal antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   897   C0313106:e Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   897   C0947659:E Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   884   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   840   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0746619:monoclonal [Finding]

Phrase: "(3B5"

Phrase: ")."
Processing 00000000.tx.114: Arrows indicate the immature (59 kDa) full-length LH receptor.  

Phrase: "Arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "the immature"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205252:Immature [Temporal Concept]

Phrase: "(59 kDa) full-length LH receptor."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   845   C0034823:Luteinizing Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   845   C1416843:LUTEINIZING HORMONE RECEPTOR [Gene or Genome]
   818   C0019929:Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   818   C1367453:HORMONE RECEPTOR [Gene or Genome]
   795   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.115: We first treated M17 neuroblastoma cells with concentrations of LH representative of serum concentrations during early adulthood (1-10 mIU/ml) and during menopause/andropause (15-30 mIU/ml) for 5 d. 

Phrase: "We first treated M17 neuroblastoma cells with concentrations of LH representative"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   736   C0007634:Cells [Cell]
   736   C0815000:neuroblastoma cell [Cell]
   736   C3282337:Cells [Cell]
   703 E C1269647:Cell [Cell]
   703 E C1704653:Cell [Medical Device]
   703 E C1948049:Cell [Spatial Concept]

Phrase: "of serum concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C0683149:serum concentration [Quantitative Concept]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "during early adulthood"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0680085:early adulthood [Age Group]
   861   C0700597:Adulthood [Temporal Concept]

Phrase: "(1-10 mIU/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439457:mIU/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "and during menopause/andropause"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025320:Menopause [Physiologic Function]
   770   C0232984:Andropause [Finding]
   770   C0567312:Menopause [Finding]
   770   C1515981:And [Idea or Concept]

Phrase: "(15-30 mIU/ml) for 5 d."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0439457:mIU/mL [Quantitative Concept]
   774   C0439446:mL/d [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.116: We then measured secreted, Triton X-100-soluble (cytoplasmic and membranous components) and Triton X-100-insoluble cell fractions for A. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "secreted, Triton X-100-soluble"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1749467:soluble [Cell Component]
   804   C1948047:Soluble [Qualitative Concept]
   717   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "(cytoplasmic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010834:Cytoplasmic [Cell Component]
  1000   C0521449:Cytoplasmic [Body Location or Region]

Phrase: "and"

Phrase: "membranous components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: ")"

Phrase: "and"

Phrase: "Triton X-100-insoluble cell fractions for A."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0805525:Cell fractions [Cell Component]
   744   C1264633:Fractions [Quantitative Concept]
   711 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.117: LH treatment at both early adult and post-menopausal concentrations significantly increased the concentration of secreted A (Fig. 2A), indicating that LH may promote secretion of A from neurons. 

Phrase: "LH treatment at both early adult"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0279025:hormone treatment [Therapeutic or Preventive Procedure]
   778   C2966671:Hormone treatment [Clinical Attribute]
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "post-menopausal concentrations significantly"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   858   C1546088:post concentration [Clinical Attribute]
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   729 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the concentration of secreted A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "(Fig. 2A"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "may"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "secretion of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0036536:secretion [Biologic Function]
   790   C0036537:Secretion [Body Substance]

Phrase: "from neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.118: No change in the concentration of Triton X-100-soluble A was detected with either LH concentration (Fig. 2B). 

Phrase: "No change in the concentration of Triton X-100-soluble A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0442739:No change [Finding]
   756   C1548568:No change [Intellectual Product]
   738   C0392747:Change [Functional Concept]
   738   C0443172:change [Quantitative Concept]
   738   C1705241:Change [Quantitative Concept]

Phrase: "was"

Phrase: "detected with either LH concentration"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0019932:Hormone [Hormone]
   753   C0086045:Concentration [Mental Process]
   753   C0442726:Detected [Finding]
   753   C1446561:Concentration [Quantitative Concept]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.119: Together these results indicate that LH is involved in either the processing of APP or the trafficking of APP/A (see below). 

Phrase: "Together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "is"

Phrase: "involved in either"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1314939:Involved [Functional Concept]

Phrase: "the processing of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709694:Processing [Activity]

Phrase: "APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   729   C0392747:Altered [Functional Concept]

Phrase: "or"

Phrase: "the"

Phrase: "trafficking of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0599896:trafficking [Cell Function]

Phrase: "APP/A"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   721   C0392747:Altered [Functional Concept]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.120: Interestingly, there was a doubling in the concentration of Triton X-100-insoluble A with 30 mIU/ml but not with 10 mIU/ml LH (Fig. 2C), suggesting higher concentrations of LH might drive the aggregation of the protein. 

Phrase: "Interestingly,"

Phrase: "there"

Phrase: "was"

Phrase: "a doubling in the concentration of Triton X-100-insoluble A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0205173:doubling [Functional Concept]
   738   C1705764:Doubling [Activity]

Phrase: "with 30 mIU/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439457:mIU/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "but"

Phrase: "not with 10 mIU/ml LH"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   778   C0439457:mIU/mL [Quantitative Concept]
   778   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0019932:Hormone [Hormone]
   748   C0439455:mIU [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]
   748   C1518422:Not [Functional Concept]
   748   C1881843:MIU [Quantitative Concept]

Phrase: "(Fig. 2C"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "higher concentrations of LH"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "might"

Phrase: "drive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "the aggregation of the protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]
Processing 00000000.tx.121: In summary, these results indicate that LH promotes the secretion of A from neuroblastoma cells and that high concentrations of LH might promote A insolubility, a cardinal feature of AD. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the secretion of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]

Phrase: "from neuroblastoma cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0815000:neuroblastoma cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "that high concentrations of LH"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "might"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "A insolubility,"

Phrase: "a cardinal feature of AD."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1521970:Feature [Qualitative Concept]
   760   C1706388:Feature [Conceptual Entity]
   760   C2346469:Feature [Qualitative Concept]
   760   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.122: LH Does Not Modulate APP or PS1 Expression in Neuroblastoma CellsTo determine how LH was promoting the increased generation of A, we examined whether LH was increasing the expression of APP. 

Phrase: "LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "Does"

Phrase: "Not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "Modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   729   C0392747:Altered [Functional Concept]

Phrase: "or"

Phrase: "PS1 Expression in Neuroblastoma CellsTo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "determine"

Phrase: "how LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0019932:Hormone [Hormone]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: "was"

Phrase: "promoting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promoting [Activity]

Phrase: "the increased generation of A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "was"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the expression of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "APP."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   729   C0392747:Altered [Functional Concept]
Processing 00000000.tx.123: M17 neuroblastoma cells were treated with increasing concentrations of LH (0-30 mIU/ml) for 2 days, and changes in the expression of APP and PS1 were determined (Fig. 3A). 

Phrase: "M17 neuroblastoma cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C0815000:neuroblastoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with increasing concentrations of LH"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   778   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0019932:Hormone [Hormone]
   748   C0086045:Concentrations [Mental Process]
   748   C0442808:Increasing [Functional Concept]
   748   C1522326:Treated [Functional Concept]
   714 E C1292734:TREAT [Functional Concept]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "(0-30 mIU/ml) for 2 days,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0439457:mIU/mL [Quantitative Concept]
   757   C0439446:mL/day [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "changes in the expression of"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   729   C0392747:Altered [Functional Concept]

Phrase: "and"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "were"

Phrase: "determined"

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.124: Subsequent experiments were preformed at 0, 10, and 30 mIU/ml LH for quantitation. 

Phrase: "Subsequent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "preformed at 0,"

Phrase: "10,"

Phrase: "and"

Phrase: "30 mIU/ml LH for quantitation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   778   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0019932:Hormone [Hormone]
Processing 00000000.tx.125: No significant change in the expression of APP was observed following quantitation at 5 days (or at 2 and 10 days, not shown), indicating that LH had no effect on modulating the expression of APP (Fig. 3, B and C). 

Phrase: "No significant change in the expression of"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0442739:No change [Finding]
   774   C1548568:No change [Intellectual Product]
   748   C0392747:Change [Functional Concept]
   748   C0443172:change [Quantitative Concept]
   748   C1705241:Change [Quantitative Concept]

Phrase: "APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   729   C0392747:Altered [Functional Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "quantitation at 5 days"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantitation [Quantitative Concept]

Phrase: "("

Phrase: "or"

Phrase: "at 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516077:At [Spatial Concept]

Phrase: "and"

Phrase: "10 days,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1547061:10 days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "had"

Phrase: "no effect on modulating"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1301751:No effect [Qualitative Concept]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "the expression of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   729   C0392747:Altered [Functional Concept]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C"

Phrase: ")."
Processing 00000000.tx.126: View larger version (39K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(39K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.127: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.128: LH does not alter APP or PS1 expression. 

Phrase: "LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   729   C0392747:Altered [Functional Concept]

Phrase: "or"

Phrase: "PS1 expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.129: Human M17 neuroblastoma cells were treated with 0-30 mIU/ml LH for 2 days (A) or 5 days (B-E) as described in Fig. 

Phrase: "Human M17 neuroblastoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   902   C0427861:Human cells [Laboratory or Test Result]
   844   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 0-30 mIU/ml LH"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0439457:mIU/mL [Quantitative Concept]
   770   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0019932:Hormone [Hormone]
   744   C0439455:mIU [Quantitative Concept]
   744   C0439526:/mL [Quantitative Concept]
   744   C1522326:Treated [Functional Concept]
   744   C1881843:MIU [Quantitative Concept]
   711 E C1292734:TREAT [Functional Concept]

Phrase: "for 2 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442455:2 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "(A"

Phrase: ")"

Phrase: "or"

Phrase: "5 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442466:5 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "(B-E)"

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.130: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.131: The cell lysates (B-E are same as used in Fig. 2) also underwent Western immunoblotting with antibodies against full-length APP (WO2), and full-length-PS1 and N-terminal PS1 (NT1). 

Phrase: "The cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "(B-E"

Phrase: "are"

Phrase: "same"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445247:Same [Qualitative Concept]

Phrase: "as"

Phrase: "used in Fig. 2"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1273517:used [Finding]
   770   C1337208:FIG [Food]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: ")"

Phrase: "also"

Phrase: "underwent"

Phrase: "Western immunoblotting with antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Immunoblotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Immunoblot [Laboratory Procedure]
   770   C0020985:Immunoblotting [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "against full-length"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0443225:Full [Qualitative Concept]
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: "APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   729   C0392747:Altered [Functional Concept]

Phrase: "(WO2"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "full-length-PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "N-terminal PS1 (NT1)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]
Processing 00000000.tx.132: The full-length APP (B), PS1 holoprotein, and N-terminal fragment (D) signals were quantitated and were expressed as a percentage of untreated cells (C and E). 

Phrase: "The full-length"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0443225:Full [Qualitative Concept]
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: "APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   729   C0392747:Altered [Functional Concept]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "PS1 holoprotein,"

Phrase: "and"

Phrase: "N-terminal fragment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragment [Functional Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "("

Phrase: "D)"

Phrase: "signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "quantitated"

Phrase: "and"

Phrase: "were"

Phrase: "expressed as a percentage of untreated cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0007634:Cells [Cell]
   748   C0332155:untreated [Finding]
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(C"

Phrase: "and"

Phrase: "E"

Phrase: ")."
Processing 00000000.tx.133: +ve = HEK-293 cells overexpressing PS1wt and APP695. 

Phrase: "+"

Phrase: "ve ="

Phrase: "HEK-293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK 293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "PS1wt"

Phrase: "and"

Phrase: "APP695."
Processing 00000000.tx.134: Experiments were performed three times in duplicate (i.e. n = 6, p < 0.05). 

Phrase: "Experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "three times in duplicate"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "(i.e. n = 6,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C1515148:I 6 [Cell]
   861   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.135: Mol. weight markers are shown on the left hand-side.  

Phrase: "Mol. weight markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0005516:Marker [Clinical Attribute]

Phrase: "are"

Phrase: "shown on the left hand-side."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0230371:Left hand [Body Part, Organ, or Organ Component]
   790   C1288949:Left hand [Body Part, Organ, or Organ Component]
   783   C0205091:Left side [Spatial Concept]
           Left
   753   C0018563:Hand [Body Part, Organ, or Organ Component]
   753   C0441987:Side [Spatial Concept]
   753   C1281583:Hand [Body Part, Organ, or Organ Component]
   753   C1552822:left [Functional Concept]
   753   C1552914:hand [Quantitative Concept]
   719   C1547282:Show [Intellectual Product]
Processing 00000000.tx.136: Because evidence suggests PS1 is a component of the -secretase complex, we also tested whether LH altered the expression of cellular full-length PS1 and its N-terminal fragment. 

Phrase: "Because"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "is"

Phrase: "a component of the -secretase complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "we also"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "whether"

Phrase: "LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "the expression of cellular full-length PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "its N-terminal fragment."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragment [Functional Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.137: No change in PS1 expression was detected, indicating that LH does not promote -secretase cleavage by increasing PS1 expression (Fig. 3, D and E). 

Phrase: "No change in PS1 expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0442739:No change [Finding]
   806   C1548568:No change [Intellectual Product]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "indicating"

Phrase: "that LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "promote -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "secretase cleavage by increasing PS1 expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "E"

Phrase: ")."
Processing 00000000.tx.138: LH also did not alter the processing of PS1 to its N-terminal fragment (Fig. 3, D and E). 

Phrase: "LH also"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0019932:Hormone [Hormone]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the processing of PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709694:Processing [Activity]

Phrase: "to its N-terminal fragment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragment [Functional Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "E"

Phrase: ")."
Processing 00000000.tx.139: These results suggest that the mechanism by which LH increases A generation is not via an increase in APP expression nor an increase in PS1 expression or processing. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the mechanism by which LH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "A generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]

Phrase: "is"

Phrase: "not via an increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442805:Increase [Functional Concept]
   770   C1518422:Not [Functional Concept]

Phrase: "in"

Phrase: "APP expression"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1171362:protein expression [Genetic Function]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   721   C0392747:Altered [Functional Concept]

Phrase: "nor"

Phrase: "an increase in PS1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "or"

Phrase: "processing."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]
Processing 00000000.tx.140: LH Modulation of Secreted -APPs Levels and APP-C99 Because LH did not affect the expression of APP or PS1 but did increase secreted A levels, we next investigated if LH modulated APP processing through the amyloidogenic pathway (as reflected by a decrease in -secretase cleavage of APP to soluble -APP). 

Phrase: "LH Modulation of Secreted -APPs Levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0443264:Modulation [Spatial Concept]

Phrase: "and"

Phrase: "APP-C99"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   721   C0392747:Altered [Functional Concept]

Phrase: "Because"

Phrase: "LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the expression of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   729   C0392747:Altered [Functional Concept]

Phrase: "or"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "but"

Phrase: "did"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "secreted A levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "we next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "if"

Phrase: "LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "modulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulated [Spatial Concept]

Phrase: "APP processing"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033666:protein processing [Molecular Function]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   804   C1709694:Processing [Activity]
   721   C0392747:Altered [Functional Concept]

Phrase: "through the amyloidogenic pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "("

Phrase: "as"

Phrase: "reflected by a decrease in -secretase cleavage of"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0010813:cleavage [Cell Function]
   744   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]
   744   C0558058:reflected [Mental Process]
   744   C0596311:Cleavage [Phenomenon or Process]
   744   C1330957:cleavage [Cell Function]

Phrase: "APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   729   C0392747:Altered [Functional Concept]

Phrase: "to soluble -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]

Phrase: "APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   729   C0392747:Altered [Functional Concept]

Phrase: ")."
Processing 00000000.tx.141: The same media collected for A analysis (Fig. 2) was used for immunoblotting of -APPs using the mouse monoclonal antibody WO2 (recognizes -APPs). 

Phrase: "The same media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "collected for A analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0936012:Analysis [Research Activity]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]
   770   C1524024:analysis [Functional Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "was"

Phrase: "used for immunoblotting of -APPs"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   781   C1524063:Use of [Functional Concept]
   760   C0020985:Immunoblotting [Laboratory Procedure]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
   726   C3538722:APP [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the mouse monoclonal antibody WO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "recognizes -"

Phrase: "APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.142: Consistent with the increased concentration of soluble A in the media of M17 neuroblastoma cells, there was a significant decrease in the concentration of -APPs (Fig. 4). 

Phrase: "Consistent with the increased concentration of soluble A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "of M17 neuroblastoma cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C0815000:neuroblastoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "there"

Phrase: "was"

Phrase: "a significant decrease in the concentration of -APPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.143: These results indicate that LH drives APP processing toward the amyloidogenic pathway. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that LH drives"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0013126:Drives [Mental Process]
   734   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   734   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "APP processing"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033666:protein processing [Molecular Function]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   804   C1709694:Processing [Activity]
   721   C0392747:Altered [Functional Concept]

Phrase: "toward the amyloidogenic pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.144: View larger version (21K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.145: 4. 

Phrase: "4."
Processing 00000000.tx.146: LH decreases -APPs and promotes APP-C99 generation. 

Phrase: "LH decreases -APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C3538722:APP [Laboratory Procedure]

Phrase: "and"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "APP-C99 generation."
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   861   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   861   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   839   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0079411:Generation [Temporal Concept]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1709634:Precursor [Idea or Concept]
   799   C3146294:Generation [Activity]
   716   C0392747:Altered [Functional Concept]
   706 E C1414672:Genesis [Gene or Genome]
   706 E C2984892:Genesis [Gene or Genome]
Processing 00000000.tx.147: Human M17 neuroblastoma cells were treated as described in Fig. 

Phrase: "Human M17 neuroblastoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   902   C0427861:Human cells [Laboratory or Test Result]
   844   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.148: 2, and the media were analyzed for revised -APPs (A) and cell lysates analyzed for APP-C99 generation (C) by immunoblot analysis. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "analyzed for revised -APPs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0936012:Analyzed [Research Activity]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]
   737   C3538722:APP [Laboratory Procedure]

Phrase: "(A"

Phrase: ")"

Phrase: "and"

Phrase: "cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "analyzed for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0936012:Analyzed [Research Activity]

Phrase: "APP-C99 generation"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   861   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   861   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   839   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0079411:Generation [Temporal Concept]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1709634:Precursor [Idea or Concept]
   799   C3146294:Generation [Activity]
   716   C0392747:Altered [Functional Concept]
   706 E C1414672:Genesis [Gene or Genome]
   706 E C2984892:Genesis [Gene or Genome]

Phrase: "(C"

Phrase: ")"

Phrase: "by immunoblot analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.149: Immunoblotting with antibodies WO2 (residues 5-8 of the A domain) or C1/1.6 revealed a band of 110 kDa representing -APPs (A) or a band of 10 kDa representing APP-C99 (C), respectively. 

Phrase: "Immunoblotting with antibodies WO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "(residues 5-8 of the A domain"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: ")"

Phrase: "or"

Phrase: "C1/1.6"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a band of 110 kDa representing -APPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0230715:A band [Cell Component]
   748   C0175723:Band [Medical Device]
   748   C0439645:Band [Spatial Concept]
   748   C1521913:band [Cell Component]

Phrase: "(A"

Phrase: ")"

Phrase: "or"

Phrase: "a band of 10 kDa representing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0230715:A band [Cell Component]
   753   C0175723:Band [Medical Device]
   753   C0439645:Band [Spatial Concept]
   753   C1521913:band [Cell Component]

Phrase: "APP-C99 (C),"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   721   C0392747:Altered [Functional Concept]

Phrase: "respectively."
Processing 00000000.tx.150: Signals were quantitated and are expressed as a percentage of untreated cells (B and D). 

Phrase: "Signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "quantitated"

Phrase: "and"

Phrase: "are"

Phrase: "expressed as a percentage of untreated cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0007634:Cells [Cell]
   748   C0332155:untreated [Finding]
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.151: Experiments were performed three times in duplicate (i.e. n = 6, p < 0.05).  

Phrase: "Experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "three times in duplicate"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "(i.e. n = 6,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C1515148:I 6 [Cell]
   861   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.152: Given that secreted A levels increased and -APPs levels decreased, we tested to confirm that there was a corresponding increase in the levels of APP-C99 (i.e. increased -secretase activity) in the cell lysates treated with LH. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that secreted A levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "and -"

Phrase: "APPs levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: ","

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that there"

Phrase: "was"

Phrase: "a corresponding increase in the levels of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "APP-C99"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   721   C0392747:Altered [Functional Concept]

Phrase: "(i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "increased -"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: ")"

Phrase: "in the cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "treated with LH."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0019932:Hormone [Hormone]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.153: The same cell lysate that was used for intracellular A levels was therefore used for Western immunoblotting analysis of APP-C99 levels. 

Phrase: "The same cell lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "that"

Phrase: "was"

Phrase: "used for intracellular A levels"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0456079:Level [Classification]
   726 E C0457083:Use [Functional Concept]
   726 E C1547707:Level [Geographic Area]
   726 E C1947944:Use [Intellectual Product]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "therefore"

Phrase: "used for Western immunoblotting analysis of"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   790   C0005863:Western Immunoblotting [Laboratory Procedure,Molecular Biology Research Technique]
   773   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblotting
   773 E C0949466:Western Immunoblot [Laboratory Procedure]
   767   C1524063:Use of [Functional Concept]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1273517:used [Finding]
   753   C1524024:analysis [Functional Concept]
   753   C1705493:Western [Spatial Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "APP-C99 levels."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   861   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   861   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   839   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   822   C0428479:Protein level [Laboratory or Test Result]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0441889:Levels [Qualitative Concept]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1709634:Precursor [Idea or Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
   716   C0392747:Altered [Functional Concept]
Processing 00000000.tx.154: Consistent with the decrease in -APPs levels, there was an increase in APP-C99 levels at both 10 and 30 mIU/ml LH, supportive of the increased processing of APP to A. 

Phrase: "Consistent with the decrease in -APPs levels,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "there"

Phrase: "was"

Phrase: "an increase in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0442805:Increase [Functional Concept]

Phrase: "APP-C99 levels"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   861   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   861   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   839   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   822   C0428479:Protein level [Laboratory or Test Result]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0441889:Levels [Qualitative Concept]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1709634:Precursor [Idea or Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
   716   C0392747:Altered [Functional Concept]

Phrase: "at both 10"

Phrase: "and"

Phrase: "30 mIU/ml LH,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0019932:Hormone [Hormone]
   733 E C0458083:Hormonal [Qualitative Concept]

Phrase: "supportive of the increased processing of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1521721:Supportive [Conceptual Entity]

Phrase: "APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   729   C0392747:Altered [Functional Concept]

Phrase: "to A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.155: These results further support the idea that LH modulates -secretase cleavage of APP in the secretory pathway. 

Phrase: "These results further"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "that LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "modulates -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "secretase cleavage of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010813:cleavage [Cell Function]
   790   C0596311:Cleavage [Phenomenon or Process]
   790   C1330957:cleavage [Cell Function]

Phrase: "APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   729   C0392747:Altered [Functional Concept]

Phrase: "in the secretory pathway."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1159342:Secretory Pathway [Cell Function]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.156: These in vitro results indicate that LH drives APP processing toward the amyloidogenic pathway by decreasing -secretase cleavage and promoting -secretase (and -secretase) cleavage of APP to yield A. 

Phrase: "These in vitro results"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "indicate"

Phrase: "that LH drives"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0013126:Drives [Mental Process]
   734   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   734   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "APP processing"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033666:protein processing [Molecular Function]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   804   C1709694:Processing [Activity]
   721   C0392747:Altered [Functional Concept]

Phrase: "toward the amyloidogenic pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "by decreasing -secretase cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "promoting -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: "and -"

Phrase: "secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "cleavage of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0010813:cleavage [Cell Function]
   833   C0596311:Cleavage [Phenomenon or Process]
   833   C1330957:cleavage [Cell Function]

Phrase: "APP to"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   721   C0392747:Altered [Functional Concept]

Phrase: "yield"

Phrase: "A."
Processing 00000000.tx.157: LH Receptor Expression and Hormonal RegulationBecause LH receptor expression is modulated in reproductive tissues by 17-estradiol (49) and LH (50), we tested to determine whether 17-estradiol (and LH) regulated LH receptor expression in neurons. 

Phrase: "LH Receptor Expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0597360:receptor expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C0034823:Luteinizing Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C1416843:LUTEINIZING HORMONE RECEPTOR [Gene or Genome]

Phrase: "and"

Phrase: "Hormonal RegulationBecause LH receptor expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597360:receptor expression [Genetic Function]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "modulated in reproductive tissues"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0035150:Reproductive [Organism Function]
   770   C0040300:Tissues [Tissue]
   770   C0443264:Modulated [Spatial Concept]
   770   C0748342:REPRODUCTIVE [Classification]
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "by 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(49"

Phrase: ")"

Phrase: "and"

Phrase: "LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "(50"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "("

Phrase: "and"

Phrase: "LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: ")"

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "LH receptor expression in neurons."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0597360:receptor expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.158: Physiological concentrations of 17-estradiol (0.1 nM) promoted an increase in the 59-kDa band representative of the immature form of the full-length LH receptor (Fig. 5) when compared with untreated M17 cells. 

Phrase: "Physiological concentrations of 17-estradiol"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "(0.1 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "promoted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0033414:Promote [Activity]

Phrase: "an increase in the 59-kDa band representative of the immature form"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0442805:Increase [Functional Concept]

Phrase: "of the full-length LH receptor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0034823:Luteinizing Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   884   C1416843:LUTEINIZING HORMONE RECEPTOR [Gene or Genome]
   840   C0019929:Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C1367453:HORMONE RECEPTOR [Gene or Genome]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "when"

Phrase: "compared with untreated M17 cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0332155:untreated [Finding]
   760   C1707455:Compared [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.159: However, treatment with increasing concentrations of 17-estradiol, including physiologically relevant concentrations of 17-estradiol (1 nM), decreased the expression of immature LH receptor in a dose-dependent manner (Fig. 5). 

Phrase: "However,"

Phrase: "treatment with increasing concentrations of 17-estradiol,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "physiologically relevant concentrations of 17-estradiol"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "(1 nM),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the expression of immature LH receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0597360:receptor expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in a dose-dependent manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.160: Interestingly, levels of the mature forms of the LH receptor (68, 92, and 110 kDa) were increased at high concentrations of 17-estradiol (10 and 100 nM). 

Phrase: "Interestingly,"

Phrase: "levels of the mature forms of the LH receptor"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   761   C0202123:Luteinising hormone level [Laboratory Procedure]
   757   C1287355:hormone levels [Laboratory or Test Result]
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "(68,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "92,"

Phrase: "and"

Phrase: "110 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "were"

Phrase: "increased at high concentrations of 17-estradiol"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   774   C0860851:Increased estradiol [Finding]
           high estradiol
   748   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   748   C0086045:Concentrations [Mental Process]
   748   C0205217:Increased [Quantitative Concept]
   748   C0205250:High [Qualitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C1299351:High [Qualitative Concept]
   748   C2700149:HIGH [Intellectual Product]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "(10"

Phrase: "and"

Phrase: "100 nM)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]
Processing 00000000.tx.161: View larger version (31K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(31K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.162: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.163: Human M17 neuroblastoma cells were treated with 17-estradiol (0-100 nM) or LH (0-30 mIU/ml), and the cell lysates were analyzed by Western immunoblot for LH receptor isoforms using a rabbit polyclonal LH receptor antibody.  

Phrase: "Human M17 neuroblastoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   902   C0427861:Human cells [Laboratory or Test Result]
   844   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 17-estradiol"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]
   715 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   715 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(0-100 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "or"

Phrase: "LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "(0-30 mIU/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439457:mIU/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "analyzed by Western immunoblot"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0949466:Western Immunoblot [Laboratory Procedure]
   770   C0020985:Immunoblot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "for LH receptor isoforms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   756   C0034823:Luteinizing Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C1416843:LUTEINIZING HORMONE RECEPTOR [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a rabbit polyclonal LH receptor antibody."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   895   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   876   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0034805:receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.164: Treatment of M17 cells with LH (as little as 1 mIU/ml) resulted in a small dose-dependent increase in immature and mature LH receptor isoforms. 

Phrase: "Treatment of M17 cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "("

Phrase: "as little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "as 1 mIU/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439457:mIU/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "resulted in a small dose-dependent increase"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C1512045:Dose-dependent [Quantitative Concept]
   748   C0178602:Dose [Quantitative Concept]
   748   C0442805:Increase [Functional Concept]
   748   C0700321:Small [Quantitative Concept]
   748   C0851827:Dependent [Qualitative Concept]
   748   C0869039:Dose [Quantitative Concept]
   748   C1114758:Dose # [Clinical Attribute]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "in immature"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205252:Immature [Temporal Concept]

Phrase: "and"

Phrase: "mature LH receptor isoforms."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   717   C0034823:Luteinizing Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C1416843:LUTEINIZING HORMONE RECEPTOR [Gene or Genome]
Processing 00000000.tx.165: Truncated forms of the LH receptor (<55 kDa) also increased in a dose-dependent manner with higher LH concentrations (10 and 30 mIU/ml). 

Phrase: "Truncated forms of the LH receptor"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "("

Phrase: "<55 kDa) also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532717:kDa [Quantitative Concept]

Phrase: "increased in a dose-dependent manner"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C1512045:Dose-dependent [Quantitative Concept]
   783   C1707810:Dose Increased [Therapeutic or Preventive Procedure]
   753   C0178602:Dose [Quantitative Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "with higher LH concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   729 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(10"

Phrase: "and"

Phrase: "30 mIU/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439457:mIU/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.166: Together these results indicate that 17-estradiol and LH can modulate LH receptor expression and maturation and may therefore regulate signaling mediated via the LH receptor.  

Phrase: "Together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "can"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "LH receptor expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0597360:receptor expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C0034823:Luteinizing Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C1416843:LUTEINIZING HORMONE RECEPTOR [Gene or Genome]

Phrase: "and"

Phrase: "maturation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0678723:Maturation [Organism Function]
  1000   C0870861:maturation [Phenomenon or Process]
  1000   C1254042:Maturation [Physiologic Function]

Phrase: "and"

Phrase: "may"

Phrase: "therefore"

Phrase: "regulate"

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "mediated via the LH receptor."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0034823:Luteinizing Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   833   C1416843:LUTEINIZING HORMONE RECEPTOR [Gene or Genome]
   790   C0019929:Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1367453:HORMONE RECEPTOR [Gene or Genome]
   790   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0019932:Hormone [Hormone]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.167: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Our results demonstrate that the gonadotropin LH modulates the processing of APP leading to increased A generation. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the gonadotropin LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0019932:Hormone [Hormone]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the processing of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709694:Processing [Activity]

Phrase: "APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   729   C0392747:Altered [Functional Concept]

Phrase: "leading to increased A generation."
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   781   C0861064:increased lead [Finding]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0079411:Generation [Temporal Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0332152:Leading [Temporal Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1522538:Leading [Functional Concept]
   760   C3146294:Generation [Activity]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.168: In vivo, the potent GnRH agonist, leuprolide acetate, which suppresses the concentrations of serum gonadotropin and sex steroids, decreased the concentration of total brain A (Fig. 1). 

Phrase: "In vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "the potent GnRH agonist,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0083220:GnRH Agonist [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   827   C2987634:Agonist [Pharmacologic Substance]

Phrase: "leuprolide acetate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0700596:Leuprolide Acetate [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   861   C0085272:Leuprolide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "which"

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "the concentrations of serum gonadotropin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0683149:concentrations serum [Quantitative Concept]
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "sex steroids,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0009253:Sex [Organism Function]
   861   C0036864:Sex [Behavior]
   861   C0038317:Steroids [Steroid]
   861   C0079399:sex [Organism Attribute]
   861   C1314687:Sex [Finding]
   861   C1522384:sex [Organism Attribute]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the concentration of total brain A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.169: In vitro, LH directed APP processing toward the amyloidogenic pathway as evidenced by increased A generation and secretion, a concurrent decrease in APP secretion and increased APP-C99 generation (Figs. 2, 3, 4). 

Phrase: "In vitro, LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0019932:Hormone [Hormone]
   741 E C0458083:Hormonal [Qualitative Concept]

Phrase: "directed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439851:Direct [Qualitative Concept]
   966   C1947931:Direct [Qualitative Concept]

Phrase: "APP processing"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033666:protein processing [Molecular Function]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   804   C1709694:Processing [Activity]
   721   C0392747:Altered [Functional Concept]

Phrase: "toward the amyloidogenic pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "as"

Phrase: "evidenced by increased A generation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0079411:Generation [Temporal Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C3146294:Generation [Activity]
   726   C0332120:Evidence [Functional Concept]

Phrase: "and"

Phrase: "secretion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "a concurrent decrease in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "APP secretion"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1159339:Protein Secretion [Cell Function]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   721   C0392747:Altered [Functional Concept]

Phrase: "and"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "APP-C99 generation"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   861   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   861   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   839   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0079411:Generation [Temporal Concept]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1709634:Precursor [Idea or Concept]
   799   C3146294:Generation [Activity]
   716   C0392747:Altered [Functional Concept]
   706 E C1414672:Genesis [Gene or Genome]
   706 E C2984892:Genesis [Gene or Genome]

Phrase: "(Figs. 2,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.170: Because LH induces biochemical changes consistent with those observed in the AD brain, our results implicate the normal age-related increase in serum LH following menopause/andropause as a potential mechanism responsible for the amyloidosis associated with aging and in AD. 

Phrase: "Because"

Phrase: "LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "biochemical changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "consistent with those"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "observed in the AD brain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1441672:Observed [Functional Concept]

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "implicate"

Phrase: "the normal age-related increase in serum LH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0520970:Hormone increase [Laboratory or Test Result]
   742   C0442805:Increase [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "menopause/andropause as a potential mechanism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0232984:Andropause [Finding]

Phrase: "responsible for the amyloidosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "associated with aging"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0001811:Ageing [Organism Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and in AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]
Processing 00000000.tx.171: Contribution of Sex Steroids and Gonadotropins to AmyloidosisThe importance of sex steroids in providing important trophic/protective support for normal brain function has been well described (51). 

Phrase: "Contribution of Sex Steroids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880177:Contribution [Activity]

Phrase: "and"

Phrase: "Gonadotropins to AmyloidosisThe importance of sex steroids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0018061:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1522385:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   714 E C3536870:Gonadotropin [Pharmacologic Substance]

Phrase: "in providing important trophic/protective support"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   825   C0242739:nutrition support [Therapeutic or Preventive Procedure]
   825   C1552221:Nutrition Support [Intellectual Product]
   825   C1555993:Nutrition Support [Professional or Occupational Group]
   804   C0183683:Support [Medical Device]
   804   C1521721:Support [Conceptual Entity]

Phrase: "for normal brain function"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0678908:brain function [Organ or Tissue Function]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "well described"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205170:Well [Qualitative Concept]
   861   C1552738:described [Idea or Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.172: That the decrease in the serum concentrations of these neurotrophic steroids following menopause (and andropause) is associated with disease progression has been based on epidemiological studies and findings that estrogen deficiency in vitro and in vivo promotes biochemical and neuropathological changes consistent with those observed in the aging and AD brains. 

Phrase: "That"

Phrase: "the decrease in the serum concentrations of these neurotrophic steroids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0392756:Decrease [Qualitative Concept]
   739   C0547047:Decrease [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "menopause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025320:Menopause [Physiologic Function]
  1000   C0567312:Menopause [Finding]

Phrase: "("

Phrase: "and"

Phrase: "andropause"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232984:Andropause [Finding]

Phrase: ")"

Phrase: "is"

Phrase: "associated with disease progression"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   833   C0242656:Disease Progression [Pathologic Function]
           progression
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1947900:Disease progression NOS [Finding]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0449258:Progression [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "based on epidemiological studies"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   833   C0002783:Epidemiological Studies [Research Activity]
   770   C0014507:Epidemiological [Biomedical Occupation or Discipline]
   770   C0947630:studies [Laboratory Procedure]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C0557651:Study [Manufactured Object]
   737 E C1880279:Base [Biomedical or Dental Material]
   737 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "that estrogen deficiency"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0853662:estrogen deficiency [Disease or Syndrome]
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "biochemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205474:Biochemical [Functional Concept]

Phrase: "and"

Phrase: "neuropathological changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "consistent with those"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "observed in the aging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001811:Ageing [Organism Function]
   770   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "AD brains."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.173: For example, 17-estradiol and testosterone have been shown to alter neuronal APP processing toward the non-amyloidogenic pathway both in vitro and in vivo. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "testosterone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0039601:Testosterone [Hormone,Pharmacologic Substance,Steroid]
   944 E C0113075:Depo-testosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "neuronal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521390:Neuronal [Immunologic Factor]
   928 E C0027882:Neuron [Cell]

Phrase: "APP processing"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033666:protein processing [Molecular Function]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   804   C1709694:Processing [Activity]
   721   C0392747:Altered [Functional Concept]

Phrase: "toward the non-amyloidogenic pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "both in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.174: 17-estradiol at concentrations between 2 and 2000 nM increases -APPs production and reduces the generation of A in both mouse and human cell lines and primary cultures of rat, mouse, and human embryonic cerebrocortical neurons (52-55). 

Phrase: "17-estradiol at concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   715 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   715 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "between 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "2000 nM increases -APPs production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "reduces"

Phrase: "the generation of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079411:Generation [Temporal Concept]
   770   C3146294:Generation [Activity]

Phrase: "in both mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "human cell lines"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   983   C0682523:Human Cell Line [Cell]
   901   C0007600:Cell lines [Cell]
   901   C0427861:human cell [Laboratory or Test Result]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "primary cultures of rat,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0010453:Cultures [Idea or Concept]
   770   C0205225:Primary [Qualitative Concept]
   770   C0439631:Primary [Therapeutic or Preventive Procedure]
   737 E C0220814:culture [Functional Concept]
   737 E C0430400:Culture [Laboratory Procedure]
   737 E C2242979:Culture [Laboratory Procedure]

Phrase: "mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "human embryonic cerebrocortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(52-55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.175: Likewise, testosterone treatment (200-2000 nM) of mouse neuroblastoma cells and rat primary cerebrocortical neurons increases secretion of -APPs and decreases the secretion of A (56). 

Phrase: "Likewise,"

Phrase: "testosterone treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "(200-2000 nM) of mouse neuroblastoma cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "rat primary cerebrocortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "secretion of -APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C3538722:APP [Laboratory Procedure]

Phrase: "and"

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the secretion of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]

Phrase: "(56"

Phrase: ")."
Processing 00000000.tx.176: Ovariectomy, which suppresses serum estrogen levels, also has been shown to increase total A concentrations in guinea pigs (18) and APP transgenic mice (19). 

Phrase: "Ovariectomy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029936:Ovariectomy [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "serum estrogen levels,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0857965:serum estrogen [Laboratory Procedure]
   827   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   827   C0441889:Levels [Qualitative Concept]
   827   C2936882:Estrogen [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "also"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "total A concentrations in guinea pigs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "(18"

Phrase: ")"

Phrase: "and"

Phrase: "APP transgenic mice"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   861   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   861   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   839   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0025936:Mice, Transgenic [Mammal]
   827   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0003069:Transgenic [Animal]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1709634:Precursor [Idea or Concept]
   716   C0392747:Altered [Functional Concept]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.177: Conversely, 17-estradiol treatment was shown to partially and totally reverse the effects of ovariectomy in guinea pigs (18) and APP transgenic mice (Tg2576 and Tg2576 x mutant PS1 (19)), respectively. 

Phrase: "Conversely,"

Phrase: "17-estradiol treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to partially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "and"

Phrase: "totally"

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "the effects of ovariectomy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "in guinea pigs"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0085979:Guinea Pigs [Mammal]
   966 E C0999699:Guinea-pig [Mammal]
   861   C0018381:Guinea [Geographic Area]
   861   C0039005:Pigs [Mammal]
   861   C1135183:pigs [Mammal]
   861   C2828412:Guinea [Reptile]
   827 E C1136016:PIG [Mammal]
   827 E C1265533:Pig [Mammal]
   827 E C1270360:Pig [Mammal]

Phrase: "(18"

Phrase: ")"

Phrase: "and"

Phrase: "APP transgenic mice"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   861   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   861   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   839   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0025936:Mice, Transgenic [Mammal]
   827   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0003069:Transgenic [Animal]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1709634:Precursor [Idea or Concept]
   716   C0392747:Altered [Functional Concept]

Phrase: "(Tg2576"

Phrase: "and"

Phrase: "Tg2576 x mutant PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1418985:PS1 [Gene or Genome]
   812   C2986918:PS1 [Gene or Genome]

Phrase: "(19"

Phrase: ")"

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.178: A more recent study using APPSWE transgenic mice did not see a significant increase in brain A following ovariectomy (57). 

Phrase: "A more recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "APPSWE transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "a significant increase in brain A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "ovariectomy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029936:Ovariectomy [Therapeutic or Preventive Procedure]

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.179: One difference that might explain this discrepancy is that the APPSWE mice were ovariectomized prior to puberty (4 weeks), whereas the Tg2576 mice were ovariectomized after puberty, indicating that establishment of an intact HPG axis is important with regards to APP processing and pathological deposition of A. 

Phrase: "One difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "that"

Phrase: "might"

Phrase: "explain"

Phrase: "this discrepancy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1290905:Discrepancy [Finding]

Phrase: "is"

Phrase: "that"

Phrase: "the APPSWE mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "ovariectomized prior to puberty"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0332152:Prior to [Temporal Concept]
           Prior
   770   C0034011:Puberty [Physiologic Function]
   770   C2826257:PRIOR [Event]

Phrase: "(4 weeks"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442465:4 Weeks [Temporal Concept]
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the Tg2576 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "ovariectomized after puberty,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0034011:Puberty [Physiologic Function]

Phrase: "indicating"

Phrase: "that establishment of an intact HPG axis"

Phrase: "is"

Phrase: "important with"

Phrase: "regards"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "APP processing"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033666:protein processing [Molecular Function]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   804   C1709694:Processing [Activity]
   721   C0392747:Altered [Functional Concept]

Phrase: "and"

Phrase: "pathological deposition of A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0011560:Amyloid deposition [Pathologic Function]
   819   C1705760:Amyloid Deposition [Finding]
   770   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.180: Although the above results indicate that a reduction in serum estrogen increases APP processing toward the amyloidogenic pathway in vivo, the fact that leuprolide acetate suppresses both gonadotropins and sex steroids suggests that the effect could well be mediated via LH. 

Phrase: "Although"

Phrase: "the above results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "a reduction in serum estrogen increases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "APP processing"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033666:protein processing [Molecular Function]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   804   C1709694:Processing [Activity]
   721   C0392747:Altered [Functional Concept]

Phrase: "toward the amyloidogenic pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "the fact"

Phrase: "that leuprolide acetate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0700596:Leuprolide Acetate [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   861   C0085272:Leuprolide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "both gonadotropins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0018061:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1522385:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   966 E C3536870:Gonadotropin [Pharmacologic Substance]

Phrase: "and"

Phrase: "sex steroids"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0009253:Sex [Organism Function]
   861   C0036864:Sex [Behavior]
   861   C0038317:Steroids [Steroid]
   861   C0079399:sex [Organism Attribute]
   861   C1314687:Sex [Finding]
   861   C1522384:sex [Organism Attribute]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "could"

Phrase: "well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "be"

Phrase: "mediated via LH."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   833   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0019932:Hormone [Hormone]
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.181: Physiological concentrations of serum estrogen are no greater than 1 nM in women, and serum testosterone concentrations are no greater than 35 nM in men (58). 

Phrase: "Physiological concentrations of serum estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0683149:concentrations serum [Quantitative Concept]
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "are"

Phrase: "no greater than 1 nM"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0439093:Greater Than [Quantitative Concept]
   760   C0443228:greater [Quantitative Concept]
   760   C1704243:Greater [Quantitative Concept]
   726 E C0549177:Great [Quantitative Concept]

Phrase: "in women,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]

Phrase: "and"

Phrase: "serum testosterone concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   896   C0683149:serum concentration [Quantitative Concept]
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0428413:Serum testosterone [Laboratory Procedure]

Phrase: "are"

Phrase: "no greater than 35 nM"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0439093:Greater Than [Quantitative Concept]
   760   C0443228:greater [Quantitative Concept]
   760   C1704243:Greater [Quantitative Concept]
   726 E C0549177:Great [Quantitative Concept]

Phrase: "in men (58"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0025266:Men [Population Group]
   827 E C0024554:MAN [Finding]
   827 E C0086418:Man [Human]

Phrase: ")."
Processing 00000000.tx.182: Given that physiologically relevant concentrations of 17-estradiol (1 nM) decreased the expression of immature LH receptor in neuroblastoma cells (Fig. 5), it is likely that the high concentrations of sex steroids used in previous in vitro studies (2-2000 nM 17-estradiol and 200-1000 nM testosterone) down-regulated neuronal gonadotropin receptors (and perhaps other HPG axis-relevant receptors). 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that physiologically relevant concentrations of 17-estradiol"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0086045:Concentrations [Mental Process]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "(1 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the expression of immature LH receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0597360:receptor expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in neuroblastoma cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0815000:neuroblastoma cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "the high concentrations of sex steroids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "used in previous in vitro studies"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   809   C0681828:in vitro study [Research Activity]
           studies vitro
   783   C0021135:In Vitro [Intellectual Product]
   783   C1533691:in vitro [Qualitative Concept]
           vitro
   783   C2827718:In Vitro [Functional Concept]
   767   C0869040:Use studies [Research Activity]
   753   C0205156:Previous [Temporal Concept]
   753   C0947630:studies [Laboratory Procedure]
   753   C1273517:used [Finding]
   753   C1552607:previous [Temporal Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C0557651:Study [Manufactured Object]
   719 E C1947944:Use [Intellectual Product]
   719 E C2603343:Study [Research Activity]

Phrase: "(2-2000 nM 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   748 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   748 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "200-1000 nM testosterone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0039601:Testosterone [Hormone,Pharmacologic Substance,Steroid]
   756 E C0113075:Depo-testosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: ")"

Phrase: "down-regulated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0851285:Regulated [Governmental or Regulatory Activity]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "neuronal gonadotropin receptors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0034812:Receptors, Gonadotropin [Amino Acid, Peptide, or Protein,Receptor]
   896   C2325760:Neuronal receptor [Cell Component]
   884 E C1416843:GONADOTROPIN RECEPTOR [Gene or Genome]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "("

Phrase: "and"

Phrase: "perhaps"

Phrase: "other HPG axis-relevant receptors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   734   C0814030:Hypothalamic-pituitary-gonadal axis [Body Part, Organ, or Organ Component]
   700   C0678897:hypothalamic pituitary axis [Organ or Tissue Function]

Phrase: ")."
Processing 00000000.tx.183: Thus, suppression of LH receptors by high concentrations of estrogen in vitro would have the same effect as elevated serum estrogen in vivo, suppressing gonadotropin signaling, diverting APP processing to the non-amyloidogenic pathway with a resultant decrease in A generation. 

Phrase: "Thus,"

Phrase: "suppression of LH receptors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0221103:Suppression [Pathologic Function]
   760   C0301625:Suppression [Organism Function]
   760   C0439181:% suppression [Quantitative Concept]
   760   C0728721:suppression [Mental Process]

Phrase: "by high concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "would"

Phrase: "have"

Phrase: "the same effect as elevated serum estrogen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0877035:Estrogen Effect [Finding]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "suppressing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1260953:suppressing [Functional Concept]
  1000   C2003921:Suppressing [Phenomenon or Process]

Phrase: "gonadotropin signaling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "diverting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0743226:diverting [Functional Concept]

Phrase: "APP processing"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033666:protein processing [Molecular Function]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   804   C1709694:Processing [Activity]
   721   C0392747:Altered [Functional Concept]

Phrase: "to the non-amyloidogenic pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "with a resultant decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392756:Decrease [Qualitative Concept]
   861   C0547047:Decrease [Quantitative Concept]

Phrase: "in A generation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]
Processing 00000000.tx.184: Although it is possible that high concentrations of LH suppress estrogen receptor expression, thereby modulating APP processing, the concentrations of LH used in this study would be unlikely to exert such an affect. 

Phrase: "Although"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that high concentrations of LH"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "estrogen receptor expression,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0597360:receptor expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   734   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "thereby"

Phrase: "modulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulating [Spatial Concept]

Phrase: "APP processing,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033666:protein processing [Molecular Function]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   804   C1709694:Processing [Activity]
   721   C0392747:Altered [Functional Concept]

Phrase: "the concentrations of LH"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "would"

Phrase: "be"

Phrase: "unlikely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "such an"

Phrase: "affect."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]
Processing 00000000.tx.185: In support of the affect of estrogen being dependent upon other hormones of the HPG axis such as LH, Manthey and colleagues have reported for mouse hippocampal HT22 and human neuroblastoma SK-N-MC cells that the enhancement of cellular -APPs release was independent of estrogen receptor expression (55). 

Phrase: "In support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "of the"

Phrase: "affect of estrogen"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0001721:Affect [Mental Process]
   790   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   790   C2936882:Estrogen [Pharmacologic Substance]
   718 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "being"

Phrase: "dependent upon other hormones of the HPG axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0851827:Dependent [Qualitative Concept]
   739   C1701901:Dependent [Qualitative Concept]
   739   C3244310:dependent [Functional Concept]

Phrase: "such as LH,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "Manthey"

Phrase: "and"

Phrase: "colleagues"

Phrase: "have"

Phrase: "reported for mouse hippocampal HT22"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "human neuroblastoma SK-N-MC cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   895   C0427861:Human cells [Laboratory or Test Result]
   859   C0815000:neuroblastoma cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "the enhancement of cellular -APPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   760   C2349975:Enhancement [Activity]

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "was independent of estrogen receptor expression"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C0332291:Independent of [Functional Concept]
   790   C0597360:receptor expression [Genetic Function]
   790   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
   790   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   753   C0043194:WAS [Disease or Syndrome]
   753   C0085862:Independent [Idea or Concept]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1299583:Independent [Finding]
   753   C1421478:WAS [Gene or Genome]
   753   C2936882:Estrogen [Pharmacologic Substance]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.186: Our results clearly indicate that 17-estradiol modulates immature LH receptor expression. 

Phrase: "Our results clearly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "immature LH receptor expression."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0597360:receptor expression [Genetic Function]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   717   C0034823:Luteinizing Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C1416843:LUTEINIZING HORMONE RECEPTOR [Gene or Genome]
Processing 00000000.tx.187: At physiological concentrations of 17-estradiol (0.1 nM), expression of the 59-kDa LH receptor was maximal (greater than 0 nM 17-estradiol) but subsequently declined in a dose-dependent manner to low levels by 10 nM. 

Phrase: "At physiological concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "(0.1 nM),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "expression of the 59-kDa LH receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0597360:receptor expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "maximal"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205289:Maximal [Qualitative Concept]
  1000   C0806909:Maximal [Quantitative Concept]
   928 E C1552615:maximum [Quantitative Concept]
   928 E C2826546:MAXIMUM [Quantitative Concept]

Phrase: "(greater than 0 nM 17-estradiol"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0439093:Greater Than [Quantitative Concept]
   753   C0443228:greater [Quantitative Concept]
   753   C1704243:Greater [Quantitative Concept]
   719 E C0549177:Great [Quantitative Concept]

Phrase: ")"

Phrase: "but"

Phrase: "subsequently"

Phrase: "declined in a dose-dependent manner"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1512045:Dose-dependent [Quantitative Concept]
   753   C0178602:Dose [Quantitative Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "to low levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "by 10 nM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]
Processing 00000000.tx.188: Thus, following menopause when 17-estradiol levels are low (<0.1 nM), a moderate expression of tissue (brain) LH receptor would still be expected. 

Phrase: "Thus,"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "menopause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025320:Menopause [Physiologic Function]
  1000   C0567312:Menopause [Finding]

Phrase: "when"

Phrase: "17-estradiol levels"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   884   C0337434:Oestradiol level [Laboratory Procedure]
   827   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   771 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "are"

Phrase: "low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "("

Phrase: "<0.1 nM),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "a moderate expression of tissue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "LH receptor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0034823:Luteinizing Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1416843:LUTEINIZING HORMONE RECEPTOR [Gene or Genome]
   901   C0019929:Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1367453:HORMONE RECEPTOR [Gene or Genome]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   734   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "would"

Phrase: "still"

Phrase: "be"

Phrase: "expected."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]
Processing 00000000.tx.189: Interestingly, the levels of higher molecular weight (mature) LH receptor isoforms increased at the higher concentrations of 17-estradiol (10-100 nM). 

Phrase: "Interestingly,"

Phrase: "the levels of higher molecular weight"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "(mature"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205286:Mature [Temporal Concept]
   928 E C0449989:Maturity [Qualitative Concept]
   928 E C0700597:Maturity [Temporal Concept]

Phrase: ")"

Phrase: "LH receptor isoforms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   756   C0034823:Luteinizing Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C1416843:LUTEINIZING HORMONE RECEPTOR [Gene or Genome]

Phrase: "increased at the higher concentrations of 17-estradiol"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   767   C0860851:Increased estradiol [Finding]
           high estradiol
   744   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   744   C0086045:Concentrations [Mental Process]
   744   C0205217:Increased [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]
   725   C0557899:Height increased [Finding]
   711   C0205250:High [Qualitative Concept]
   711   C1299351:High [Qualitative Concept]
   711 E C1446561:Concentration [Quantitative Concept]
   711   C2700149:HIGH [Intellectual Product]

Phrase: "(10-100 nM)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]
Processing 00000000.tx.190: Although the physiological relevance of this finding is unclear, high concentrations of 17-estradiol might drive LH receptor maturation at such times when pituitary LH secretion is decreased in order to mediate lowered LH signaling. 

Phrase: "Although"

Phrase: "the physiological relevance of this finding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347946:Relevance [Qualitative Concept]

Phrase: "is"

Phrase: "unclear, high concentrations of 17-estradiol"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "might"

Phrase: "drive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "LH receptor maturation at such times"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0678723:Maturation [Organism Function]
   748   C0870861:maturation [Phenomenon or Process]
   748   C1254042:Maturation [Physiologic Function]

Phrase: "when"

Phrase: "pituitary LH secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1819180:luteinizing hormone secretion [Organ or Tissue Function]
   861   C0312431:Hormone secretion [Organ or Tissue Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0023607:Pituitary luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   708   C0032015:Pituitary hormone [Amino Acid, Peptide, or Protein,Hormone]

Phrase: "is"

Phrase: "decreased in order to"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C1705175:Order [Intellectual Product]
   770   C1705176:Order [Qualitative Concept]
   770   C1705177:Order [Classification]
   770   C1705178:Order [Activity]
   770   C1882348:Order [Qualitative Concept]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "lowered LH signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037083:Signaling [Cell Function]
   812   C3537152:signaling [Biologic Function]
Processing 00000000.tx.191: In rat ovaries (and testis), the preovulatory LH surge causes a marked down-regulation of cell surface LH receptors and its cognate mRNA, but both of these recover upon luteinization (reviewed in Ref. 50). 

Phrase: "In rat ovaries"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C1882808:Rat Ovary [Body Part, Organ, or Organ Component]
   861   C0029939:Ovaries [Body Part, Organ, or Organ Component]
   861   C0227898:ovaries [Body Part, Organ, or Organ Component]
   827 E C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "("

Phrase: "and"

Phrase: "testis"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039597:Testis [Body Part, Organ, or Organ Component]
  1000   C1278981:Testis [Body Part, Organ, or Organ Component]
   916 E C0021358:Testes [Body Part, Organ, or Organ Component]
   907 E C0205070:Testicular [Spatial Concept]
   888 E C1284096:Testicle [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: ","

Phrase: "the preovulatory LH surge"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: "down-regulation of cell surface LH receptors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   776   C0949469:Receptor Down-Regulation [Molecular Function]
   770   C0013081:Down-Regulation [Cell Function,Molecular Function]
   767   C0920552:hormone regulation [Organism Function]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "its cognate mRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "but"

Phrase: "both of these"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]

Phrase: "recover upon luteinization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0334024:Luteinisation [Organ or Tissue Function]
   790   C0521108:recover [Qualitative Concept]
   790   C2004454:recover [Organism Function]

Phrase: "("

Phrase: "reviewed in Ref. 50"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.192: At typical adult and post-reproductive concentrations of LH (10 and 30 mIU/ml, respectively) used in this study, we found that LH receptor expression increased slightly (Fig. 5). 

Phrase: "At typical adult"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001675:Adult [Age Group]
   861   C1706450:Adult [Human]

Phrase: "and"

Phrase: "post-reproductive concentrations of LH"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C1546088:post concentration [Clinical Attribute]
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "(10"

Phrase: "and"

Phrase: "30 mIU/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439457:mIU/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: "used in this study,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that LH receptor expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0597360:receptor expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C0034823:Luteinizing Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C1416843:LUTEINIZING HORMONE RECEPTOR [Gene or Genome]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.193: It will be interesting in future studies to determine the affects of LH concentrations normally detected during the LH surge (80 mIU/ml) on LH receptor numbers. 

Phrase: "It"

Phrase: "will"

Phrase: "be"

Phrase: "interesting in future"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0016884:Future [Temporal Concept]
   790   C0543488:interesting [Mental Process]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the"

Phrase: "affects of LH concentrations normally"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0001721:Affect [Mental Process]
   753   C0019932:Hormone [Hormone]
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "detected during the LH surge"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0019932:Hormone [Hormone]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(80 mIU/ml) on LH receptor numbers."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439457:mIU/mL [Quantitative Concept]
   744   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.194: Although down-regulation of receptor number by LH is associated with decreased responsiveness to subsequent LH administration, loss of receptor number alone may not completely explain the desensitization, because cAMP was shown to be ineffective in reversing desensitization, suggesting LH also inhibits some post-receptor signaling events (59). 

Phrase: "Although"

Phrase: "down-regulation of receptor number"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   844   C0949469:Receptor Down-Regulation [Molecular Function]
   806   C0013081:Down-Regulation [Cell Function,Molecular Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "by LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "is"

Phrase: "associated with decreased responsiveness"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   737 E C0547047:Decrease [Quantitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "to subsequent LH administration,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0199780:hormone administration [Therapeutic or Preventive Procedure]
   812   C0001554:Administration [Occupational Activity]
   812   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "loss of receptor number"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "may"

Phrase: "not completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "explain"

Phrase: "the desensitization,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178702:Desensitization [Therapeutic or Preventive Procedure]
  1000   C1709852:Desensitization [Molecular Function]

Phrase: "because"

Phrase: "cAMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "ineffective in reversing desensitization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3242229:ineffective [Idea or Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "LH also"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0019932:Hormone [Hormone]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "some post-receptor signaling events"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   886   C1546087:post {event} [Clinical Attribute]
   812   C0441471:Events [Event]
   812   C3541888:Events [Classification]

Phrase: "(59"

Phrase: ")."
Processing 00000000.tx.195: Our results suggest that LH regulates A generation via modulation of APP processing rather than via its clearance. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "regulates"

Phrase: "A generation via modulation of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "APP processing"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033666:protein processing [Molecular Function]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   804   C1709694:Processing [Activity]
   721   C0392747:Altered [Functional Concept]

Phrase: "rather than via its clearance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0449297:Clearance [Qualitative Concept]
   760   C1382187:Clearance [Clinical Attribute]
   760   C2825073:Clearance [Natural Phenomenon or Process]
Processing 00000000.tx.196: It is unclear whether LH is mediating its affects via the LH receptor, although the modulation of LH receptor expression by both 17-estradiol and LH (Fig. 5) supports this possibility. 

Phrase: "It"

Phrase: "is"

Phrase: "unclear"

Phrase: "whether"

Phrase: "LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "is"

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "its"

Phrase: "affects via the LH receptor,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0034823:Luteinizing Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   833   C1416843:LUTEINIZING HORMONE RECEPTOR [Gene or Genome]
   790   C0019929:Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1367453:HORMONE RECEPTOR [Gene or Genome]
   790   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0001721:Affect [Mental Process]
   753   C0019932:Hormone [Hormone]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "although"

Phrase: "the modulation of LH receptor expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0443264:Modulation [Spatial Concept]

Phrase: "by both 17-estradiol"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0014912:Estradiol [Hormone,Pharmacologic Substance,Steroid]
   805 E C0699352:Estrace [Hormone,Pharmacologic Substance,Steroid]
   805 E C0878472:Progynon [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "this possibility."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]
Processing 00000000.tx.197: Full-length LH receptor consists of 335 residues containing six N-linked glycosylation sites (60, 61). 

Phrase: "Full-length LH receptor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0034823:Luteinizing Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   884   C1416843:LUTEINIZING HORMONE RECEPTOR [Gene or Genome]
   840   C0019929:Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C1367453:HORMONE RECEPTOR [Gene or Genome]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "consists of 335 residues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332529:CONSIST [Qualitative Concept]
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "six N-linked glycosylation sites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   804   C0017982:glycosylation [Natural Phenomenon or Process]
   804   C0205145:Sites [Spatial Concept]
   804   C0376322:Glycosylation [Molecular Function]
   771 E C1515974:Site [Body Location or Region]
   771 E C2825164:Site [Spatial Concept]

Phrase: "(60,"

Phrase: "61"

Phrase: ")."
Processing 00000000.tx.198: We have identified mature, immature, and truncated forms of the LH receptor in M17 neuroblastoma cells (Fig. 2D). 

Phrase: "We"

Phrase: "have"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "mature, immature,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205252:Immature [Temporal Concept]

Phrase: "and"

Phrase: "truncated forms of the LH receptor"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "in M17 neuroblastoma cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C0815000:neuroblastoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1705052:2D [Spatial Concept]
   861   C2986796:2D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.199: Similar findings have recently been reported in numerous mouse, rat, and human tissues, including brain (62). 

Phrase: "Similar findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "reported in numerous mouse,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C0439064:Numerous [Quantitative Concept]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "rat,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "and"

Phrase: "human tissues,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0440744:human tissues [Tissue]
   861   C0040300:Tissues [Tissue]
   861   C0086418:Human [Human]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(62"

Phrase: ")."
Processing 00000000.tx.200: Post-translational changes in glycosylation and phosphorylation of the immature LH receptor (59 kDa) result in several LHR variants that migrate between 93 and 44 kDa (Ref. 62 and references therein). 

Phrase: "Post-translational changes in glycosylation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "phosphorylation of the immature LH receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "(59 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "result in several LHR variants"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0201504:LHR [Laboratory Procedure]
   760   C0205419:variants [Qualitative Concept]
   760   C1274040:Result [Functional Concept]
   760   C1416843:LHR [Gene or Genome]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]
   760   C3156876:LHR [Molecular Function]

Phrase: "that"

Phrase: "migrate between 93"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0232902:migrate [Functional Concept]

Phrase: "and"

Phrase: "44 kDa (Ref. 62"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1425988:REF [Gene or Genome]
   812   C1532717:kDa [Quantitative Concept]

Phrase: "and"

Phrase: "references"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "therein"

Phrase: ")."
Processing 00000000.tx.201: Lower molecular mass species, below 48 kDa, are thought to represent the glycosylated extracellular domain (truncated receptor) and retain hormone-binding specificity (63). 

Phrase: "Lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "molecular mass species,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1705920:Species [Conceptual Entity]
   734   C3152252:Molecular Mass [Quantitative Concept]

Phrase: "below 48 kDa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "are"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the glycosylated extracellular domain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1517050:Extracellular Domain [Spatial Concept]
   827   C0521119:Extracellular [Cell Component]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(truncated receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: "and"

Phrase: "retain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "hormone-binding specificity"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0037791:Specificity [Quantitative Concept]
   827   C1511884:Specificity [Quantitative Concept]
   755 E C0205369:Specific [Qualitative Concept]
   755 E C1552740:specific [Intellectual Product]
   734   C1148622:hormone binding [Molecular Function]

Phrase: "(63"

Phrase: ")."
Processing 00000000.tx.202: Whether mature, immature, or other variants of LH receptor identified in neuroblastoma cells play a role in regulating amyloidogenesis remains to be determined. 

Phrase: "Whether"

Phrase: "mature, immature,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205252:Immature [Temporal Concept]

Phrase: "or"

Phrase: "other variants of LH receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:variants [Qualitative Concept]

Phrase: "identified in neuroblastoma cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   819   C0805527:Cells identified [Laboratory or Test Result]
   816   C0815000:neuroblastoma cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0027819:Neuroblastoma [Neoplastic Process]
   770   C0205396:Identified [Qualitative Concept]
   770   C0700095:neuroblastoma [Neoplastic Process]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C3282337:Cells [Cell]
   770   C3540583:Neuroblastoma [Intellectual Product]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "regulating"

Phrase: "amyloidogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706803:Amyloidogenesis [Cell or Molecular Dysfunction]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.203: It also is becoming clear that LH can mediate its affects not only via LH receptors but via mechanisms independent of the LH receptor and traditional downstream signaling mechanisms (59, 64). 

Phrase: "It also"

Phrase: "is"

Phrase: "becoming"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "can"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "its"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "not only via LH receptors"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   833   C0034823:Receptors, Luteinizing Hormone [Amino Acid, Peptide, or Protein,Receptor]
   816 E C1416843:LUTEINIZING HORMONE RECEPTOR [Gene or Genome]
   790   C0019929:hormone receptors [Amino Acid, Peptide, or Protein,Receptor]
   790   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   756 E C1367453:HORMONE RECEPTOR [Gene or Genome]
   753   C0019932:Hormone [Hormone]
   753   C0205171:Only [Quantitative Concept]
   753   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   753   C1518422:Not [Functional Concept]
   753   C1720467:Only [Intellectual Product]

Phrase: "but via mechanisms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0233535:but [Mental or Behavioral Dysfunction]
   790   C0441712:Mechanisms [Functional Concept]
   756 E C1706376:Mechanism [Manufactured Object]

Phrase: "independent of the LH receptor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0034823:Luteinizing Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1416843:LUTEINIZING HORMONE RECEPTOR [Gene or Genome]
   901   C0019929:Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1367453:HORMONE RECEPTOR [Gene or Genome]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   734   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "traditional downstream signaling mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0441712:Mechanisms [Functional Concept]
   779 E C1706376:Mechanism [Manufactured Object]

Phrase: "(59,"

Phrase: "64"

Phrase: ")."
Processing 00000000.tx.204: These mechanisms by which LH exerts its LH receptor-independent affects are yet to be defined. 

Phrase: "These mechanisms by which LH"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "its LH receptor-independent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0085862:Independent [Idea or Concept]
   812   C1299583:Independent [Finding]
   756   C0034823:Luteinizing Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C1416843:LUTEINIZING HORMONE RECEPTOR [Gene or Genome]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "are"

Phrase: "yet to"

Phrase: "be"

Phrase: "defined."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.205: Whether LH acts via one of these traditional or non-traditional pathways, or both, in regulating APP processing, remains to be determined. 

Phrase: "Whether"

Phrase: "LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "acts via one of these traditional"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0079613:ACT [Therapeutic or Preventive Procedure]
   753   C0205447:One [Quantitative Concept]
   753   C0443324:Traditional [Functional Concept]
   753   C1548559:Traditional [Idea or Concept]

Phrase: "or"

Phrase: "non-traditional pathways,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "or"

Phrase: "both,"

Phrase: "in"

Phrase: "regulating"

Phrase: "APP processing,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033666:protein processing [Molecular Function]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   804   C1709694:Processing [Activity]
   721   C0392747:Altered [Functional Concept]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.206: Given the complex feedback loops present within the HPG axis, it will be prudent in future studies to examine other HPG axis hormones and their receptors in mediating AD-related neurodegenerative changes. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the complex feedback loops"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0181687:loops [Medical Device]
   793 E C0419518:Loop [Medical Device]
   793 E C0445022:Loop [Spatial Concept]

Phrase: "present within the HPG axis,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   853   C0814030:Hypothalamic-pituitary-gonadal axis [Body Part, Organ, or Organ Component]
   814   C0597247:pituitary gonadal axis [Body System]
   804   C0678897:hypothalamic pituitary axis [Organ or Tissue Function]
   748   C0004457:Axis [Body Part, Organ, or Organ Component]
   748   C0018067:Gonadal [Body Part, Organ, or Organ Component]
   748   C0020663:Hypothalamic [Body Part, Organ, or Organ Component]
   748   C0032005:Pituitary, NOS [Body Part, Organ, or Organ Component]
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]
   748   C0999597:Axis [Mammal]
   748   C1522496:Axis [Spatial Concept]

Phrase: "it"

Phrase: "will"

Phrase: "be"

Phrase: "prudent in future"

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "other HPG axis hormones"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   897   C0020656:Hypothalamic Hormones [Amino Acid, Peptide, or Protein,Hormone]
   894   C1260930:Hypothalamic/pituitary hormone [Hormone]
   875   C0032015:Pituitary Hormones [Amino Acid, Peptide, or Protein,Hormone]
   853   C0301819:Gonadal Hormones [Hormone]
   804   C0019932:Hormones [Hormone]
   771   C0814030:Hypothalamic-pituitary-gonadal axis [Body Part, Organ, or Organ Component]
   722   C0678897:hypothalamic pituitary axis [Organ or Tissue Function]
   721 E C0458083:Hormonal [Qualitative Concept]
   717   C0597247:pituitary gonadal axis [Body System]

Phrase: "and"

Phrase: "their receptors in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "AD-related neurodegenerative changes."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0392747:changes [Functional Concept]
   812   C0443172:changes [Quantitative Concept]
   779 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.207: Menopause/Andropause-induced Dysregulation of the HPG AxisThe decline in reproductive function late in life leads to the complete dysregulation in the concentrations of all hormones of the hypothalamic-pituitary-gonadal (HPG) axis. 

Phrase: "Menopause/Andropause-induced Dysregulation"

Phrase: "of the HPG AxisThe decline"

Phrase: "in reproductive function"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0232896:Reproductive function [Physiologic Function]
   861   C0031843:function [Physiologic Function]
   861   C0035150:Reproductive [Organism Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C0748342:REPRODUCTIVE [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "late in life"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205087:Late [Temporal Concept]
   827   C0376558:Life [Idea or Concept]
   743 E C0595998:lives [Finding]

Phrase: "leads to the complete dysregulation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0181586:leads [Medical Device]
   760   C0205197:Complete [Qualitative Concept]
   760   C0725685:COMPLEAT [Food]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of all hormones"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019932:Hormones [Hormone]
   916 E C0458083:Hormonal [Qualitative Concept]

Phrase: "of the hypothalamic-pituitary-gonadal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018067:Gonadal [Body Part, Organ, or Organ Component]

Phrase: "(HPG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018067:Gonadal [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "axis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0004457:Axis [Body Part, Organ, or Organ Component]
  1000   C0999597:Axis [Mammal]
  1000   C1522496:Axis [Spatial Concept]
Processing 00000000.tx.208: In particular, the loss of negative feedback of 17-estradiol and testosterone on the hypothalamus/pituitary leads to a large increase in the circulating concentrations of the gonadotropins, LH and FSH. 

Phrase: "In particular,"

Phrase: "the loss of negative feedback of 17-estradiol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "testosterone on the hypothalamus/pituitary"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0039601:Testosterone [Hormone,Pharmacologic Substance,Steroid]
   704 E C0113075:Depo-testosterone [Hormone,Pharmacologic Substance,Steroid]

Phrase: "leads to a large increase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0181586:leads [Medical Device]
   760   C0442805:Increase [Functional Concept]
   760   C0549177:Large [Quantitative Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the circulating concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of the gonadotropins,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0018061:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1522385:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   966 E C3536870:Gonadotropin [Pharmacologic Substance]

Phrase: "LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "FSH."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0733758:Follicle Stimulating Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0018120:Follicle [Body Part, Organ, or Organ Component]
   827   C0019932:Hormone [Hormone]
   827   C1571705:Follicle [Body Part, Organ, or Organ Component]
   827   C1948023:Stimulating [Natural Phenomenon or Process]
   755 E C0439682:Follicular [Qualitative Concept]
   755 E C0458083:Hormonal [Qualitative Concept]
Processing 00000000.tx.209: Ovariectomy also results in a well-documented increase in serum LH and FSH concentrations in the mouse and other species (66-69). 

Phrase: "Ovariectomy also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029936:Ovariectomy [Therapeutic or Preventive Procedure]

Phrase: "results in a well-documented increase"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   753   C0205170:Well [Qualitative Concept]
   753   C0442805:Increase [Functional Concept]
   753   C1274040:Result [Functional Concept]
   753   C1301725:Documented [Health Care Activity]
   753   C1546471:Result [Idea or Concept]
   753   C1609436:documented [Idea or Concept]
   753   C2825142:Result [Finding]
   753   C3146287:Well [Manufactured Object]
   719 E C1301746:document [Intellectual Product]
   719 E C1547673:Document [Intellectual Product]

Phrase: "in serum LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0019932:Hormone [Hormone]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "FSH concentrations in the mouse"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0086045:Concentrations [Mental Process]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "other species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]

Phrase: "(66-69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450388:69 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.210: Therefore, during menopause/andropause or following castration, our results suggest that elevated LH could drive APP processing toward the amyloidogenic pathway. 

Phrase: "Therefore,"

Phrase: "during menopause/andropause"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0232984:Andropause [Finding]

Phrase: "or"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "castration,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007344:Castration [Therapeutic or Preventive Procedure]
  1000   C0029189:Castration [Therapeutic or Preventive Procedure]

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that elevated LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0019932:Hormone [Hormone]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: "could"

Phrase: "drive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "APP processing"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033666:protein processing [Molecular Function]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   804   C1709694:Processing [Activity]
   721   C0392747:Altered [Functional Concept]

Phrase: "toward the amyloidogenic pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.211: It is interesting to speculate that the increased deposition of A in female compared with male APP-transgenic mice (70, 71) might be due to the more rapid dysregulation of the HPG axis in females compared with males. 

Phrase: "It"

Phrase: "is"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "speculate"

Phrase: "that"

Phrase: "the increased deposition of A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0011560:Amyloid deposition [Pathologic Function]
   797   C1705760:Amyloid Deposition [Finding]
   760   C0333562:Deposition [Functional Concept]

Phrase: "in female"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0015780:Female [Finding]
  1000   C0043210:female [Population Group]
  1000   C0086287:female [Population Group]
  1000   C1705497:Female [Qualitative Concept]
  1000   C1705498:Female [Qualitative Concept]

Phrase: "compared with male"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0024554:Male [Finding]
   790   C0086582:male [Population Group]
   790   C1706180:Male [Qualitative Concept]
   790   C1706428:Male [Qualitative Concept]
   790   C1706429:Male [Organism Attribute]
   790   C1707455:Compared [Activity]

Phrase: "APP-transgenic mice"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   861   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   861   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   839   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0025936:Mice, Transgenic [Mammal]
   827   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0003069:Transgenic [Animal]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1709634:Precursor [Idea or Concept]
   716   C0392747:Altered [Functional Concept]

Phrase: "(70,"

Phrase: "71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: ")"

Phrase: "might"

Phrase: "be due to the more rapid dysregulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0439831:Rapid [Qualitative Concept]
   748   C2987476:Be [Conceptual Entity]
   748   C3146286:Due [Idea or Concept]

Phrase: "of the HPG axis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0814030:Hypothalamic-pituitary-gonadal axis [Body Part, Organ, or Organ Component]
   923   C0597247:pituitary gonadal axis [Body System]
   923   C0678897:hypothalamic pituitary axis [Organ or Tissue Function]
   812   C0004457:Axis [Body Part, Organ, or Organ Component]
   812   C0999597:Axis [Mammal]
   812   C1522496:Axis [Spatial Concept]

Phrase: "in females"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0015780:Females [Finding]
  1000   C0086287:Females [Population Group]
   966 E C0043210:female [Population Group]
   966 E C1705497:Female [Qualitative Concept]
   966 E C1705498:Female [Qualitative Concept]

Phrase: "compared with males."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0024554:Males [Finding]
   790   C0086582:Males [Population Group]
   790   C1707455:Compared [Activity]
   756 E C1706180:Male [Qualitative Concept]
   756 E C1706428:Male [Qualitative Concept]
   756 E C1706429:Male [Organism Attribute]
Processing 00000000.tx.212: LH, FSH, and human chorionic gonadotropin have been shown to play a critical role in brain development and neuron differentiation (72). 

Phrase: "LH,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "FSH,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0733758:Follicle Stimulating Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0018120:Follicle [Body Part, Organ, or Organ Component]
   827   C0019932:Hormone [Hormone]
   827   C1571705:Follicle [Body Part, Organ, or Organ Component]
   827   C1948023:Stimulating [Natural Phenomenon or Process]
   755 E C0439682:Follicular [Qualitative Concept]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "human chorionic gonadotropin"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0018062:human chorionic gonadotrophin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
           Chorionic Gonadotropin
  1000   C1141639:Human Chorionic Gonadotropin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1527152:Human Chorionic Gonadotropin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
           GONADOTROPHIN, CHORIONIC
   845 E C0309130:FOLLUTEIN [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0008503:Chorionic [Embryonic Structure]
   827   C0018061:Gonadotrophin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0086418:Human [Human]
   827   C0521454:Chorionic [Body Location or Region]
   827   C3536870:Gonadotropin [Pharmacologic Substance]
   755 E C1384315:chorion [Cell Component]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a critical role in brain development"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "neuron differentiation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1159970:neuron differentiation [Cell Function]
   964 E C1518294:Neuronal Differentiation [Finding]
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "(72"

Phrase: ")."
Processing 00000000.tx.213: During fetal development human chorionic gonadotropin, which binds to LH receptors, is present at concentrations 5000 times higher than during young adulthood. 

Phrase: "During fetal development human chorionic gonadotropin,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   884   C0018062:human chorionic gonadotrophin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
           Chorionic Gonadotropin
   884   C1141639:Human Chorionic Gonadotropin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   884   C1527152:Human Chorionic Gonadotropin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
           GONADOTROPHIN, CHORIONIC
   804   C0008503:Chorionic [Embryonic Structure]
   804   C0018061:Gonadotrophin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0086418:Human [Human]
   804   C0521454:Chorionic [Body Location or Region]
   804   C3536870:Gonadotropin [Pharmacologic Substance]
   784 E C0309130:FOLLUTEIN [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   733 E C1384315:chorion [Cell Component]

Phrase: "which"

Phrase: "binds to LH receptors,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0034823:Receptors, Luteinizing Hormone [Amino Acid, Peptide, or Protein,Receptor]
   845 E C1416843:LUTEINIZING HORMONE RECEPTOR [Gene or Genome]
   806   C0019929:hormone receptors [Amino Acid, Peptide, or Protein,Receptor]
   806   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   806   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   797   C1148622:hormone bind [Molecular Function]
   773 E C1367453:HORMONE RECEPTOR [Gene or Genome]
   760   C0019932:Hormone [Hormone]
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]

Phrase: "is"

Phrase: "present at concentrations 5000 times"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "higher than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0205250:High [Qualitative Concept]
   799   C1299351:High [Qualitative Concept]
   799   C2700149:HIGH [Intellectual Product]
   750 E C0489786:Height [Organism Attribute]

Phrase: "during young adulthood."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0680085:young adulthood [Age Group]
   861   C0700597:Adulthood [Temporal Concept]
Processing 00000000.tx.214: With the onset of menopause/andropause, LH concentrations increase to consistently higher levels (73, 74). 

Phrase: "With the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of menopause/andropause,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0232984:Andropause [Finding]

Phrase: "LH concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   734   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "to consistently higher levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "(73,"

Phrase: "74"

Phrase: ")."
Processing 00000000.tx.215: Interestingly, the increase in LH is higher and occurs earlier in women, who are more susceptible to AD than men. 

Phrase: "Interestingly,"

Phrase: "the increase in LH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0520970:Hormone increase [Laboratory or Test Result]
   760   C0442805:Increase [Functional Concept]

Phrase: "is"

Phrase: "higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0205250:High [Qualitative Concept]
   966   C1299351:High [Qualitative Concept]
   966   C2700149:HIGH [Intellectual Product]
   916 E C0489786:Height [Organism Attribute]

Phrase: "and"

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "earlier in women,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1279919:Early [Temporal Concept]

Phrase: "who"

Phrase: "are"

Phrase: "more susceptible to AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0231204:Susceptible [Functional Concept]
   770   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "than men."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]
Processing 00000000.tx.216: The increase in gonadotropins following menopause/andropause suggests that the neuron hormonal environment reverts back to one more akin to that of the fetal brain, which has been shown to display many similarities to AD brains, namely the presence of A (75), hyperphosphorylated tau (76), and presenilin expression (77). 

Phrase: "The increase in gonadotropins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "menopause/andropause"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0232984:Andropause [Finding]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the neuron hormonal environment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014406:Environment [Spatial Concept]

Phrase: "reverts"

Phrase: "back to one"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0004600:Back [Body Location or Region]
   790   C0205095:Back [Spatial Concept]
   790   C0460009:Back [Body Location or Region]
   790   C1995000:Back [Body Location or Region]

Phrase: "more akin to that of the fetal brain,"

Phrase: "which"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "many similarities to AD brains,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C2348205:Similarity [Qualitative Concept]

Phrase: "namely"

Phrase: "the presence of A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(75"

Phrase: ")"

Phrase: ","

Phrase: "hyperphosphorylated tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "(76"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "presenilin expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(77"

Phrase: ")."
Processing 00000000.tx.217: Because the expression of these biochemical parameters is normally associated with neurogenesis, it is possible that the post-reproductive change in HPG hormones might promote abberant re-entry of neurons into the cell cycle. 

Phrase: "Because"

Phrase: "the expression of these biochemical parameters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "normally"

Phrase: "associated with neurogenesis,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0814002:Neurogenesis [Cell Function,Organism Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   718 E C0597047:neurogenetic [Biomedical Occupation or Discipline]

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the post-reproductive change in HPG hormones"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0025320:The change [Physiologic Function]
   742   C0392747:Change [Functional Concept]
   742   C0443172:change [Quantitative Concept]
   742   C1705241:Change [Quantitative Concept]
   720   C1134488:Hormonal Change [Finding]

Phrase: "might"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "abberant re-entry of neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705654:Entry [Intellectual Product]
   760   C2986904:RE [Idea or Concept]

Phrase: "into the cell cycle."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.218: Our results indicate that the role of HPG axis hormones, other than the sex steroids, in the etiology of AD warrants further investigation. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the role of HPG axis hormones,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "other than the sex steroids,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0009253:Sex [Organism Function]
   861   C0036864:Sex [Behavior]
   861   C0038317:Steroids [Steroid]
   861   C0079399:sex [Organism Attribute]
   861   C1314687:Sex [Finding]
   861   C1522384:sex [Organism Attribute]

Phrase: "in the etiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:aetiology [Functional Concept]
  1000   C1314792:Aetiology [Functional Concept]
  1000   C1524003:Etiology [Conceptual Entity]

Phrase: "of AD warrants further investigation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C1261322:Investigation [Health Care Activity]
   812   C1552578:investigation [Idea or Concept]
   741 E C1517586:Investigational [Qualitative Concept]
   741 E C3245491:investigational [Intellectual Product]
Processing 00000000.tx.219: Because leuprolide acetate suppressed A generation in our in vivo study, blockage of the age-related increase in serum gonadotropins using gonadotropin-releasing hormone agonists/antagonists may represent a novel treatment strategy for AD.  

Phrase: "Because"

Phrase: "leuprolide acetate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0700596:Leuprolide Acetate [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   861   C0085272:Leuprolide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "A generation in our in vivo study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079411:Generation [Temporal Concept]
   748   C3146294:Generation [Activity]

Phrase: "blockage of the age-related increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1706968:Blockage [Finding]
   753   C1879887:Blockage [Phenomenon or Process]

Phrase: "in serum gonadotropins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0018061:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1522385:Gonadotropins [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827 E C3536870:Gonadotropin [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "gonadotropin-releasing hormone agonists/antagonists"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   916   C1268855:Gonadotrophin releasing hormone antagonist [Hormone,Pharmacologic Substance]
   916   C3537040:Gonadotropin Releasing Hormone Antagonist [Pharmacologic Substance]
   853   C0019927:Hormone Antagonists [Pharmacologic Substance]
   840   C0682770:agonists antagonists [Pharmacologic Substance]
   836 E C0522259:Hormone antagonist [Biologically Active Substance,Organic Chemical]
   804   C0243076:antagonists [Chemical Viewed Functionally]
   771 E C0231491:Antagonist [Organ or Tissue Function]
   737   C1268900:gonadotropin-releasing hormone agonist [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   717   C0023610:Gonadotrophin releasing hormone [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a novel treatment strategy for AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0679199:strategy [Mental Process]
Processing 00000000.tx.220: FOOTNOTES  * This work was supported by National Institute of Health Grant RO1-AG19356 and Voyager Pharmaceutical Corporation (to C. S. A.) and by The McCusker Foundation for Alzheimer's Disease Research (to R. N. M.). 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by National Institute of Health Grant RO1-AG19356"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   784   C0027468:health national institute [Health Care Related Organization]
   742   C0018173:Grant [Quantitative Concept]
   742   C0018684:Health [Idea or Concept]
   742   C0021622:institute [Organization]
   742   C1272753:Institute [Idea or Concept]
   742   C1521721:Supported [Conceptual Entity]
   742   C1548284:Grant [Idea or Concept]
   742   C3245503:national [Intellectual Product]
   708 E C0183683:Support [Medical Device]

Phrase: "and"

Phrase: "Voyager Pharmaceutical Corporation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0683758:Corporation [Organization]

Phrase: "("

Phrase: "to C. S. A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "and by The McCusker Foundation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0016617:Foundation [Organization]
   760   C1515981:And [Idea or Concept]

Phrase: "for Alzheimer's Disease Research"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "("

Phrase: "to R. N."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0687673:R.N. [Professional or Occupational Group]

Phrase: "M."

Phrase: ")."
Processing 00000000.tx.221: Drs. 

Phrase: "Drs."
Processing 00000000.tx.222: Perry, Smith, and Atwood are consultants of Voyager Pharmaceutical Corporation. 

Phrase: "Perry,"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "and"

Phrase: "Atwood"

Phrase: "are"

Phrase: "consultants of Voyager Pharmaceutical Corporation."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0009817:Consultants [Professional or Occupational Group]
   726 E C1549076:consultant [Idea or Concept]
Processing 00000000.tx.223: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.224: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.225: Section 1734 solely to indicate this fact. b Both authors contributed equally to this work. i To whom correspondence should be addressed: Dept. of Medicine, University of Wisconsin-Madison and William S. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact. b"

Phrase: "Both authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "equally to this work. i To"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0021966:I- [Inorganic Chemical]
   753   C0043227:Work [Occupational Activity]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013227:Medicine, NOS [Pharmacologic Substance]
  1000   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "University of Wisconsin-Madison"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0041740:University [Manufactured Object,Organization]
   812   C0043193:Wisconsin [Geographic Area]

Phrase: "and"

Phrase: "William S."
Processing 00000000.tx.226: Middleton Memorial VA Hospital (GRECC 11G), 2500 Overlook Terrace, Madison, WI 53705. 

Phrase: "Middleton Memorial VA Hospital"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   812   C1510665:Hospital [Qualitative Concept]
   729 E C1609061:Hospitals [Intellectual Product]

Phrase: "(GRECC 11G"

Phrase: ")"

Phrase: ","

Phrase: "2500 Overlook Terrace,"

Phrase: "Madison,"

Phrase: "WI 53705."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043193:WI [Geographic Area]
Processing 00000000.tx.227: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.228: 608-256-1901 (ext. 11664); 

Phrase: "608-256-1901"

Phrase: "(ext. 11664"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.229: Fax: 608-280-7291; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "608-280-7291"

Phrase: ";"
Processing 00000000.tx.230: E-mail: csa{at}medicine.wisc.edu . 1 The abbreviations used are: AD, Alzheimer's disease; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "csa{at}medicine.wisc.edu . 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0013227:Medicine, NOS [Pharmacologic Substance]
   799   C0025118:Medicine [Biomedical Occupation or Discipline]
   799   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
   799   C0204457:WISC [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.231: A, amyloid-; 

Phrase: "A,"

Phrase: "amyloid-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.232: HPG, hypothalamic-pituitary-gonadal; 

Phrase: "HPG, hypothalamic-pituitary-gonadal"

Phrase: ";"
Processing 00000000.tx.233: LH, luteinizing hormone; 

Phrase: "LH,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "luteinizing hormone"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.234: FSH, follicle-stimulating hormone; 

Phrase: "FSH,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0733758:Follicle Stimulating Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0018120:Follicle [Body Part, Organ, or Organ Component]
   827   C0019932:Hormone [Hormone]
   827   C1571705:Follicle [Body Part, Organ, or Organ Component]
   827   C1948023:Stimulating [Natural Phenomenon or Process]
   755 E C0439682:Follicular [Qualitative Concept]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: "follicle-stimulating hormone"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0733758:Follicle Stimulating Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0018120:Follicle [Body Part, Organ, or Organ Component]
   827   C0019932:Hormone [Hormone]
   827   C1571705:Follicle [Body Part, Organ, or Organ Component]
   827   C1948023:Stimulating [Natural Phenomenon or Process]
   755 E C0439682:Follicular [Qualitative Concept]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.235: APP, amyloid- precursor protein; 

Phrase: "APP,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   729   C0392747:Altered [Functional Concept]

Phrase: "amyloid- precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.236: ELISA, enzyme-linked immunosorbent assay; 

Phrase: "ELISA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014441:ELISA [Laboratory Procedure]

Phrase: "enzyme-linked immunosorbent assay"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.237: FCS, fetal calf serum; 

Phrase: "FCS,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0230445:Calf [Body Location or Region]
   827   C0521457:Fetal [Functional Concept]
   827   C1305418:Calf [Body Part, Organ, or Organ Component]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   771 E C0626053:sural [Pharmacologic Substance]

Phrase: "fetal calf serum"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0230445:Calf [Body Location or Region]
   827   C0521457:Fetal [Functional Concept]
   827   C1305418:Calf [Body Part, Organ, or Organ Component]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   771 E C0626053:sural [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.238: PBS, phosphate-buffered saline; 

Phrase: "PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.239: GnRH, gonadotropin-releasing hormone; 

Phrase: "GnRH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023610:Gn-RH [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]

Phrase: "gonadotropin-releasing hormone"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
  1000   C0023610:Gonadotrophin releasing hormone [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   827   C0018061:Gonadotrophin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0019932:Hormone [Hormone]
   827   C1283071:Releasing [Functional Concept]
   827   C3536870:Gonadotropin [Pharmacologic Substance]
   793 E C0030685:Release [Health Care Activity]
   793 E C0391871:Release [Functional Concept]
   793 E C0439180:% release [Quantitative Concept]
   793 E C0680255:release [Health Care Activity]
   793 E C1963578:Release [Therapeutic or Preventive Procedure]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.240: PS1, presenilin-1; 

Phrase: "PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "presenilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ";"
Processing 00000000.tx.241: -APPs, -APP soluble. 

Phrase: "-APPs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: "-"

Phrase: "APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   729   C0392747:Altered [Functional Concept]

Phrase: "soluble."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]
Processing 00000000.tx.242: 2 LH: control mice (8 months old = 0.5 ng/ml versus ovariectomized mice (8 months old) = 2.1 ng/ml; 

Phrase: "2 LH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0023607:Luteinising hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C1704298:Leuteinizing Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0019932:Hormone [Hormone]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: ":"

Phrase: "control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(8 months old = 0.5 ng/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C0439275:ng/mL [Quantitative Concept]
   795   C0439526:/mL [Quantitative Concept]

Phrase: "versus"

Phrase: "ovariectomized mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(8 months old) = 2.1 ng/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C0439275:ng/mL [Quantitative Concept]
   795   C0439526:/mL [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.243: FSH: control mice (8 months old) = 10.2 ng/ml versus ovariectomized mice (8 months old) = 74.5 ng/ml (65).  

Phrase: "FSH"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0733758:Follicle Stimulating Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0018120:Follicle [Body Part, Organ, or Organ Component]
   827   C0019932:Hormone [Hormone]
   827   C1571705:Follicle [Body Part, Organ, or Organ Component]
   827   C1948023:Stimulating [Natural Phenomenon or Process]
   755 E C0439682:Follicular [Qualitative Concept]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: ":"

Phrase: "control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(8 months old) = 10.2 ng/ml"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   852   C3642200:10^2/mL [Quantitative Concept]
   818   C0439275:ng/mL [Quantitative Concept]
   795   C0439526:/mL [Quantitative Concept]

Phrase: "versus"

Phrase: "ovariectomized mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(8 months old) = 74.5 ng/ml (65"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0439275:ng/mL [Quantitative Concept]
   793   C0439231:months [Temporal Concept]
   793   C0439526:/mL [Quantitative Concept]
   793   C0450385:65 [Intellectual Product]
   793   C0580836:Old [Temporal Concept]
   760 E C0439507:/month [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.244: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Cai, X. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X."
Processing 00000000.tx.245: D., Golde, T. 

Phrase: "D."

Phrase: ","

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.246: E., and Younkin, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.247: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.248: (1993) Science 259, 514-516[Medline] [OrderarticleviaInfotrieve] Haass, C., Hung, A. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Science 259,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "514-516"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Haass,"

Phrase: "C.,"

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.249: Y., Selkoe, D. 

Phrase: "Y.,"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.250: J., and Teplow, D. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.251: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.252: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.253: Biol. 

Phrase: "Biol."
Processing 00000000.tx.254: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.255: 269, 17741-17748[Abstract/Free FullText] Suzuki, N., Cheung, T. 

Phrase: "269,"

Phrase: "17741-17748"

Phrase: "[Abstract/Free FullText"

Phrase: "] Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Cheung,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.256: T., Cai, X. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X."
Processing 00000000.tx.257: D., Odaka, A., Otvos, L., Jr., Eckman, C., Golde, T. 

Phrase: "D."

Phrase: ","

Phrase: "Odaka,"

Phrase: "A.,"

Phrase: "Otvos,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Eckman,"

Phrase: "C.,"

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.258: E., and Younkin, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.259: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.260: (1994) Science 264, 1336-1340[Medline] [OrderarticleviaInfotrieve] Martins, R. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Science 264,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1336-1340"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Martins,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.261: N., Turner, B. 

Phrase: "N., Turner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.262: A., Carroll, R. 

Phrase: "A.,"

Phrase: "Carroll,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.263: T., Sweeney, D., Kim, K. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sweeney,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0270811:Sweeney [Disease or Syndrome]

Phrase: "D."

Phrase: ","

Phrase: "Kim,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.264: S., Wisniewski, H. 

Phrase: "S."

Phrase: ","

Phrase: "Wisniewski,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.265: M., Blass, J. 

Phrase: "M."

Phrase: ","

Phrase: "Blass,"

Phrase: "J."
Processing 00000000.tx.266: P., Gibson, G. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gibson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.267: E., and Gandy, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.268: (1995) Neuroreport 7, 217-220[Medline] [OrderarticleviaInfotrieve] Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Neuroreport 7,"

Phrase: "217-220"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Scheuner,"

Phrase: "D."

Phrase: ","

Phrase: "Eckman,"

Phrase: "C.,"

Phrase: "Jensen,"

Phrase: "M."

Phrase: ","

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "X.,"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.269: D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lahad, E., Viitanen, M., Peskind, E., Poorkaj, P., Schellenberg, G., Tanzi, R., Wasco, W., Lannfelt, L., Selkoe, D., and Younkin, S. 

Phrase: "D."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Kukull,"

Phrase: "W.,"

Phrase: "Larson,"

Phrase: "E.,"

Phrase: "Levy-Lahad,"

Phrase: "E.,"

Phrase: "Viitanen,"

Phrase: "M."

Phrase: ","

Phrase: "Peskind,"

Phrase: "E.,"

Phrase: "Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Schellenberg,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Tanzi,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Selkoe,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.270: (1996) Nat. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.271: Med. 

Phrase: "Med."
Processing 00000000.tx.272: 2, 864-870[Medline] [OrderarticleviaInfotrieve] Borchelt, D. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "864-870"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Borchelt,"

Phrase: "D."
Processing 00000000.tx.273: R., Thinakaran, G., Eckman, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.274: B., Lee, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.275: K., Davenport, F., Ratovitsky, T., Prada, C. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Davenport,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Ratovitsky,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Prada,"

Phrase: "C."
Processing 00000000.tx.276: M., Kim, G., Seekins, S., Yager, D., Slunt, H. 

Phrase: "M."

Phrase: ","

Phrase: "Kim,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Seekins,"

Phrase: "S."

Phrase: ","

Phrase: "Yager,"

Phrase: "D."

Phrase: ","

Phrase: "Slunt,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.277: H., Wang, R., Seeger, M., Levey, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wang,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Seeger,"

Phrase: "M."

Phrase: ","

Phrase: "Levey,"

Phrase: "A."
Processing 00000000.tx.278: I., Gandy, S. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.279: E., Copeland, N. 

Phrase: "E.,"

Phrase: "Copeland,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.280: G., Jenkins, N. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Jenkins,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.281: A., Price, D. 

Phrase: "A.,"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.282: L., Younkin, S. 

Phrase: "L., Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.283: G., and Sisodia, S. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.284: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.285: (1996) Neuron 17, 1005-1013[Medline] [OrderarticleviaInfotrieve] Lemere, C. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neuron 17,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "1005-1013"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lemere,"

Phrase: "C."
Processing 00000000.tx.286: A., Lopera, F., Kosik, K. 

Phrase: "A.,"

Phrase: "Lopera,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Kosik,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.287: S., Lendon, C. 

Phrase: "S."

Phrase: ","

Phrase: "Lendon,"

Phrase: "C."
Processing 00000000.tx.288: L., Ossa, J., Saido, T. 

Phrase: "L., Ossa,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0262950:Ossa [Body Part, Organ, or Organ Component]
   861   C1825255:OSSA [Gene or Genome]

Phrase: "J.,"

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.289: C., Yamaguchi, H., Ruiz, A., Martinez, A., Madrigal, L., Hincapie, L., Arango, J. 

Phrase: "C.,"

Phrase: "Yamaguchi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ruiz,"

Phrase: "A.,"

Phrase: "Martinez,"

Phrase: "A.,"

Phrase: "Madrigal,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hincapie,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Arango,"

Phrase: "J."
Processing 00000000.tx.290: C., Anthony, D. 

Phrase: "C.,"

Phrase: "Anthony,"

Phrase: "D."
Processing 00000000.tx.291: C., Koo, E. 

Phrase: "C.,"

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.292: H., Goate, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Goate,"

Phrase: "A."
Processing 00000000.tx.293: M., and Selkoe, D. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.294: J. 

Phrase: "J."
Processing 00000000.tx.295: (1996) Nat. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.296: Med. 

Phrase: "Med."
Processing 00000000.tx.297: 2, 1146-1150[Medline] [OrderarticleviaInfotrieve] Glenner, G. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "1146-1150"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Glenner,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.298: G., and Wong, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Wong,"

Phrase: "C."
Processing 00000000.tx.299: W. 

Phrase: "W."
Processing 00000000.tx.300: (1984) Biochem. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.301: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.302: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.303: Commun. 

Phrase: "Commun."
Processing 00000000.tx.304: 120, 885-890[Medline] [OrderarticleviaInfotrieve] Masters, C. 

Phrase: "120,"

Phrase: "885-890"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.305: L., Simms, G., Weinman, N. 

Phrase: "L., Simms,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Weinman,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.306: A., Multhaup, G., McDonald, B. 

Phrase: "A.,"

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "McDonald,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.307: L., and Beyreuther, K. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.308: (1985) Proc. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.309: Natl. 

Phrase: "Natl."
Processing 00000000.tx.310: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.311: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.312: U. 

Phrase: "U."
Processing 00000000.tx.313: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.314: A. 

Phrase: "A."
Processing 00000000.tx.315: 82, 4245-4249[Abstract] Jorm, A. 

Phrase: "82,"

Phrase: "4245-4249"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Jorm,"

Phrase: "A."
Processing 00000000.tx.316: F., Korten, A. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Korten,"

Phrase: "A."
Processing 00000000.tx.317: E., and Henderson, A. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Henderson,"

Phrase: "A."
Processing 00000000.tx.318: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.319: (1987) Acta Psychiatr. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Acta Psychiatr."
Processing 00000000.tx.320: Scand. 

Phrase: "Scand."
Processing 00000000.tx.321: 76, 465-479[Medline] [OrderarticleviaInfotrieve] McGonigal, G., Thomas, B., McQuade, C., Starr, J. 

Phrase: "76,"

Phrase: "465-479"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] McGonigal,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Thomas,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "McQuade,"

Phrase: "C.,"

Phrase: "Starr,"

Phrase: "J."
Processing 00000000.tx.322: M., MacLennan, W. 

Phrase: "M."

Phrase: ","

Phrase: "MacLennan,"

Phrase: "W."
Processing 00000000.tx.323: J., and Whalley, L. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Whalley,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.324: J. 

Phrase: "J."
Processing 00000000.tx.325: (1993) Br. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Br."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704648:Br. [Conceptual Entity]
Processing 00000000.tx.326: Med. 

Phrase: "Med."
Processing 00000000.tx.327: J. 

Phrase: "J."
Processing 00000000.tx.328: 306, 680-683[Medline] [OrderarticleviaInfotrieve] Manly, J. 

Phrase: "306,"

Phrase: "680-683"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Manly, J."
Processing 00000000.tx.329: J., Merchant, C. 

Phrase: "J.,"

Phrase: "Merchant,"

Phrase: "C."
Processing 00000000.tx.330: A., Jacobs, D. 

Phrase: "A.,"

Phrase: "Jacobs,"

Phrase: "D."
Processing 00000000.tx.331: M., Small, S. 

Phrase: "M."

Phrase: ","

Phrase: "Small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.332: A., Bell, K., Ferin, M., and Mayeux, R. 

Phrase: "A.,"

Phrase: "Bell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706917:Bell [Manufactured Object]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ferin,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Mayeux,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.333: (2000) Neurology 54, 833-837[Abstract/Free FullText] Bowen, R. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neurology 54,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "833-837"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bowen,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.334: L., Isley, J. 

Phrase: "L., Isley,"

Phrase: "J."
Processing 00000000.tx.335: P., Atkinson, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Atkinson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.336: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.337: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.338: Neuroendocrinol. 

Phrase: "Neuroendocrinol."
Processing 00000000.tx.339: 12, 351-354[CrossRef][Medline] [OrderarticleviaInfotrieve] Hogervorst, E., Williams, J., Budge, M., Barnetson, L., Combrinck, M., and Smith, A. 

Phrase: "12,"

Phrase: "351-354"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hogervorst,"

Phrase: "E.,"

Phrase: "Williams,"

Phrase: "J.,"

Phrase: "Budge"

Phrase: ","

Phrase: "M."

Phrase: ","

Phrase: "Barnetson,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Combrinck,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "A."
Processing 00000000.tx.340: D. 

Phrase: "D."
Processing 00000000.tx.341: (2001) Neuroendocrinol. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Neuroendocrinol."
Processing 00000000.tx.342: Lett. 

Phrase: "Lett."
Processing 00000000.tx.343: 22, 163-168[Medline] [OrderarticleviaInfotrieve] Henderson, V. 

Phrase: "22,"

Phrase: "163-168"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Henderson,"

Phrase: "V."
Processing 00000000.tx.344: W., Paganini-Hill, A., Miller, B. 

Phrase: "W., Paganini-Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442532:Hill [Spatial Concept]

Phrase: "A.,"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.345: L., Elble, R. 

Phrase: "L., Elble,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.346: J., Reyes, P. 

Phrase: "J.,"

Phrase: "Reyes,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.347: F., Shoupe, D., McCleary, C. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Shoupe,"

Phrase: "D."

Phrase: ","

Phrase: "McCleary,"

Phrase: "C."
Processing 00000000.tx.348: A., Klein, R. 

Phrase: "A.,"

Phrase: "Klein,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.349: A., Hake, A. 

Phrase: "A.,"

Phrase: "Hake,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0452985:Hake [Food]
  1000   C1021854:hake [Fish]

Phrase: "A."
Processing 00000000.tx.350: M., and Farlow, M. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Farlow,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.351: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.352: (2000) Neurology 54, 295-301[Abstract/Free FullText] Tang, M. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neurology 54,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "295-301"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tang,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.353: X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H., and Mayeux, R. 

Phrase: "X.,"

Phrase: "Jacobs,"

Phrase: "D."

Phrase: ","

Phrase: "Stern,"

Phrase: "Y.,"

Phrase: "Marder,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Schofield,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gurland,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Andrews,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Mayeux,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.354: (1996) Lancet 348, 429-432[CrossRef][Medline] [OrderarticleviaInfotrieve] Kawas, C., Resnick, S., Morrison, A., Brookmeyer, R., Corrada, M., Zonderman, A., Bacal, C., Lingle, D. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Lancet 348,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: "429-432"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kawas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521083:Kawas [Plant]

Phrase: "C.,"

Phrase: "Resnick,"

Phrase: "S."

Phrase: ","

Phrase: "Morrison,"

Phrase: "A.,"

Phrase: "Brookmeyer,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Corrada,"

Phrase: "M."

Phrase: ","

Phrase: "Zonderman,"

Phrase: "A.,"

Phrase: "Bacal,"

Phrase: "C.,"

Phrase: "Lingle,"

Phrase: "D."
Processing 00000000.tx.355: D., and Metter, E. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Metter,"

Phrase: "E."
Processing 00000000.tx.356: (1997) Neurology 48, 1517-1521[Abstract] Petanceska, S. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neurology 48,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "1517-1521"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Petanceska,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.357: S., Nagy, V., Frail, D., and Gandy, S. 

Phrase: "S."

Phrase: ","

Phrase: "Nagy,"

Phrase: "V.,"

Phrase: "Frail,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871754:Frail [Finding]
   928 E C0424594:Frailty [Finding]

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.358: (2000) Exp. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.359: Gerontol. 

Phrase: "Gerontol."
Processing 00000000.tx.360: 35, 1317-1325[CrossRef][Medline] [OrderarticleviaInfotrieve] Zheng, H., Xu, H., Uljon, S. 

Phrase: "35,"

Phrase: "1317-1325"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Zheng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986502:Zheng [Therapeutic or Preventive Procedure]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Xu,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Uljon,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.361: N., Gross, R., Hardy, K., Gaynor, J., Lafrancois, J., Simpkins, J., Refolo, L. 

Phrase: "N., Gross, R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "Hardy,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gaynor,"

Phrase: "J.,"

Phrase: "Lafrancois,"

Phrase: "J.,"

Phrase: "Simpkins,"

Phrase: "J.,"

Phrase: "Refolo,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.362: M., Petanceska, S., Wang, R., and Duff, K. 

Phrase: "M."

Phrase: ","

Phrase: "Petanceska,"

Phrase: "S."

Phrase: ","

Phrase: "Wang,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Duff,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.363: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.364: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.365: 80, 191-196[CrossRef][Medline] [OrderarticleviaInfotrieve] Couzinet, B., and Schaison, G. 

Phrase: "80,"

Phrase: "191-196"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Couzinet,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Schaison,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.366: (1993) Human. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Human."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]
Processing 00000000.tx.367: Reprod. 

Phrase: "Reprod."
Processing 00000000.tx.368: Suppl. 

Phrase: "Suppl."
Processing 00000000.tx.369: 2, 97-101 Chakravarti, S., Collins, W. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "97-101 Chakravarti,"

Phrase: "S."

Phrase: ","

Phrase: "Collins,"

Phrase: "W."
Processing 00000000.tx.370: P., Forecast, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Forecast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016538:forecast [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.371: D., Newton, J. 

Phrase: "D."

Phrase: ","

Phrase: "Newton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0542569:newton [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.372: R., Oram, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Oram,"

Phrase: "D."
Processing 00000000.tx.373: H., and Studd, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Studd,"

Phrase: "J."
Processing 00000000.tx.374: W. 

Phrase: "W."
Processing 00000000.tx.375: (1976) Br. 

Phrase: "(1976"

Phrase: ")"

Phrase: "Br."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704648:Br. [Conceptual Entity]
Processing 00000000.tx.376: Med. 

Phrase: "Med."
Processing 00000000.tx.377: J. 

Phrase: "J."
Processing 00000000.tx.378: 2, 784-787[Medline] [OrderarticleviaInfotrieve] Neaves, W. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "784-787"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Neaves,"

Phrase: "W."
Processing 00000000.tx.379: B., Johnson, L., Porter, J. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Johnson,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Porter,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0402671:Porter [Professional or Occupational Group]
  1000   C2244327:porter [Molecular Function]

Phrase: "J."
Processing 00000000.tx.380: C., Parker, C. 

Phrase: "C.,"

Phrase: "Parker,"

Phrase: "C."
Processing 00000000.tx.381: R., Jr., and Petty, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "and"

Phrase: "Petty, C."
Processing 00000000.tx.382: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.383: (1984) J. 

Phrase: "(1984"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.384: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.385: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.386: Metab. 

Phrase: "Metab."
Processing 00000000.tx.387: 59, 756-763[Abstract] Short, R. 

Phrase: "59,"

Phrase: "756-763"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Short, R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.388: A., Bowen, R. 

Phrase: "A.,"

Phrase: "Bowen,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.389: L., O'Brien, P. 

Phrase: "L., O'Brien,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.390: C., and Graff-Radford, N. 

Phrase: "C.,"

Phrase: "and"

Phrase: "Graff-Radford,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.391: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.392: (2001) Mayo Clin. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Mayo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0454788:Mayo [Geographic Area]
  1000   C1077578:mayo [Plant]

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.393: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.394: 76, 906-909[Medline] [OrderarticleviaInfotrieve] Lei, Z. 

Phrase: "76,"

Phrase: "906-909"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lei,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "Z."
Processing 00000000.tx.395: M., Rao, C. 

Phrase: "M."

Phrase: ","

Phrase: "Rao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412430:RAO [Gene or Genome]

Phrase: "C."
Processing 00000000.tx.396: V., Kornyei, J. 

Phrase: "V., Kornyei,"

Phrase: "J."
Processing 00000000.tx.397: L., Licht, P., and Hiatt, E. 

Phrase: "L., Licht,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Hiatt,"

Phrase: "E."
Processing 00000000.tx.398: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.399: (1993) Endocrinology 132, 2262-2270[Abstract] Al-Hader, A. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Endocrinology 132,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: "2262-2270"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Al-Hader,"

Phrase: "A."
Processing 00000000.tx.400: A., Lei, Z. 

Phrase: "A.,"

Phrase: "Lei,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "Z."
Processing 00000000.tx.401: M., and Rao, C. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Rao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412430:RAO [Gene or Genome]

Phrase: "C."
Processing 00000000.tx.402: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.403: (1997) Biol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biol."
Processing 00000000.tx.404: Reprod. 

Phrase: "Reprod."
Processing 00000000.tx.405: 56, 501-507[Abstract] Al-Hader, A. 

Phrase: "56,"

Phrase: "501-507"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450381:507 [Intellectual Product]

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Al-Hader,"

Phrase: "A."
Processing 00000000.tx.406: A., Lei, Z. 

Phrase: "A.,"

Phrase: "Lei,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "Z."
Processing 00000000.tx.407: M., and Rap, C. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Rap,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416920:RAP [Gene or Genome]

Phrase: "C."
Processing 00000000.tx.408: V. 

Phrase: "V."
Processing 00000000.tx.409: (1997) Biol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biol."
Processing 00000000.tx.410: Reprod. 

Phrase: "Reprod."
Processing 00000000.tx.411: 56, 1071-1076[Abstract] Lukacs, H., Hiatt, E. 

Phrase: "56,"

Phrase: "1071-1076"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lukacs,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hiatt,"

Phrase: "E."
Processing 00000000.tx.412: S., Lei, Z. 

Phrase: "S."

Phrase: ","

Phrase: "Lei,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "Z."
Processing 00000000.tx.413: M., and Rao, C. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Rao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412430:RAO [Gene or Genome]

Phrase: "C."
Processing 00000000.tx.414: V. 

Phrase: "V."
Processing 00000000.tx.415: (1995) Horm. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Horm."
Processing 00000000.tx.416: Behav. 

Phrase: "Behav."
Processing 00000000.tx.417: 29, 42-58[CrossRef][Medline] [OrderarticleviaInfotrieve] Bowen, R. 

Phrase: "29,"

Phrase: "42-58"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bowen,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.418: L., Smith, M. 

Phrase: "L., Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.419: A., Harris, P. 

Phrase: "A.,"

Phrase: "Harris,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.420: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.421: R., Kubat, Z., Martins, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kubat,"

Phrase: "Z.,"

Phrase: "Martins,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.422: N., Castellani, R. 

Phrase: "N., Castellani,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.423: J., Perry, G., and Atwood, C. 

Phrase: "J.,"

Phrase: "Perry,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Atwood,"

Phrase: "C."
Processing 00000000.tx.424: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.425: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.426: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.427: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.428: 70, 514-518[CrossRef][Medline] [OrderarticleviaInfotrieve] Verdile, G., Fraser, P., St George Hyslop, P., Kwok, J. 

Phrase: "70,"

Phrase: "514-518"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Verdile,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Fraser,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "St George Hyslop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1553316:St. George [Population Group]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kwok,"

Phrase: "J."
Processing 00000000.tx.429: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.430: J., Schofield, P. 

Phrase: "J.,"

Phrase: "Schofield,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.431: R., Fisher, C., Helmerhorst, E., and Martins, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Fisher,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325045:Fisher [Mammal]

Phrase: "C.,"

Phrase: "Helmerhorst,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Martins,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.432: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.433: (1999) Alzheimer's Rep. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Alzheimer's Rep."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1744664:REP [Molecular Function]
Processing 00000000.tx.434: 2, 231-239 Mathews, P. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "231-239 Mathews,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.435: M., Guerra, C. 

Phrase: "M."

Phrase: ","

Phrase: "Guerra,"

Phrase: "C."
Processing 00000000.tx.436: B., Jiang, Y., Grbovic, O. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Jiang,"

Phrase: "Y.,"

Phrase: "Grbovic,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.437: M., Kao, B. 

Phrase: "M."

Phrase: ","

Phrase: "Kao,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.438: H., Schmidt, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Schmidt,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.439: D., Dinakar, R., Mercken, M., Hille-Rehfeld, A., Rohrer, J., Mehta, P., Cataldo, A. 

Phrase: "D."

Phrase: ","

Phrase: "Dinakar,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Mercken,"

Phrase: "M."

Phrase: ","

Phrase: "Hille-Rehfeld,"

Phrase: "A.,"

Phrase: "Rohrer,"

Phrase: "J.,"

Phrase: "Mehta,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Cataldo,"

Phrase: "A."
Processing 00000000.tx.440: M., and Nixon, R. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Nixon,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.441: A. 

Phrase: "A."
Processing 00000000.tx.442: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.443: Biol. 

Phrase: "Biol."
Processing 00000000.tx.444: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.445: 277, 5299-5307[Abstract/Free FullText] Ida, N., Hartmann, T., Pantel, J., Schroder, J., Zerfass, R., Forstl, H., Sandbrink, R., Masters, C. 

Phrase: "277,"

Phrase: "5299-5307"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ida,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020789:IDA [Organic Chemical,Pharmacologic Substance]
  1000   C0063555:IdA [Organic Chemical,Pharmacologic Substance]
  1000   C2275731:Ida [Plant]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hartmann,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Pantel,"

Phrase: "J.,"

Phrase: "Schroder,"

Phrase: "J.,"

Phrase: "Zerfass,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Forstl,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sandbrink,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.446: L., and Beyreuther, K. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.447: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.448: Biol. 

Phrase: "Biol."
Processing 00000000.tx.449: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.450: 271, 22908-22914[Abstract/Free FullText] Verdile, G., Martins, R. 

Phrase: "271,"

Phrase: "22908-22914"

Phrase: "[Abstract/Free FullText"

Phrase: "] Verdile,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Martins,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.451: N., Duthie, M., Holmes, E., St George-Hyslop, P. 

Phrase: "N., Duthie,"

Phrase: "M."

Phrase: ","

Phrase: "Holmes,"

Phrase: "E.,"

Phrase: "St George-Hyslop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1553316:St. George [Population Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.452: H., and Fraser, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.453: E. 

Phrase: "E."
Processing 00000000.tx.454: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.455: Biol. 

Phrase: "Biol."
Processing 00000000.tx.456: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.457: 275, 20794-20798[Abstract/Free FullText] Johnson-Wood, K., Lee, M., Motter, R., Hu, K., Gordon, G., Barbour, R., Khan, K., Gordon, M., Tan, H., Games, D., Lieberburg, I., Schenk, D., Seubert, P., and McConlogue, L. 

Phrase: "275,"

Phrase: "20794-20798"

Phrase: "[Abstract/Free FullText"

Phrase: "] Johnson-Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Motter,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gordon,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Barbour,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Khan,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gordon,"

Phrase: "M."

Phrase: ","

Phrase: "Tan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302595:tan [Individual Behavior]
  1000   C1537110:Tan [Clinical Attribute]
  1000   C3275241:Tan [Qualitative Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Games,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150593:games [Daily or Recreational Activity]

Phrase: "D."

Phrase: ","

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "McConlogue,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.458: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.459: Natl. 

Phrase: "Natl."
Processing 00000000.tx.460: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.461: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.462: U. 

Phrase: "U."
Processing 00000000.tx.463: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.464: A. 

Phrase: "A."
Processing 00000000.tx.465: 94, 1550-1555[Abstract/Free FullText] Morishima-Kawashima, M., and Ihara, Y. 

Phrase: "94,"

Phrase: "1550-1555"

Phrase: "[Abstract/Free FullText"

Phrase: "] Morishima-Kawashima,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Ihara,"

Phrase: "Y."
Processing 00000000.tx.466: (1998) Biochemistry 37, 15247-15253[CrossRef][Medline] [OrderarticleviaInfotrieve] Misonou, H., Morishima-Kawashima, M., and Ihara, Y. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochemistry 37,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "15247-15253"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Misonou,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Morishima-Kawashima,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Ihara,"

Phrase: "Y."
Processing 00000000.tx.467: (2000) Biochemistry 39, 6951-6959[CrossRef][Medline] [OrderarticleviaInfotrieve] Mehta, P. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Biochemistry 39,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "6951-6959"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mehta,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.468: D., Dalton, A. 

Phrase: "D."

Phrase: ","

Phrase: "Dalton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678223:dalton [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.469: J., Mehta, S. 

Phrase: "J.,"

Phrase: "Mehta,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.470: P., Kim, K. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kim,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.471: S., Sersen, E. 

Phrase: "S."

Phrase: ","

Phrase: "Sersen,"

Phrase: "E."
Processing 00000000.tx.472: A., and Wisniewski, H. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Wisniewski,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.473: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.474: (1998) Neurosci. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.475: Lett. 

Phrase: "Lett."
Processing 00000000.tx.476: 241, 13-16[CrossRef][Medline] [OrderarticleviaInfotrieve] Mehta, P. 

Phrase: "241,"

Phrase: "13-16"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mehta,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.477: D., Pirttila, T., Mehta, S. 

Phrase: "D."

Phrase: ","

Phrase: "Pirttila,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mehta,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.478: P., Sersen, E. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sersen,"

Phrase: "E."
Processing 00000000.tx.479: A., Aisen, P. 

Phrase: "A.,"

Phrase: "Aisen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.480: S., and Wisniewski, H. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Wisniewski,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.481: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.482: (2000) Arch. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.483: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.484: 57, 100-105[Abstract/Free FullText] Beffert, U., Cohn, J. 

Phrase: "57,"

Phrase: "100-105"

Phrase: "[Abstract/Free FullText"

Phrase: "] Beffert,"

Phrase: "U.,"

Phrase: "Cohn,"

Phrase: "J."
Processing 00000000.tx.485: S., Petit-Turcotte, C., Tremblay, M., Aumont, N., Ramassamy, C., Davignon, J., and Poirier, J. 

Phrase: "S."

Phrase: ","

Phrase: "Petit-Turcotte,"

Phrase: "C.,"

Phrase: "Tremblay,"

Phrase: "M."

Phrase: ","

Phrase: "Aumont,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Ramassamy,"

Phrase: "C.,"

Phrase: "Davignon,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Poirier,"

Phrase: "J."
Processing 00000000.tx.486: (1999) Brain Res. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.487: 843, 87-94[CrossRef][Medline] [OrderarticleviaInfotrieve] Vaucher, E., Aumont, N., Pearson, D., Rowe, W., Poirier, J., and Kar, S. 

Phrase: "843,"

Phrase: "87-94"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Vaucher,"

Phrase: "E.,"

Phrase: "Aumont,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Pearson,"

Phrase: "D."

Phrase: ","

Phrase: "Rowe,"

Phrase: "W.,"

Phrase: "Poirier,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Kar,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1324112:KAR [Molecular Function]
  1000   C1425673:KAR [Gene or Genome]
  1000   C1862520:KAR [Disease or Syndrome]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.488: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.489: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.490: Neuroanat. 

Phrase: "Neuroanat."
Processing 00000000.tx.491: 21, 323-329[CrossRef][Medline] [OrderarticleviaInfotrieve] Okada, H., Doken, Y., Ogawa, Y., and Toguchi, H. 

Phrase: "21,"

Phrase: "323-329"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Okada,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Doken,"

Phrase: "Y.,"

Phrase: "Ogawa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443037:Ogawa [Intellectual Product]

Phrase: "Y.,"

Phrase: "and"

Phrase: "Toguchi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.492: (1994) Pharm. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Pharm."
Processing 00000000.tx.493: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.494: 11, 1199-1203[CrossRef][Medline] [OrderarticleviaInfotrieve] Okada, H., Doken, Y., and Ogawa, Y. 

Phrase: "11,"

Phrase: "1199-1203"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Okada,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Doken,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Ogawa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443037:Ogawa [Intellectual Product]

Phrase: "Y."
Processing 00000000.tx.495: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.496: Pharm. 

Phrase: "Pharm."
Processing 00000000.tx.497: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.498: 85, 1044-1048[CrossRef][Medline] [OrderarticleviaInfotrieve] Schally, A. 

Phrase: "85,"

Phrase: "1044-1048"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Schally,"

Phrase: "A."
Processing 00000000.tx.499: V., Comaru-Schally, A. 

Phrase: "V., Comaru-Schally,"

Phrase: "A."
Processing 00000000.tx.500: M., Nagy, A., Kovacs, M., Szepeshazi, K., Plonowski, A., Varga, J. 

Phrase: "M."

Phrase: ","

Phrase: "Nagy,"

Phrase: "A.,"

Phrase: "Kovacs,"

Phrase: "M."

Phrase: ","

Phrase: "Szepeshazi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Plonowski,"

Phrase: "A.,"

Phrase: "Varga,"

Phrase: "J."
Processing 00000000.tx.501: L., and Halmos, G. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Halmos,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.502: (2001) Front. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Front."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205094:front [Spatial Concept]
   928 E C0205123:Frontal [Spatial Concept]
   907 E C0016540:Forehead [Body Location or Region]
Processing 00000000.tx.503: Neuroendocrinol. 

Phrase: "Neuroendocrinol."
Processing 00000000.tx.504: 22, 248-291[CrossRef][Medline] [OrderarticleviaInfotrieve] Clayton, R. 

Phrase: "22,"

Phrase: "248-291"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Clayton,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.505: N., and Catt, K. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Catt,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.506: J. 

Phrase: "J."
Processing 00000000.tx.507: (1981) Endocr. 

Phrase: "(1981"

Phrase: ")"

Phrase: "Endocr."
Processing 00000000.tx.508: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.509: 2, 186-209[Medline] [OrderarticleviaInfotrieve] Atwood, C. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "186-209"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Atwood,"

Phrase: "C."
Processing 00000000.tx.510: S., Verdile, G., Liu, T., Smith, M. 

Phrase: "S."

Phrase: ","

Phrase: "Verdile,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Liu,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.511: A., Martins, R. 

Phrase: "A.,"

Phrase: "Martins,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.512: N., and Bowen, R. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Bowen,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.513: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.514: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.515: Menopause/Andropause Induced Elevations in Serum Gonadotropins Drive APP Processing Towards the Amyloidogenic Pathway, Society for Neuroscience, 29, Program No. 

Phrase: "Menopause/Andropause Induced Elevations in Serum Gonadotropins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0702240:elevations [Spatial Concept]
   714 E C0439775:Elevation [Therapeutic or Preventive Procedure]

Phrase: "Drive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "APP Processing"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033666:protein processing [Molecular Function]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
   804   C1709694:Processing [Activity]
   721   C0392747:Altered [Functional Concept]

Phrase: "Towards the Amyloidogenic Pathway,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "Society for Neuroscience,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0037455:society [Organization]

Phrase: "29,"

Phrase: "Program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1709697:Program [Conceptual Entity]
  1000   C2728259:Program [Pharmacologic Substance]
  1000   C3484370:Program [Functional Concept]

Phrase: "No."
Processing 00000000.tx.516: 523.22 (abstr.) 

Phrase: "523.22"

Phrase: "(abstr."

Phrase: ")"
Processing 00000000.tx.517: Washington, D. 

Phrase: "Washington,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043038:Washington [Geographic Area]

Phrase: "D."
Processing 00000000.tx.518: C. 

Phrase: "C."
Processing 00000000.tx.519: Shoji, M., Golde, T. 

Phrase: "Shoji,"

Phrase: "M."

Phrase: ","

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.520: E., Ghiso, J., Cheung, T. 

Phrase: "E.,"

Phrase: "Ghiso,"

Phrase: "J.,"

Phrase: "Cheung,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.521: T., Estus, S., Shaffer, L. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Estus,"

Phrase: "S."

Phrase: ","

Phrase: "Shaffer,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.522: M., Cai, X. 

Phrase: "M."

Phrase: ","

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X."
Processing 00000000.tx.523: D., McKay, D. 

Phrase: "D."

Phrase: ","

Phrase: "McKay,"

Phrase: "D."
Processing 00000000.tx.524: M., Tintner, R., and Frangione, B., and Younkin, S. 

Phrase: "M."

Phrase: ","

Phrase: "Tintner,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.525: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.526: (1992) Science, 258, 126-129[Medline] [OrderarticleviaInfotrieve] Golde, T. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "258,"

Phrase: "126-129"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.527: E., Cai, X. 

Phrase: "E.,"

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X."
Processing 00000000.tx.528: D., Shoji, M., and Younkin, S. 

Phrase: "D."

Phrase: ","

Phrase: "Shoji,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.529: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.530: (1993) Ann. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.531: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.532: Y. 

Phrase: "Y."
Processing 00000000.tx.533: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.534: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.535: 695, 103-108[Abstract] Indrapichate, K., Meehan, D., Lane, T. 

Phrase: "695,"

Phrase: "103-108"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Indrapichate,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Meehan,"

Phrase: "D."

Phrase: ","

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.536: A., Chu, S. 

Phrase: "A.,"

Phrase: "Chu,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.537: Y., Rao, C. 

Phrase: "Y.,"

Phrase: "Rao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412430:RAO [Gene or Genome]

Phrase: "C."
Processing 00000000.tx.538: V., Johnson, D., Chen, T. 

Phrase: "V., Johnson,"

Phrase: "D."

Phrase: ","

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.539: T., and Wimalasena, J. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Wimalasena,"

Phrase: "J."
Processing 00000000.tx.540: (1992) Biol. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Biol."
Processing 00000000.tx.541: Reprod. 

Phrase: "Reprod."
Processing 00000000.tx.542: 46, 265-278[Abstract] Bukovsky, A., Chen, T. 

Phrase: "46,"

Phrase: "265-278"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bukovsky,"

Phrase: "A.,"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.543: T., Wimalasena, J., and Caudle, M. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Wimalasena,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Caudle,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.544: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.545: (1993) Biol. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Biol."
Processing 00000000.tx.546: Reprod. 

Phrase: "Reprod."
Processing 00000000.tx.547: 48, 1367-1382[Abstract] Gawronska, B., Paukku, T., Huhtaniemi, I., Wasowicz, G., and Ziecik, A. 

Phrase: "48,"

Phrase: "1367-1382"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Gawronska,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Paukku,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Huhtaniemi,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Wasowicz,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Ziecik,"

Phrase: "A."
Processing 00000000.tx.548: J. 

Phrase: "J."
Processing 00000000.tx.549: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.550: Reprod. 

Phrase: "Reprod."
Processing 00000000.tx.551: Fertil. 

Phrase: "Fertil."
Processing 00000000.tx.552: 115, 293-301[Abstract] Ascoli, M., Fanelli, F., and Segaloff, D. 

Phrase: "115,"

Phrase: "293-301"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ascoli,"

Phrase: "M."

Phrase: ","

Phrase: "Fanelli,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Segaloff,"

Phrase: "D."
Processing 00000000.tx.553: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.554: (2002) Endocr. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Endocr."
Processing 00000000.tx.555: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.556: 23, 141-174[Abstract/Free FullText] McEwen, B. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "141-174"

Phrase: "[Abstract/Free FullText"

Phrase: "] McEwen,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.557: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.558: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.559: Appl. 

Phrase: "Appl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1858559:APPL [Gene or Genome]
Processing 00000000.tx.560: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.561: 91, 2785-2801[Abstract/Free FullText] Jaffe, A. 

Phrase: "91,"

Phrase: "2785-2801"

Phrase: "[Abstract/Free FullText"

Phrase: "] Jaffe,"

Phrase: "A."
Processing 00000000.tx.562: B., Toran-Allerand, C. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Toran-Allerand,"

Phrase: "C."
Processing 00000000.tx.563: D., Greengard, P., and Gandy, S. 

Phrase: "D."

Phrase: ","

Phrase: "Greengard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.564: E. 

Phrase: "E."
Processing 00000000.tx.565: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.566: Biol. 

Phrase: "Biol."
Processing 00000000.tx.567: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.568: 269, 13065-13068[Abstract/Free FullText] Xu, H., Gouras, G. 

Phrase: "269,"

Phrase: "13065-13068"

Phrase: "[Abstract/Free FullText"

Phrase: "] Xu,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Gouras,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.569: K., Greenfield, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Greenfield,"

Phrase: "J."
Processing 00000000.tx.570: P., Vincent, B., Naslund, J., Mazzarelli, L., Fried, G., Jovanovic, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Vincent,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Naslund,"

Phrase: "J.,"

Phrase: "Mazzarelli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Fried,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1825319:FRY [Gene or Genome]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Jovanovic,"

Phrase: "J."
Processing 00000000.tx.571: N., Seeger, M., Relkin, N. 

Phrase: "N., Seeger,"

Phrase: "M."

Phrase: ","

Phrase: "Relkin,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.572: R., Liao, F., Checler, F., Buxbaum, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Liao,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Checler,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Buxbaum,"

Phrase: "J."
Processing 00000000.tx.573: D., Chait, B. 

Phrase: "D."

Phrase: ","

Phrase: "Chait,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.574: T., Thinakaran, G., Sisodia, S. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.575: S., Wang, R., Greengard, P., and Gandy, S. 

Phrase: "S."

Phrase: ","

Phrase: "Wang,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Greengard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.576: (1998) Nat. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.577: Med. 

Phrase: "Med."
Processing 00000000.tx.578: 4, 447-451[Medline] [OrderarticleviaInfotrieve] Chang, D., Kwan, J., and Timiras, P. 

Phrase: "4,"

Phrase: "447-451"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Chang,"

Phrase: "D."

Phrase: ","

Phrase: "Kwan,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Timiras,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.579: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.580: (1997) Adv. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Adv."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001483:ADV [Virus]
Processing 00000000.tx.581: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.582: Med. 

Phrase: "Med."
Processing 00000000.tx.583: Biol. 

Phrase: "Biol."
Processing 00000000.tx.584: 429, 261-271[Medline] [OrderarticleviaInfotrieve] Manthey, D., Heck, S., Engert, S., and Behl, C. 

Phrase: "429,"

Phrase: "261-271"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Manthey,"

Phrase: "D."

Phrase: ","

Phrase: "Heck,"

Phrase: "S."

Phrase: ","

Phrase: "Engert,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Behl,"

Phrase: "C."
Processing 00000000.tx.585: (2001) Eur. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.586: J. 

Phrase: "J."
Processing 00000000.tx.587: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.588: 268, 4285-4291[Abstract/Free FullText] Gouras, G. 

Phrase: "268,"

Phrase: "4285-4291"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gouras,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.589: K., Xu, H., Gross, R. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Xu,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Gross,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439806:Gross [Qualitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.590: S., Greenfield, J. 

Phrase: "S."

Phrase: ","

Phrase: "Greenfield,"

Phrase: "J."
Processing 00000000.tx.591: P., Hai, B., Wang, R., and Greengard, P. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hai,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Wang,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Greengard,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.592: (2000) Proc. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.593: Natl. 

Phrase: "Natl."
Processing 00000000.tx.594: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.595: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.596: U. 

Phrase: "U."
Processing 00000000.tx.597: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.598: A. 

Phrase: "A."
Processing 00000000.tx.599: 97, 1202-1205[Abstract/Free FullText] Levin-Allerhand, J. 

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "1202-1205"

Phrase: "[Abstract/Free FullText"

Phrase: "] Levin-Allerhand,"

Phrase: "J."
Processing 00000000.tx.600: A., Lominska, C. 

Phrase: "A.,"

Phrase: "Lominska,"

Phrase: "C."
Processing 00000000.tx.601: E., Wang, J., and Smith, J. 

Phrase: "E.,"

Phrase: "Wang,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.602: D. 

Phrase: "D."
Processing 00000000.tx.603: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.604: Alzheimers Dis. 

Phrase: "Alzheimers Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0451119:DIS [Intellectual Product]
   861   C1444662:DIS [Finding]
Processing 00000000.tx.605: 4, 449-457[Medline] [OrderarticleviaInfotrieve] Larson, J., Larson, P. 

Phrase: "4,"

Phrase: "449-457"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Larson,"

Phrase: "J.,"

Phrase: "Larson,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.606: R., Kronenberg, H. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kronenberg,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.607: M., Melmed, S., and Polonsky, K. 

Phrase: "M."

Phrase: ","

Phrase: "Melmed,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Polonsky,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.608: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.609: (2002) Williams Textbook of Endocrinology, 10th Ed., Saunders, Philadelphia, PA West, A. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Williams Textbook of Endocrinology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0039712:textbook [Intellectual Product,Manufactured Object]

Phrase: "10th Ed.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]

Phrase: "Saunders,"

Phrase: "Philadelphia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031525:Philadelphia [Geographic Area]

Phrase: "PA West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705493:West [Spatial Concept]

Phrase: "A."
Processing 00000000.tx.610: P., and Cooke, B. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Cooke,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.611: A. 

Phrase: "A."
Processing 00000000.tx.612: (1992). 

Phrase: "(1992"

Phrase: ")."
Processing 00000000.tx.613: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.614: Soc. 

Phrase: "Soc."
Processing 00000000.tx.615: Trans. 

Phrase: "Trans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2826298:TRANS [Idea or Concept]
Processing 00000000.tx.616: 20, 320S[Medline] [OrderarticleviaInfotrieve] Minegishi, T., Delgado, C., and Dufau, M. 

Phrase: "20,"

Phrase: "320S"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Minegishi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Delgado,"

Phrase: "C.,"

Phrase: "and"

Phrase: "Dufau,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.617: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.618: (1989) Proc. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.619: Natl. 

Phrase: "Natl."
Processing 00000000.tx.620: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.621: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.622: U. 

Phrase: "U."
Processing 00000000.tx.623: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.624: A. 

Phrase: "A."
Processing 00000000.tx.625: 86, 1470-1474[Abstract] Minegishi, T., Nakamura, K., Takakura, Y., Miyamoto, K., Hasegawa, Y., Ibuki, Y., Igarashi, M., and Minegish, T (1990) Biochem. 

Phrase: "86,"

Phrase: "1470-1474"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Minegishi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nakamura,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takakura,"

Phrase: "Y.,"

Phrase: "Miyamoto,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hasegawa,"

Phrase: "Y.,"

Phrase: "Ibuki,"

Phrase: "Y.,"

Phrase: "Igarashi,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Minegish,"

Phrase: "T (1990"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.626: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.627: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.628: Commun. 

Phrase: "Commun."
Processing 00000000.tx.629: 172, 1049-1054[Medline] [OrderarticleviaInfotrieve] Bukovsky, A., Indrapichate, K., Fujiwara, H., Cekanova, M., Ayala, M. 

Phrase: "172,"

Phrase: "1049-1054"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bukovsky,"

Phrase: "A.,"

Phrase: "Indrapichate,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fujiwara,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Cekanova,"

Phrase: "M."

Phrase: ","

Phrase: "Ayala,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.630: E., Dominguez, R., Caudle, M. 

Phrase: "E.,"

Phrase: "Dominguez,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Caudle,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.631: R., Wimalsena, J., Elder, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wimalsena,"

Phrase: "J.,"

Phrase: "Elder,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331055:Elder [Plant]
  1000   C0994408:Elder [Organic Chemical,Pharmacologic Substance]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.632: F., Copas, P., Foster, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Copas,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0055598:COPA [Therapeutic or Preventive Procedure]
  1000   C0163868:COPA [Therapeutic or Preventive Procedure]
  1000   C1413605:COPA [Gene or Genome]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Foster,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242298:foster [Daily or Recreational Activity]
  1000   C0344349:foster [Family Group]

Phrase: "J."
Processing 00000000.tx.633: S., Fernando, R. 

Phrase: "S."

Phrase: ","

Phrase: "Fernando,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.634: I., Henley, D. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Henley,"

Phrase: "D."
Processing 00000000.tx.635: C., and Upadhyaya, N. 

Phrase: "C.,"

Phrase: "and"

Phrase: "Upadhyaya,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.636: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.637: (2003) Reprod. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Reprod."
Processing 00000000.tx.638: Biol. 

Phrase: "Biol."
Processing 00000000.tx.639: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.640: 1, 46[CrossRef][Medline] [OrderarticleviaInfotrieve] Thomas, D. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "46"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Thomas,"

Phrase: "D."
Processing 00000000.tx.641: M., and Segaloff, D. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Segaloff,"

Phrase: "D."
Processing 00000000.tx.642: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.643: (1994) Endocrinology 135, 1902-1912[Abstract] Yarram, S. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Endocrinology 135,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: "1902-1912"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Yarram,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.644: J., Perry, M. 

Phrase: "J.,"

Phrase: "Perry,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.645: J., Christopher, T. 

Phrase: "J.,"

Phrase: "Christopher,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.646: J., Westby, K., Brown, N. 

Phrase: "J.,"

Phrase: "Westby,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.647: L., Lamminen, T., Rulli, S. 

Phrase: "L., Lamminen,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Rulli,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.648: B., Zhang, F. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Zhang,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.649: P., Huhtaniemi, I., Sandy, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Huhtaniemi,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sandy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0037098:Sand [Biomedical or Dental Material,Inorganic Chemical]

Phrase: "J."
Processing 00000000.tx.650: R., and Mansell, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Mansell,"

Phrase: "J."
Processing 00000000.tx.651: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.652: (2003) Endocrinology 144, 3555-3564[Abstract/Free FullText] Parlow, A. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Endocrinology 144,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: "3555-3564"

Phrase: "[Abstract/Free FullText"

Phrase: "] Parlow,"

Phrase: "A."
Processing 00000000.tx.653: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.654: (1964) Endocrinology 74, 102-107[Medline] [OrderarticleviaInfotrieve] Monroe, S. 

Phrase: "(1964"

Phrase: ")"

Phrase: "Endocrinology 74,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: "102-107"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Monroe,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.655: E., Jaffee, R. 

Phrase: "E.,"

Phrase: "Jaffee,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.656: B., and Midgley, A. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Midgley,"

Phrase: "A."
Processing 00000000.tx.657: R., Jr. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.658: (1972) J. 

Phrase: "(1972"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.659: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.660: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.661: 34, 420-422[Medline] [OrderarticleviaInfotrieve] Wise, P. 

Phrase: "34,"

Phrase: "420-422"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wise, P."
Processing 00000000.tx.662: M., and Ratner, A. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Ratner,"

Phrase: "A."
Processing 00000000.tx.663: (1980) Neuroendocrinology 30, 15-19[Medline] [OrderarticleviaInfotrieve] Olson, D. 

Phrase: "(1980"

Phrase: ")"

Phrase: "Neuroendocrinology 30,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027827:Neuroendocrinology [Biomedical Occupation or Discipline]

Phrase: "15-19"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Olson,"

Phrase: "D."
Processing 00000000.tx.664: R., and Blake, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Blake,"

Phrase: "C."
Processing 00000000.tx.665: A. 

Phrase: "A."
Processing 00000000.tx.666: (1991) Neuroendocrinology 53, 124-133[Medline] [OrderarticleviaInfotrieve] Burger, L. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Neuroendocrinology 53,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027827:Neuroendocrinology [Biomedical Occupation or Discipline]

Phrase: "124-133"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Burger,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0452929:Burger [Food]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.667: L., Dalkin, A. 

Phrase: "L., Dalkin,"

Phrase: "A."
Processing 00000000.tx.668: C., Aylor, K. 

Phrase: "C.,"

Phrase: "Aylor,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.669: W., Workman, L. 

Phrase: "W., Workman,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.670: J., Haisenleder, D. 

Phrase: "J.,"

Phrase: "Haisenleder,"

Phrase: "D."
Processing 00000000.tx.671: J., and Marshall, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Marshall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551881:Marshall [Population Group]

Phrase: "J."
Processing 00000000.tx.672: C. 

Phrase: "C."
Processing 00000000.tx.673: (2001) Endocrinology 142, 3435-3442[Abstract/Free FullText] Lee, J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Endocrinology 142,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: "3435-3442"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lee,"

Phrase: "J."
Processing 00000000.tx.674: Y., Cole, T. 

Phrase: "Y.,"

Phrase: "Cole,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.675: B., Palmiter, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Palmiter,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.676: D., Suh, S. 

Phrase: "D."

Phrase: ","

Phrase: "Suh,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416171:SUH [Gene or Genome]
  1000   C1422188:SUH [Gene or Genome]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.677: W., and Koh, J. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Koh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071767:KOH [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "J."
Processing 00000000.tx.678: Y. 

Phrase: "Y."
Processing 00000000.tx.679: (2002) Proc. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.680: Natl. 

Phrase: "Natl."
Processing 00000000.tx.681: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.682: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.683: U. 

Phrase: "U."
Processing 00000000.tx.684: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.685: A. 

Phrase: "A."
Processing 00000000.tx.686: 99, 7705-7710[Abstract/Free FullText] Wang, J., Tanila, H., Puolivali, J., Kadish, I., and van Groen, T. 

Phrase: "99,"

Phrase: "7705-7710"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wang,"

Phrase: "J.,"

Phrase: "Tanila,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Puolivali,"

Phrase: "J.,"

Phrase: "Kadish,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "van Groen,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.687: (2003) Neurobiol. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.688: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.689: 14, 318-327[CrossRef][Medline] [OrderarticleviaInfotrieve] Konishi, I., Kuroda, H., and Mandai, M. 

Phrase: "14,"

Phrase: "318-327"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Konishi,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Kuroda,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Mandai,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.690: (1999) Oncology 57, Suppl. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Oncology 57,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0278627:Oncology [Biomedical Occupation or Discipline]
   789 E C0205478:Oncologic [Biomedical Occupation or Discipline]

Phrase: "Suppl."
Processing 00000000.tx.691: 2, 45-48[CrossRef][Medline] [OrderarticleviaInfotrieve] Andersson, A. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "45-48"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Andersson,"

Phrase: "A."
Processing 00000000.tx.692: M., Toppari, J., Haavisto, A. 

Phrase: "M."

Phrase: ","

Phrase: "Toppari,"

Phrase: "J.,"

Phrase: "Haavisto,"

Phrase: "A."
Processing 00000000.tx.693: M., Petersen, J. 

Phrase: "M."

Phrase: ","

Phrase: "Petersen,"

Phrase: "J."
Processing 00000000.tx.694: H., Simell, T., Simell, O., and Skakkebaek, N. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Simell,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Simell,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Skakkebaek,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.695: E. 

Phrase: "E."
Processing 00000000.tx.696: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.697: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.698: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.699: Metab. 

Phrase: "Metab."
Processing 00000000.tx.700: 83, 675-681[Abstract/Free FullText] Boyar, R., Finkelstein, J., Roffwarg, H., Kapen, S., Weitzman, E., and Hellman, L. 

Phrase: "83,"

Phrase: "675-681"

Phrase: "[Abstract/Free FullText"

Phrase: "] Boyar,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Finkelstein,"

Phrase: "J.,"

Phrase: "Roffwarg,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kapen,"

Phrase: "S."

Phrase: ","

Phrase: "Weitzman,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Hellman,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.701: (1972) N. 

Phrase: "(1972"

Phrase: ")"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.702: Engl. 

Phrase: "Engl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414400:ENGL [Gene or Genome]
Processing 00000000.tx.703: J. 

Phrase: "J."
Processing 00000000.tx.704: Med. 

Phrase: "Med."
Processing 00000000.tx.705: 287, 582-586[Medline] [OrderarticleviaInfotrieve] Takashima, S., Kuruta, H., Mito, T., Nishizawa, M., Kunishita, T., and Tabira, T. 

Phrase: "287,"

Phrase: "582-586"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Takashima,"

Phrase: "S."

Phrase: ","

Phrase: "Kuruta,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mito,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002475:MITO [Antibiotic,Organic Chemical]
  1000   C1624538:mito [Plant]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nishizawa,"

Phrase: "M."

Phrase: ","

Phrase: "Kunishita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Tabira,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.706: (1990) Brain Dev. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Brain Dev."
Processing 00000000.tx.707: 12, 367-371[Medline] [OrderarticleviaInfotrieve] Goedert, M., Jakes, R., Crowther, R. 

Phrase: "12,"

Phrase: "367-371"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.708: A., Six, J., Lubke, U., Vandermeeren, M., Cras, P., Trojanowski, J. 

Phrase: "A.,"

Phrase: "Six,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205452:Six [Quantitative Concept]

Phrase: "J.,"

Phrase: "Lubke,"

Phrase: "U.,"

Phrase: "Vandermeeren,"

Phrase: "M."

Phrase: ","

Phrase: "Cras,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.709: Q., and Lee, V. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.710: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.711: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.712: Natl. 

Phrase: "Natl."
Processing 00000000.tx.713: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.714: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.715: U. 

Phrase: "U."
Processing 00000000.tx.716: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.717: A. 

Phrase: "A."
Processing 00000000.tx.718: 90, 5066-5070[Abstract] Berezovska, O., Xia, M. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "5066-5070"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Berezovska,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Xia,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.719: Q., Page, K., Wasco, W., Tanzi, R. 

Phrase: "Q., Page,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704732:Page [Intellectual Product]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.720: E., and Hyman, B. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.721: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.722: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.723: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.724: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.725: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.726: 56, 40-44[Medline] [OrderarticleviaInfotrieve]

Phrase: "56,"

Phrase: "40-44"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]"

